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Chapter 1
An acquired brain injury is an injury caused to the brain since birth, which means 
it is not hereditary, congenital, degenerative or induced by birth trauma. Acquired 
brain injury can be classified as either a traumatic (e.g. traumatic brain injury 
(TBI)) or non-traumatic injury (e.g. subarachnoid hemorrhage (SAH), tumor, stroke, 
encephalitis)[1]. Acquired brain injury is a rapidly growing public health problem, 
and affects clinical outcome and quality of life of survivors[2]. It has profound 
implications for individuals, relatives and society, since it often results in physical, 
cognitive, emotional and social changes[3]. The most common causes of acquired 
brain injury include TBI and stroke, which are leading causes of injury-related death 
and disability worldwide[2, 4-7]. 
In the past decades, mortality due to TBI and stroke have decreased substantially, 
however, equivalent reductions in disability have remained behind[8, 9]. Additionally, 
besides the fact that TBI and stroke are major public health problems, they also 
impose high health care costs on individuals and society and the consequential 
economic burden on patients and health care systems are tremendous[10-12]. 
Economic evaluations have become an integral part in decision making for patients 
with TBI and stroke. Well-founded evaluations of implementation of cost-effective 
treatments, allocation of resources, prevention intervention, identifying best 
practices and quality of care, and assessing future care demand have become 
essential for informing decisions by policy- and decision makers[10]. More research 
into health (e.g. functional outcome and quality of life) and economic outcomes of 
TBI and stroke is fundamental. 
In this thesis we address two important and majorly discussed subjects in TBI and 
stroke research. First, we focus on outcome assessment following mild TBI, with an 
emphasis on prevalence, risk factors, classification and pre-injury reporting of post-
concussion symptoms. Second, we focus on individual preferences for specific TBI 
and stroke related outcomes.
This chapter will introduce concepts related to assessing outcome and preferences 
for TBI and stroke. Subsequently, the research questions will be addressed and an 
outline of this thesis will be provided. 
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1Acquired Brain Injury
Traumatic Brain Injury
Traumatic Brain Injury (TBI) is defined as “an alteration in brain function, or other 
evidence of brain pathology, caused by an external force”[13, 14]. TBI has 
tremendous economic repercussions, considering it is costing the global economy 
approximately $US400 billion per year[4]. Annually, 50-60 million new TBI cases 
occur worldwide and over 80% are in developing countries[4]. Approximately one 
out of two people in the world’s population will experience a TBI during their lifetime. 
In the European Union (EU; 28 Member States), around 2.5 million new cases of TBI 
occur each year(1)(Panel 1). 
Panel 1. Statistics concerning traumatic brain injury
Source: Infographic CENTER-TBI      
Abbreviations. TBI, traumatic brain injury; US, United States; EU, European Union.
The severity of TBI ranges from mild TBI (mTBI) to moderate and severe.[1] The 
vast majority of patients presenting to hospital with a TBI are diagnosed as having 
mild TBI (mTBI; Glasgow Coma Score (GCS): 13-15).[4, 15] Furthermore, additional 
diagnostic criteria such as loss of consciousness (LOC) and the presence and 
duration of posttraumatic amnesia (PTA) are frequently used.[16] On top of this, 
mTBI could also be conceptualized into subgroups, since some patients may 
have intracranial abnormalities on the computed tomography (CT) performed on 
presentation to hospital.[17] Using this information, a more detailed differentiation 
for patients with mTBI can be made: patients with a complicated (intracranial 
abnormalities present on CT) and uncomplicated (no intracranial abnormalities 
present on CT) mTBI.[17]
50 million people suffer 
from a TBI worldwide 
every year - over 80% in 
developing countries
Annual global costs of 
care and consequences 
of TBI are up to US$400 
billion
57 000 TBI-related 
deaths and 1.5 million 
hospitalisations occur in 
the EU-28 every year
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Stroke 
Stroke is defined by The World Health Organization (WHO) as: “a clinical syndrome 
consisting of rapidly developing clinical signs of focal (or global in case of coma) 
disturbance of cerebral function lasting more than 24 hours or leading to death 
with no apparent cause other than a vascular origin.” The arteries leading to and 
within the brain are affected by this disease. It is the second leading cause of 
death worldwide[18] and its incidence is increasing due to an ageing population.[7] 
Strokes can be divided up in two types: ischemic or hemorrhagic, and the majority 
(80%) of strokes are ischemic.[19] 
Functional outcome in case of stroke outcome is measured by the modified Rankin 
Scale (mRS), which is the most widely used clinical outcome measure in clinical 
trials concerning stroke.[20, 21] The mRS evaluates the degree of disability or 
dependence in daily life, and is measured on an ordinal scale consisting of seven 
grades ranging from 0 (no symptoms) to 6 (death) (Figure 1).[22]
Even though the causes of TBI and stroke are different, the consequences and effects 
are often very similar, since both result in physical, cognitive and psychological, 
and social dysfunction.[23] 
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Chapter 1
Part I - Outcome assessment following traumatic brain injury
TBI is considered as “the most complex disease in the most complex organ”[24] and 
it is known that no two TBIs are rendered exactly the same, thus the recovery after 
TBI leads to variability and uncertainty.[1] Consequently, it remains unclear why 
TBI affects some patients for a short period of time and others remain permanently 
disabled.[1, 25]
Over the past 25 years, a spotlight has been put on the need and importance of 
research into TBI and billions of dollars have been spent on research investment 
in TBI,[24] which has resulted in a better comprehension of the disease. However, 
besides all these efforts, substantial improvement in outcome for patients has been 
lagging behind.[24, 26] In addition, many questions remain unanswered regarding 
the impact of mTBI in specific. Mortality rates in patients after sustaining a mTBI are 
low, nevertheless, a considerable amount of patients experience several cognitive, 
somatic and emotional problems lasting for months or even years. Additionally, 
besides the objective burden, the experienced burden as described by patients 
themselves has become crucial in outcome research. For these reasons, outcome 
assessment in current research has undergone a transformation from focusing on 
mortality as an endpoint, to other outcome measurements such as clinical outcome, 
health-related quality of life (HRQoL) and post-concussion symptoms.[26, 27] 
Figure 1 shows an overview of the most important instruments and measurements 
scales used throughout this thesis. 
Clinical outcome
Clinical outcome describes the level of functioning, recovery and residual disability 
for TBI and stroke survivors.[28, 29] Levels of functioning in case of TBI outcome 
are frequently measured by use of the Glasgow Outcome Scale (GOS)[30] or the 
Glasgow Outcome Scale Extended (GOSE) [8, 29, 31] with a 5-point and an 8-point 
scale, respectively. These scales are both specifically designed to assess functional 
outcome after TBI and allocate patients who suffered acute brain damage into broad 
categories of functional outcome.[29] The GOSE instrument evaluates functional 
outcome through eight categories encompassing consciousness, independence 
at home and outside the home, work, social and leisure activities, family and 
friendship, and return to normal life.[30] An eight point scale ranging from 1 (dead) 
to 8 (completely recovered) is established from these categories, which has the 
ability to distinguish among functional outcomes (Figure 1). The GOS/GOSE are 
the most widely used functional measurement scales after TBI, however, they have 
been criticized since they do not represent a patient’s self-reported experience of 
their health[31] and especially for patients with mTBI, the majority of patients will be 
categorized in the upper level categories.[32] 
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1Post-concussion symptoms and syndrome 
Many patients following mTBI experience post-concussion symptoms, which 
manifest as physical symptoms (e.g., headaches, dizziness, blurred vision, fatigue, 
and sleep disturbances), cognitive deficits (e.g., poor memory, and attention and 
executive difficulties), and behavioral/emotional symptoms (e.g., depression, 
irritability, anxiety-related disorders, and emotional lability).[16, 33] For the majority 
of patients these symptoms will resolve and/or diminish spontaneously within weeks 
to months after the injury[34]. However, a subgroup of patients (estimated between 
5%–43%[35-38]), have lasting post-concussion symptoms for weeks, months or 
even longer. When a set of these symptoms persist for over 3 months, it is often 
referred to as post-concussion syndrome (PCS).[37, 38] The presence of PCS is 
generally determined by the International Classification of Diseases,10th revision 
(ICD-10)[39] and the Diagnostic and Statistical Manual of Mental Disorders, 4th 
edition (DSM-IV).[33] Post-concussion symptoms are usually measured by self-
report questionnaires. The Rivermead Post-Concussion Symptoms Questionnaire 
(RPQ) is a frequently used instrument to assess the presence and severity of post-
concussion symptoms.[40] Patients are asked to rate the severity of 16 different 
post-concussion symptoms, commonly found after TBI, over the past 24 hours 
in comparison to before the injury (Figure 1). There is currently no gold standard 
concerning the use of the RPQ to classify PCS, and besides the RPQ total score,[40] 
there are multiple different evaluation methods including: dividing the scale up in 
two (RPQ3 and RPQ13),[41] or dividing it up in three (cognitive, emotional and 
somatic) subscales.[42, 43] Furthermore, aside from heterogeneity in usage of the 
RPQ for classification of PCS, there is currently no ground rule in place on whether 
symptoms should be incorporated if they are rated as 2 (mild problem or worse) 
or only if they are rated as 3 (moderate problem or worse). Another instrument to 
assess post-concussion symptoms is the Head Injury Symptom Checklist (HISC), 
which consists of 21 frequently reported symptoms after TBI, and patients are 
asked to rate these symptoms for the situation before the injury and after the injury, 
e.g. during the last week (Figure 1). [44]
Health-related quality of life (HRQoL)
The WHO has defined Quality of Life (QoL) as follows: “an individual’s perception 
of their position in life in the context of the culture and value systems in which they 
live and in relation to their goals, expectations, standards and concerns. It is a 
broad ranging concept affected in a complex way by the person’s physical health, 
psychological state, personal beliefs, social relationships and their relationship 
to salient features of their environment”.[45] The definition of QoL is very broad 
and for this reason the concept of HRQoL was introduced.[46] HRQoL reflects 
an individual’s perception of how an illness and its treatment affect the physical, 
mental, and social aspects of his or her life.[46-48] When comparing HRQoL to 
functional outcomes scales, it is seen as a more thorough approach in measuring 
outcome.[26] 
Previously, it was assumed that HRQoL could not be rated adequately by patients 
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with TBI, since the brain damage, and especially the cognitive impairments, might 
influence a patients’ ability to self-report on their functioning and overall well-being.
[49] However, nowadays, it has become a central part in outcome assessment 
following TBI.[47, 50] Additionally, two patients with TBI and exactly the same 
GOSE score, may have dramatically different HRQoL responses. These responses 
are influenced by the perspective on their own subjective health. This amplifies the 
importance of HRQoL measurement in TBI research. 
Generic versus disease specific measurements
HRQoL can be measured by two approaches: generic and disease specific 
instruments (Figure 1). Generic HRQoL questionnaires, such as the 36-item Short-
Form Health Survey (SF-36), Perceived Quality of Life Scale (PQoL) and EuroQol 
5D (EQ-5D), allow for comparison of health across disease states and populations. 
The SF-36 instrument is a multidimensional self-report questionnaire consisting of 
36 questions assessing eight domains of health.[51] A physical and mental health 
summary component scores can be generated from the weighted sums of the 
subscales.[52] The SF-36 has been determined as the most widely used instrument 
to assess HRQoL after TBI.[47]
The PQoL instrument is seen as a measure of global life satisfaction and particularly 
measures an individual’s satisfaction with their functional status. It contains 19 
items in three different domains (physical health, cognitive health and social health) 
and has an 11-point scale ranging from 0 (extremely dissatisfied) to 10 (extremely 
satisfied).[53] Good internal reliability was shown for the PQoL in a TBI population.
[54]
The EQ-5D[55] consists of two different components: the EQ-5D descriptive system 
(health state description) and the EQ visual analogue scale (EQ VAS)(evaluation). 
The EQ-5D descriptive system covers five dimensions (mobility, self-care, usual 
activities, pain/discomfort, and anxiety/depression). Nowadays, there are two 
formats of the EQ-5D descriptive classification systems: EQ-5D-3L and EQ-5D-5L.
[56] Differences between the two are based on the number of response categories 
per dimension. The expansion to five levels was done to increase the sensitivity and 
reduce the ceiling effect.[57] The EQ VAS is a vertical scale ranging from 0 (worst 
imaginable health state) to 100 (best imaginable health state).[55]
Nonetheless, generic HRQol questionnaires have been sharply criticized,[48, 58] 
since generic instruments may not always be particularly sensitive to or adequately 
assess specific aspects of HRQoL associated with a disease,[50] such as cognitive 
functioning in the case of TBI.[48, 59] Therefore, condition-specific questionnaires 
have been developed. The Quality of Life after Brain Injury (QOLIBRI)[48] and 
Quality of Life after Brain Injury overall scale (QOLIBRI-OS)[60] are TBI-specific 
instruments. This means they assess HRQoL of individuals by measuring areas and 
domains of health typically affected after sustaining a TBI.[61] 
The QOLIBRI consists of 37 items covering six dimensions of HRQoL after TBI, 
which measure physical, psychological, daily life and psychosocial changes typical 
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1for TBI.[23] The six dimensions encompasses four “satisfaction” and two “feeling 
bothered” dimensions.[62] The QOLIBRI-OS is a short, six-item version of QOLIBRI 
and assesses a single overall score, which provides a brief summary measure of 
HRQoL.[60] For both instruments, a 5-point Likert scale ranging from “not at all 
satisfied/bothered” to “very satisfied/bothered” is used to record responses. These 
condition-specific instruments are on occasion used in combination with generic 
measures.
Generally, self-rating is used to acquire measurements of these HRQoL instruments, 
however, when a patient has severely impaired cognition, proxies, or in other words, 
someone who knows the patient well (e.g. parent/partner), are used.[31] 
Part II - Preferences for outcome in traumatic brain injury
Economic evaluation studies
A method for evaluating choices and decision making in reimbursement, health care 
resource allocation, and quality of care and clinical effectiveness measurements 
is economic evaluation.[63] Economic evaluations are a quantitative evaluation 
between two or more interventions on both the costs and outcomes.[63] It gives a 
complete overview of the impact on, and representation of a cost-effective use of 
limited health care resources. Different types of economic evaluation techniques 
exist, and the type is dependent on how the outcome is assessed. The four major 
types of economic evaluation methods are: cost-effectiveness analysis (CEA), cost-
utility analysis (CUA), cost-benefit analysis and cost-minimization analysis (CMA). 
In CEA the outcomes are measured by natural units (e.g. life years gained, years 
of life saved, hospital days prevented etc.).[64] Cost-effectiveness analyses have 
become an integral part of decision making processes in TBI[10, 11] and stroke[12] 
research since both diseases have high economic costs. CUA measures outcomes 
in units that relate to a person’s level of wellbeing. It determines costs in terms of 
utilities, and measures outcomes in terms of quantity and quality.[65] Ultimately, it 
combines this into a single measure (e.g. Quality-adjusted life year (QALY)).[66] 
QALY
QALY is a measure in which a quantitative measure (months/years gained) and 
qualitative measure (e.g. EQ-5D) are combined[67] into a single index.[68]  It 
permits comparisons of interventions across different disease states. QALY’s are 
derived from the number of life years multiplied by the quality of life experienced 
during these years, which is expressed in health utility weights (Figure 2).[63] 
Calculating QALYs is done by use of the following formula:
In this formula, y is the amount of life years lived in a health state, v(q) is the utility 
value associated with a given health state.[69] In a number of countries, such as the 
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Netherlands and United Kingdom, the ED-5D is specified as its preferred method 
of utility measurement.[70]
Figure 2. Quality-adjusted life year (QALY)
Adapted from: By Jmarchn - Own work, CC BY-SA 3.0, https://commons.wikimedia.org/w/index.
php?curid=67001576
Health utility indices
The responses on generic and disease specific measurements represent 
preferences for health states measured by these instruments. Nevertheless, to be 
able to use these responses in economic evaluations, they have to be converted into 
utility weights. Utilities are anchored on a scale ranging from 0 (death) to 1 (perfect 
health). A less than 0 value is given to health states which are reported to be worse 
than dead.[71] Utility weights represent the relative preference for a year of life in a 
given health state. Preferences can be equated with value or desirability,[72] which 
means that health state utilities are based on preferences for these diverse health 
states. Furthermore, a greater weight is given to a more desirable/preferred health 
state,[63, 73] which leads to a ranking of health states. 
Value set 
To assign utilities to each health state described by generic or disease specific 
measurements, an algorithm is used, which is called a value set.[74] A value set 
converts each health state into a single index value, which means that each of 
the levels in each dimension has a value (weight) assigned to it. In other words, 
a value set is a collection of index values for all possible health states described 
in an instrument. When looking at the EQ-5D, a value set provides weights to 
Time (years)
Perfect 
health
Dead
Health-related 
Quality of Life
Death Death
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1each of the levels in each EQ-5D dimension.[75] Additionally, a value set has the 
ability to summarize general population preferences for health states that could 
be experienced by patients and the HRQoL of patients can be compared with 
other (patient) groups. Nowadays, in economic evaluations, value sets for generic 
instruments (e.g. EQ-5D)[76] are widely available and are used extensively.[74] 
Every so often, there is no value set available for an instrument, and to make these 
instruments suitable for use in economic evaluations, a value set needs to be 
generated by means of a preference elicitation method.  
Preferences in a value set can be based on a variety of preference elicitation 
methods and the valuation of preferences could be performed by different groups 
of people. 
Preference elicitation methods 
There are different preference elicitation methods for deriving preference based 
weights for a health state. These methods could be direct or indirect.[73] Direct 
methods for data collection on utilities include the Visual Analogue Scale (VAS), 
standard gamble (SG), time trade-off (TTO) and discrete choice experiment (DCE).
[77-79] The VAS is a valuation technique that records participants’ views about 
hypothetical health states on a scale from 0 (worst imaginable health state) to 100 
(best imaginable health state)(Figure 3).[80]
DCEs are increasingly being promoted among elicitation methods,[78] and 
makes it possible to generate values for alternatives in hypothetical situations or 
conditions that cannot be judged in the real world[81]. DCE questions consist of 
a pair of health states (labelled Health state A and Health state B, Figure 4) with 
no implication concerning the time of the health states, and respondents have to 
decide which health state they would prefer. Ultimately, the responses are utilized 
to generate preferences and to estimate the impact of altering severity and different 
combinations of health states on these preferences.[80]
Indirect methods obtain health state values by indirectly mapping preferences onto 
the utility scale via a HRQoL questionnaire and  afterwards predetermined value 
sets are applied to these questionnaire responses.[82] The main indirect methods 
of utility measurement are: the use of generic preference instruments (e.g. EQ-5D, 
SF-36); the use of disease specific measures (e.g. QOLIBRI, QOLIBRI-OS, GOSE); 
and mapping or cross-walking from disease specific instrument to a generic 
instrument (e.g. SF-36 to GOSE).[83] 
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Figure 3. Visual Analogue Scale (VAS)
Adapted from: the EuroQol Group: www.euroqol.org
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1Figure 4. Discrete Choice Experiment (DCE)
General population versus patient valuation
The valuation of preferences using different preference elicitation methods 
can be performed by either patients, patient proxies, members of the general 
population, or health professionals.[84] The responses on the valuation task reflect 
the preferences between different health states,[85] and are eventually used to 
generate and model value sets. The general public values a health state usually 
lower (‘worse’) compared to the values for equivalent health states elicited from 
patients.[86] There are arguments in favor and against either valuation population, 
however, valuations based on preferences of the general population are currently 
being used in practice in the United Kingdom.[73] 
DALY
In current CUA research, besides QALYs, there is also another outcome measure 
being used frequently, which is portrayed in disability adjusted life years (DALYs)
(Figure 5).[87] The difference between QALYs and DALYs is that QALYs measure 
years lived in perfect health and DALYs measure years in perfect health lost.[88] 
DALYs represent the overall disease burden expressed in the number of years lost 
due to ill-health, disability or death, and combines mortality and morbidity in one 
single index measure. DALYs are the sum of two components: the Years of Life Lost 
(YLL) due to premature death, and the Years Lost due to Disability (YLD) for people 
living with the health condition or its consequences.[89] DALYs are calculated by 
use of the following formula:  
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n is the number of deaths due to the disease and l is the standard life expectancy 
at age of death in years
i is the number of incident cases, dw is disability weight and l is the average duration 
of the case until remission or death in years.[69, 89, 90]
Figure 5. Disability adjusted life year (DALY)
Adapted from: PlanemadVector:Radio89 - This file was derived from: DALY disability affected life year 
infographic.png:, CC BY-SA 3.0, https://commons.wikimedia.org/w/index.php?curid=20278903
Disability weights
Levels of loss of functioning caused by diseases is represented in disability weights, 
which are a key component in DALY calculations. The disability weight demonstrates 
the impact of a disease or injury and is measured on a scale with values ranging 
from 0, corresponding to perfect health, to 1, corresponding to death.[91] Disability 
weights are assigned to health states by a panel of judges, which could be patients, 
proxies, medical experts, or members from the general population, but can also be 
derived using multi-attribute utility instruments.
DALY
Disability Adjusted Life Year is 
a measure of overall disease 
burden, expressed as the 
cumulative number of years 
lost due to ill-health, disability 
or early death
YLD
Years Lived with Disability
YLL
Years of Life Lost= +
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1Aims and outline of this thesis
The main aim of this thesis is to expand our knowledge on assessing outcome 
following traumatic brain injury, and measuring outcome preferences for traumatic 
brain injury and stroke among patients and the general population. We used a wide 
range of methods, including analysis of prospective observational longitudinal 
patient data, survey data of the general population, and a simulation study. 
The aim of this thesis is operationalized in the following research questions:
1. What is the association between post-concussion symptoms and HRQoL
 in mTBI?
a. What is the outcome in divergent mTBI patient groups?  
b. What are the prevalence and risk factors of post-concussion symptoms in  
 mTBI patients and the general population? 
c. How can we classify post-concussion symptoms and post-concussion   
 syndrome after mTBI and to what extent are pre-injury ratings reliable? 
2. What are preferences and utility weights for TBI and stroke health states  
 and how could they be applied? 
a. What are preferences of the general population for disease specific   
 outcome measures for TBI and which utility weights can be assigned to 
 TBI value sets? 
b. How can value sets and patient data be u used to determine utility and/or  
 disability weights for TBI and stroke health states?
This thesis consists of two parts. Part I (Chapter 2-8) describes the association 
between post-concussion symptoms and HRQoL in mTBI and assesses the 
outcome following mTBI, the prevalence and risk factors of post-concussion 
symptoms in patients with mTBI and the general population and lastly, classifies 
post-concussion symptoms.
Chapter 2 provides the prevalence and risk factors of post-concussion symptoms, 
and functional outcome of mTBI patients and an overview on different classification 
methods for post-concussion syndrome. Chapter 3 examines the impact of post-
concussion symptoms on HRQoL for patients with mTBI. Chapter 4 and 5 study the 
prevalence rates of post-concussion symptoms and outcome following divergent 
mTBI patient groups. Chapter 6 describes the prevalence and risk factors of post-
concussion-like symptoms in the general population of three European countries. 
Chapter 7 determines the prevalence and prediction of post-concussion symptoms 
in children and adolescents with mTBI. Chapter 8 assesses the ratings of pre-injury 
symptoms in patients with mTBI over time. 
In Part II (Chapter 9-12) of this thesis we examine the preferences and utility weights 
for TBI and stroke health states and their application. Chapter 9 starts with the 
elicitation of preferences and development of value sets for a TBI specific instrument 
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to measure HRQoL in three European countries. Chapter 10 describes the 
assessment of impact following TBI by developing disability weights for a functional 
outcome instrument and uses HRQoL data of patients with TBI to achieve this. 
Chapter 11 describes a simulation study in which we evaluate statistical efficiency 
of a new outcome measure in stroke research. Reference values from the general 
Dutch and United Kingdom population are developed for a TBI specific instrument 
to assess HRQoL in Chapter 12.
This thesis is part of the Collaborative European NeuroTrauma Effectiveness 
Research in Traumatic Brain Injury (CENTER-TBI) project, which has received 
funding from the European Union Framework Program (FP7 2007-2013) under 
grant agreement n° 602150. Additional funding was obtained from the Hannelore 
Kohl Stiftung (Germany), from OneMind (USA) and from Integra LifeSciences 
Corporation (USA). CENTER-TBI is a prospective longitudinal observational cohort 
study on patients of all severities of TBI, presenting between December 19, 2014 and 
December 17, 2017, to centers across Europe and Israel. The main project aims are 
to better characterize TBI as a disease, and describe it in a European context and 
identify the most effective clinical interventions for managing TBI. Specific aims, 
which are addressed in this thesis, are to refine and improve outcome assessment 
and develop health utility indices for TBI.
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Abstract
Mild traumatic brain injury (mTBI) is a common diagnosis and approximately one 
third of mTBI patients experience a variety of cognitive, emotional, psychosocial, 
and behavioral post-concussion symptoms. When a cluster of these symptoms 
persists for more than 3 months they are often classified as post-concussion 
syndrome (PCS). The objective of this study was to determine prevalence rates, risk 
factors and functional outcome associated with PCS 6 months after mTBI, applying 
divergent classification methods. Follow-up questionnaires at 6 months after mTBI 
included the Rivermead Post-Concussion Symptoms Questionnaire (RPQ) and the 
Glasgow Outcome Scale Extended (GOSE). The RPQ was analyzed according 
to different classification methods: the mapped International Classification of 
Diseases, 10th revision (ICD-10)/Diagnostic and Statistical Manual of Mental 
Disorders, 4th edition (DSM-IV), the RPQ total score, the RPQ3 and the three-factor 
model using two different cutoff points (mild or worse and moderate or worse). Our 
results from a sample of 731 mTBI patients showed that prevalence rates of PCS 
ranged from 11.4% to 38.7% using divergent classification methods. According 
to all eight methods, 6.3% (n=46) of mTBI patients experienced PCS. Applying 
the divergent classification methods resulted in a different set of predictors being 
statistically significantly associated with PCS, and a different percentage of overlap 
with functional impairment, measured with the GOSE.  In conclusion, depending on 
the classification method and rating score used, prevalence rates of PCS deviated 
considerably. For future research, consensus regarding the diagnostic criteria for 
PCS and the analysis of the RPQ should be reached, to enhance comparability of 
studies regarding PCS after mTBI. 
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Introduction
Traumatic brain injury (TBI) is a leading cause of death and disability worldwide 
with an annual incidence of 262 per 100,000 admitted TBI patients in Europe.[1] 
The large majority (70-80%) of all TBI cases are evaluated as mild TBI (mTBI). In the 
first weeks following mTBI, many patients experience post-concussion symptoms 
comprising physical symptoms (e.g., headaches, dizziness, blurred vision, fatigue 
and sleep disturbances), cognitive deficits (e.g., poor memory, and attention and 
executive difficulties), and behavioral/emotional symptoms (e.g., depression, 
irritability, anxiety-related disorders, emotional lability).[2] For most patients, these 
symptoms will diminish spontaneously,[3] but for a subset of patients (estimated 
between 5%–43%[4-9]) symptoms last for months and sometimes even longer. 
When a set of symptoms persists for >3 months, it is often referred to as post-
concussion syndrome (PCS).
It is challenging to define PCS, because there is no consensus as to the criteria 
for diagnosis.[10] The most used criteria for diagnosis are those specified in 
the International Classification of Diseases, 10th revision (ICD-10)[11] and the 
Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV).[2] Even 
though the ICD-10 and DSM-IV classifications deviate, they both include a brain 
injury with potential loss or alteration of consciousness, and the existence of certain 
symptoms. A frequently used instrument to assess the presence and severity of post-
concussion symptoms is the Rivermead Post-Concussion Symptoms Questionnaire 
(RPQ).[12] The RPQ was developed by King and colleagues, who proposed to use 
the total scale score for analyses.[12] Subsequently, other evaluation methods have 
been applied. Potter and colleagues proposed a ≥ 12 cutoff for the total scale score.
[13] Eyres and colleagues suggested the use of a two subscale version, one scale 
containing three items (RPQ3) and one containing 13 items (RPQ13), because of 
a possible lack of unidimensionality for the RPQ total scale.[14] Smith-Seemiller 
and colleagues recommended a modified scoring system with three subscales 
(cognitive, emotional and somatic symptoms) or two subscales (collapsing somatic 
and emotional symptoms versus cognitive symptoms) to be more sensitive.[13, 15] 
The majority of studies, however, mapped the ICD-10 or DSM-IV criteria to the RPQ.
[16-18]. Patients are subsequently classified with PCS if they report at least three 
out of the following symptoms: headaches, dizziness, fatigue, irritability, impaired 
memory, impaired concentration, and insomnia. In addition to heterogeneity in 
classification methods, there is also no consensus on whether symptoms should be 
incorporated in the rating for PCS if they are rated as 2 (mild problem) or worse or 
only if they are rated as 3 (moderate problem) or worse.[19, 20]
An abundance of studies are being done in the field of PCS regarding predictors 
and prediction modeling.[20-22] We investigated whether classification methods 
have different predictors or have more predictive power, and expected that 
different risk factors would be significant depending on the classification method 
used. Advances and developments in prediction modeling are difficult, because an 
unambiguous definition for PCS is missing, and it is possible that different predictors 
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are associated with PCS according to divergent classification methods.[20]
The application of different classification methods and cutoffs may lead to 
incomparability of studies assessing PCS. The main objective of this study was to 
examine how the four divergent classification methods and two different rating scores 
as cutoff defining PCS using the RPQ differ among patients 6 months after mTBI. 
First, descriptive analyses were done according to the four classification methods. 
Subsequently, the sample was analyzed on whether the risk factors predicting 
PCS differed across PCS classification methods, and lastly, the association with 
the clinically relevant Glasgow Outcome Scale Extended (GOSE) and different 
classification methods was observed. We expect differences in prevalence of PCS 
per classification method. We also hypothesize differences in predictors associated 
with PCS according to the divergent classification methods. Additionally, it was 
hypothesized that the functional outcome, measured by the GOSE, would differ, 
depending on the classification method used.
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Methods
Study design 
Data were obtained from the prospective observational Radboud University Brain 
Injury Cohort Study (RUBICS).[23-26] All patients with mild, moderate or severe TBI 
admitted between January 1998 and December 2010 to the emergency department 
(ED) of the Radboud University Medical Centre (RUNMC), a level I trauma center in 
the Netherlands, were included in the database. The ethical standards committee 
of the RUNMC had approved this study. 
Study participants
In the current study, 797 patients were selected from the RUBICS database based 
on the following inclusion criteria: patients’ age was ≥16 years, written informed 
consent was given by patients (or guardians), patients had mTBI and were admitted 
to the ED of RUNMC between January 2003 and June 2010. Diagnosis of mTBI was 
based on a Glasgow Coma Scale (GCS) score of 13-15 after initial resuscitation 
or followed by sedation and intubation during resuscitation for a non-neurological 
cause. Exclusion criteria were alcohol or drug abuse or dementia, unknown 
address, and not being able to speak or write Dutch. We selected 92% (n=731) of 
mTBI patients who completed the RPQ (filled in all items) at 6 month follow-up for all 
analyses throughout this study.  
Measurements 
Clinical data were registered in the ED at admission by a neurologist and/
or neurosurgeon and entered by a research nurse into the RUBICS databank. 
Demographic data (age, sex, and educational level), trauma mechanism, 
hospitalization, clinical variables, comorbidities, functional outcome (GOSE), and 
the RPQ were all collected with a postal questionnaire, which was self-rated by 
patients or guardians at 6 months after the trauma. Structured interviews during 
regular visits to the outpatient clinic or during consultation by telephone were used 
to determine GOSE scores.[27]  
Assessment of persistent post-concussion symptoms and diagnosis of PCS 
The prevalence rates and severity of persistent post-concussion symptoms were 
assessed with the postal RPQ at 6 month follow-up. Patients were asked to rate 
the severity of 16 different symptoms, commonly found after TBI, over the past 24 
h. In each case, the symptoms were compared with how severe they had been 
before the injury occurred (premorbid). The patient was asked to rate the symptoms 
on a five-point Likert scale: 0 (not experienced at all), 1 (not a problem), 2 (mild 
problem), 3 (moderate problem) and 4 (severe problem).
In the literature, there is not a gold standard concerning the use of the RPQ. 
Therefore, we used the following classification methods to classify patients as 
having PCS: mapped ICD-10/DSM-IV, RPQ total score[12], RPQ 3,[14] and three-
factor model (Table 1).[15] The mapped ICD-10/DSM-IV requires that three or more 
symptoms in the list in Table 1 reach cutoff, the RPQ3 requires that one or more 
symptoms in the list in Table 1 reach cutoff, the RPQ total score requires a sum 
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score of all items of the RPQ of ≥ 12, and the three- factor model requires that one 
or more items within each of the cognitive, emotional, and somatic scales reaches 
cutoff. For each classification method, we used two different rating scores as cutoff 
(≥ 2 and ≥ 3), resulting in eight different classification methods in total. Because 
no clear cutoff was found in the literature for the RPQ13, this scale was not taken 
into consideration. It should also be noted that the RPQ is based on self-report 
rather than clinical examination, and does not include information on the duration of 
the symptoms and clinically significant impairment. Therefore, it cannot accurately 
diagnose PCS.[20] 
Risk factors
Looking at the available data in our dataset and using previous literature [20-22], 
the variables age, gender, level of education, injury mechanism (assault vs. other 
mechanisms), Injury Severity Scale (ISS), Abbreviated Injury Score of the Head 
(AISH), comorbidity, traumatic abnormalities on the head computed tomography 
(CT) scan, and whether the patient was admitted to the hospital were considered 
as risk factors. We hypothesized that older age, female gender, lower years of 
education, higher ISS and AISH scores, comorbidity, abnormalities on CT, and 
being hospitalized would be associated with PCS. 
Functional outcome
Functional outcome was assessed using the 6 month GOSE, which was completed 
as a postal questionnaire. The GOSE is a functional measurement scale specifically 
designed for TBI.[28, 29] The instrument evaluates functional outcome through eight 
categories encompassing consciousness, independence at home and outside the 
home, work, social and leisure activities, family and friendship and return to normal 
life.[30] After accumulating these categories an eight point scale ranging from 1 
(dead) to 8 (completely recovered) is established, which has the ability to distinguish 
among functional outcomes. For 20 patients included in our study, the GOSE score 
was missing. When there was no available outcome at exactly 6 months, outcomes 
measured within a 2 month range were also approved. Functional impairment was 
classified as a GOSE score of ≤6.[27]
Statistical analysis
For demographic data (age, sex and educational level), trauma mechanisms, 
hospitalization, clinical injury variables and comorbidities, descriptive analyses 
were performed. Patients included in the current study were compared with those 
having incomplete RPQ data on demographic (gender, age, educational level) and 
clinical variables using Chi-Square tests (categorical variables) and Student’s t 
tests (continuous variables).
Prevalence of PCS using the eight divergent classification methods was determined 
by computing the percentage of patients meeting the specific criteria of each 
classification method. We subsequently determined overlap between classification 
methods by calculating the number and percentage of patients diagnosed with 
PCS according to multiple classification methods.
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The univariable associations between predictors and PCS according to multiple 
classification methods were explored by using Chi-Square tests (categorical 
variables) and an independent samples t test (continuous variables). All variables 
were included in a stepwise backwards multivariable logistical regression to 
identify significant risk factors (p < 0.05) of PCS. The association between PCS and 
functional impairment (GOSE ≤6) was determined by calculating the percentage 
of patients for each classification method of PCS that was functionally impaired. 
McNemar tests were used to see if the classification methods differed significantly 
in PCS/no PCS pattern at the population level, and a Cochran’s Q test was used 
to see if the classification methods differed significantly (p < 0.05) at an individual 
level. Multiple imputation technique with five datasets was used to impute missing 
data for the following predictor variables: education (182 missing), comorbidity 
(237 missing) and hospital admission (2 missing).
All statistical analyses were performed using SPSS version 21 for Windows (IBM 
SPSS Statistics, SPSS Inc, Chicago, IL).
Results
Study population 
In total, 731 mTBI patients were included in this study. Patients with a missing 6 
month RPQ (n = 66) did not differ from those included in this study, except that their 
median age was 54.5 (interquartile range [IQR]: 42.75-68), which was significant 
on a p < 0.01 level. The characteristics of our study sample are shown in Table 2. 
The median age of the respondents was 44 years and 63% were male. Almost half 
(48%) of the patients were injured in road traffic accidents and a third were injured 
due to falls. One out of five people had one or more comorbid conditions and ~ 13% 
showed abnormalities on the CT scan. Approximately 50% of the respondents were 
admitted to the hospital, and they were hospitalized for an average of 3 days. A total 
of 35 patients were admitted to the intensive care unit (ICU). 
Six-month persistent post-concussion symptoms 
The three most frequently reported symptoms on the 6 month RPQ were 
fatigue, forgetfulness/poor memory and poor concentration (Fig. S1) (see online 
supplementary material at http://www.liebertpub.com). Fatigue was experienced 
by 308 patients (42.1%), and 32 (4.4%) patients evaluated this as a severe 
problem. Nausea and/or vomiting was the least reported symptom (n=42, 5.7%). 
Approximately one-third of the patients (n=242) experienced none of the symptoms 
(total RPQ score of 0), whereas three patients had an RPQ score of 59, which 
means they experienced severe problems 6 months after the injury with almost 
every symptom on the list. Around 30% (n=234) had a total RPQ score of ≥ 12. The 
median score on the RPQ for the study population was 4 (IQR, 4 -15). 
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Prevalence rates of PCS according to the different classification methods
The use of divergent classification methods resulted in prevalence rates for 6 
month PCS ranging from 11.4% (three-factor model with rating score 3) to 38.7% 
(mapped ICD-10/DSM-IV with rating score 2; Figure 1 A and B). Classification 
methods overlapped substantially; for example, 95.6% (n =108) of patients who 
met the criteria for PCS according to the mapped ICD-10/DSM-IV with rating score 
2 also met the criteria for PCS according to the RPQ total score with rating score 2. 
The lowest amount of overlap was found for the classification methods RPQ3 and 
three-factor model with rating score 3 (n = 49, 51%) A total of 46 (6.3%) patients 
met the criteria for PCS according to all classification methods. When looking at the 
difference in PCS/no PCS pattern for the classification methods with rating score 2, 
a significant result was found for all classification methods, except for the mapped 
ICD-10/DSM-IV compared with the RPQ3 (p = 0.07) and the RPQ total score 
compared with the three-factor model (p = 0.81). For the classification methods 
with rating score 3, all had significant differences in pattern, except for the mapped 
ICD-10/DSM-IV compared with the RPQ3 (p = 0.78) and the RPQ3 compared with 
the three-factor model (p = 0.18). The lack of significant differences in PCS/no PCS 
pattern were characterized by the shared symptom overlap between the RPQ3 
and the three-factor model, and the mapped ICD-10/DSM-IV. A Cochran’s Q test 
determined that all classification methods differed significantly from each other. 
These results demonstrated that the choice of classification method influenced PCS 
diagnosis both at a population level, and at an individual level. 
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Table 2. Characteristics of the study population 
n 731
Gender (male) 463 (63.3%)
Agea (years) 44 (27-57)
Education
Primary education 21 (2.9%)
Secondary education 336 (46.0%)
Higher professional education 108 (14.8%)
Academic education 84 (11.5%)
Unknown 182 (24.9%)
Injury Mechanism
Road traffic accident 351 (48.0%)
Fall 240 (32.8%)
Sports 77 (10.5%)
Assault 41 (5.6%)
Other/Unknown 22 (3.0%)
Injury characteristics
ISSa 6 (4-14)
AISHa 2 (2-2)
Head AIS 3 93 (12.7%)
Head AIS 4 57 (7.8%)
Head AIS 5 11 (1.5%)
Comorbidityb
No pre-existing disease 329 (45.0%)
1 comorbid disease 92 (12.6%)
2 comorbid disease 33 (4.5%)
3 or more comorbidities 40 (5.5%)
Unknown 237 (32.4%)
CT scan
No CT scan 45 (6.2%)
CT scan, no abnormalities 591 (81.0%)
CT scan, abnormalities 94 (12.9%)
Hospitalizationc
Hospital admission 373 (51.0%)
Number of days hospitalizeda 3 (1-8)
ICU admission 35 (4.8%)
45
1
2
GCSa 15 (14-15)
13 40 (5.5%)
14 152 (20.8%)
15 539 (73.7%)
GOSEa 7 (6-8)
RPQ total scorea 4 (4-15)
a Data are displayed as median, with the first and third quartile given in parentheses.
b Comorbidity is defined as the presence of any co-existing diseases or disease processes additional to 
injury that the traumatic brain injury (TBI) patients sustained. The following diseases were assessed as 
comorbid disease: asthma, chronic bronchitis, chronic nonspecific lung disease (not asked about), heart 
disease, diabetes, back hernia or chronic backache, osteoarthritis, rheumatoid arthritis, and cancer.
c Hospital or ICU admission for ≥1 day or more after arrival at emergency department.
Abbreviations. ISS, Injury Severity Score; AISH, Abbreviated Injury Scale of the Head; AIS, Abbreviated 
Injury Scale; CT, Computed Tomography; ICU, Intensive Care Unit; GOSE, Glasgow Outcome Scale 
Extended; RPQ, Rivermead Post-Concussion Symptoms Questionnaire.
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Figure 1 A and B.  
RPQ3
Mapped ICD-
10/DSM-IV
283 patients
(38.7%)
Three-factor model: 214 (75.6%)
Three-factor model: 154 (59.0%)
Three-factor model: 197 (84.2%)
RPQ Total score: 222 (38.7%)
RPQ Total score: 172 (65.9%)
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Risk factors for PCS 
Assault was significantly associated with 6 month PCS according to all classification 
methods, whereas traumatic abnormalities on the head CT scan and age were not 
statistically significantly associated with PCS according to any of the classification 
methods (Table 3, Tables S1-S4) (see online supplementary material at http://www.
liebertpub.com). Female gender and lower education were significantly associated 
with all classification methods, except for the three-factor model with rating score 3. 
The significance of the predictors ISS, AISH, comorbidity and hospital admission, 
however, depended on the classification method used; for example, hospital 
admission was a significant predictor for PCS using six out of eight classification 
methods. Multivariable prediction models explained 6-14% (Nagelkerke R2) of the 
variation in PCS according to the different classification methods.
PCS and functional outcome
A total of 198 (27.1%) patients were functionally impaired (GOSE ≤6) 6 months 
post-injury. There was a significant association between PCS according to all 
classification methods and functional impairment (p < 0.01). The highest percentage 
of functional impairment for patients with PCS was found for the RPQ total scale with 
rating score 3 (72.8%, n = 91), whereas the RPQ3 with rating score 2 recorded the 
lowest percentage (46.0%, n =120) (Table 4).
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Table 3. Significant predictors in multivariable model of 6 month PCS using 
divergent classification methods on a p < 0.05 level
Mapped ICD-
10/DSM-IV
RPQ total 
score RPQ3
Three-factor 
model
Predictor ≥ 2* ≥ 3** ≥ 2 ≥ 3 ≥ 2 ≥ 3 ≥ 2 ≥ 3
Gender 0.53 0.48 0.53 0.54 0.38 0.4 0.59
Age
Education (Primary/Secondary) 1.73 1.8 1.69 1.82 1.55 1.8 1.62
Injury mechanism (Assault vs. 
other mechanisms) 0.38 0.26 0.25 0.34 0.34 0.21 0.27 0.29
ISS 1.03
AISH 1.21 1.24 1.29 1.22 1.29
CT abnormalities
Comorbidity 0.54 0.51 0.6 0.65 0.59 0.52
Hospital admission 0.45 0.45 0.61 0.43 0.52 0.53
R2 0.13 0.09 0.14 0.11 0.1 0.1 0.11 0.06
Note. Cells in grey indicate that the predictor is statistically significantly (p < 0.05) associated with PCS 
in multivariable logistic regression analysis and in the cells are the odds ratios. Cells in white indicate 
that the predictor is not statistically significantly associated with PCS.
* For each classification method, we used two different rating scores as cutoff: rating score 2 (* ≥ 2) 
and rating score 3 (** ≥ 3)
Abbreviations. PCS, Post-Concussion Syndrome; ICD, International Classification of Diseases; DSM, 
Diagnostic and Statistical Manual; RPQ, Rivermead Post-Concussion Symptoms Questionnaire; CT, 
Computed Tomography; ISS, Injury Severity Scale; AISH, Abbreviated Injury Severity Scale of the Head.
Mapped ICD-10/
DSM-IV RPQ total score RPQ3 Three-factor model
Rating score 2a 51.6% (146) 58.1% (136) 46.0% (120) 54.5% (126)
Rating score 3b 71.7% (81) 72.8% (91) 67.7% (65) 71.7% (59)
a mild or worse.
b moderate or worse.
Note: p<0.01 on all associations.
Table 4. MTBI patients with PCS and functionally impaired (GOSE ≤6)
Abbreviations. MTBI, mild traumatic brain injury; GOSE, Glasgow Outcome Scale Extended; DSM, 
Diagnostic and Statistical Manual; ICD, International Classification of Diseases; PCS, Post-Concussion 
Syndrome; RPQ, Rivermead Post-Concussion Symptoms Questionnaire.
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Discussion
The prevalence of PCS 6 months following mTBI ranged from 11.4% to 38.7%, 
depending on the classification method and rating score applied. The divergent 
classification methods in this study additionally influenced the statistical significance 
of predictors and the association with functional outcome, as measured with the 
GOSE.
The prevalence rates of PCS in our study are in line with preceding studies, which 
reported that prevalence rates of PCS after mTBI fluctuate and are estimated to 
range from 5% to 43%.[4-9] The prevalence rates that were found in the literature 
were dependent on many aspects, such as case mix of the sample and setting, but 
they were also dependent on the rating score applied and the classification method 
used to identify mTBI patients with PCS. Yeates has pointed out that the inconsistency 
in definition and classification criteria interferes with the righteous classification and 
identification of patients with PCS,[31] which ultimately leads to incommensurable 
prevalence rates and outcomes. Additionally, Waljas and colleagues have also 
stated that the rate of PCS diagnosis varies greatly based on which rating scale is 
being used,[19] which substantiates the decision during the writing of this article 
to research two different rating scores as cutoff points. Recently, the DSM criteria 
for PCS have been revised substantially. As this definition deviates significantly 
from the DSM-IV (e.g. the term mild neurocognitive impairment (MNI) from TBI 
was introduced instead of PCS),[32] it is likely that this will result in even more 
heterogeneity in prevalence rates. Tator and colleagues have recently emphasized 
“a refinement of the definition of PCS,”[33] and also the lack of consensus with 
regard to the definitions of PCS has previously been identified as a problem.[8] This 
problem presented itself as an opportunity in our study to explore and compare 
prevalence rates, risk factors and functional outcome when divergent cutoff rating 
scores and classification methods of the RPQ are applied. 
When comparing divergent classification methods, different patients were identified 
as having PCS. There was a difference of almost 30% in prevalence rates between 
the classification method with the highest (mapped ICD-10/DSM-IV with rating score 
2; 38.7%) and lowest (three-factor model with rating score 3; 11.4%) percentage. 
Forty-six patients experienced PCS according to all eight classification methods. 
The most overlap in identifying the same patients experiencing PCS was found 
between the mapped ICD-10/DSM-IV and the RPQ total score (95.6%), both with 
rating score 3. This can be explained by the overlap between symptoms included in 
both classification methods and by the fact that six out of seven eligible symptoms 
from the RPQ enclosed in the mapped ICD-10/DSM-IV are in the top eight most 
reported symptoms in this population. The lowest percentage of overlap was found 
between the RPQ3 and the three-factor model (51.0%) when a rating score of 3 
was used as a cutoff. This can be explained by the fact that the RPQ3 only defines 
three somatic symptoms, whereas four out of the five most reported symptoms 
(forgetfulness/poor memory, poor concentration, taking longer to think, feeling 
frustrated or impatient) in this study population are cognitive or emotional, which are 
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captured in the three-factor model. This also is in line with the thought that the RPQ3 
measures symptoms that occur more often in the acute phase after a mTBI.[18]
In this study, we found that the classification method used influenced the statistical 
significance of predictors; that is, several predictors were statistically significantly 
associated with PCS using some classification methods but not using others. This 
might be one of the reasons for the substantial heterogeneity in studies on predictors 
and prediction modelling for PCS,[21, 22] hampering prognostic research. However, 
the results also showed that assault was associated with all classification methods, 
and female gender and lower education with all but one classification method. 
Although PCS was statistically significantly associated with functional impairment 
(GOSE ≤6), there was variation in the amount of overlap between PCS and 
functional impairment dependent on the classification methods applied, ranging 
from 46.0% to 72.8%. Restricting PCS to only those symptoms that were reported as 
being ‘moderate or worse’ resulted in higher overlap between PCS and functional 
impairment. This may indicate that symptoms reported as moderate or worse 
are more likely to represent clinically relevant symptomatology than symptoms 
reported as mild. This is in line with the findings by Waljas and colleagues,[19] who 
reported that when using rating score 3 as a cutoff, patients with head injury were 
successfully distinguished from healthy controls, whereas when rating score 2 was 
used as cutoff, this resulted in a substantial proportion of healthy controls being 
diagnosed with PCS.
The present study is unique because eight divergent classification methods for PCS 
were applied, and the statistical effect this might have had on predictors associated 
with PCS and the different percentages seen as functionally impaired, measured by 
the GOSE, were assessed.
Our study had several limitations. First, Ruff declared that PCS concerns a complex 
interplay of biological, psychological and social factors that include prior health, 
life stressors and compensation/litigation issues.[8] This implies that an overview 
of many aspects of a patient’s current, but also previous life before the trauma, is 
required for correct assessment.
Our study was a post-hoc analysis of prospectively collected data of individuals after 
mTBI, and there were no pre-injury data available except for pre-existing comorbidity. 
Additionally, post-concussion symptoms in our study were self-reported, which 
might have led to more or fewer reported symptoms on the questionnaire than if the 
respondents had been interviewed by a physician.[34] Response bias might also 
have played a role during our study. Respondents with symptoms may have been 
more likely to participate in the 6 month follow-up questionnaires than patients who 
were currently not experiencing/or had never experienced any symptoms.
Further, it has been argued that the RPQ is not the most ideal instrument to use in an 
mTBI population,[35] but there is currently no consensus on what would be a better 
instrument to use. Looking at the RPQ total scale, one should keep in mind that even 
though the total RPQ score has been proposed by the developer of the instrument 
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and is used in most articles until now, Eyres and colleagues have revalidated the 
RPQ, and have pointed out that the various items of the RPQ have very low construct 
validity and in consequence of this, should not be computed into a sum score[14], 
but into two subscales. During this study, we have decided to not take the RPQ13 
into consideration, because no clear cutoff was found in the literature. For future 
studies, it would be interesting to look at the RPQ13 and establish a cutoff in view of 
the fact that a large number of the reported symptoms at 6 months are considered 
cognitive, provided that enough clinical data and concurrent evidence are available 
to define and diagnose TBI.
A limitation concerning the use of mapped ICD-10/DSM-IV in this study was that 
we imposed them as the same, because we do not have the required data to 
differentiate between the ICD-10 and DSM-IV. This might have led to over/under 
reporting of prevalence rates, and limited the ability to report about the differences 
among the most applied definitions. Previous studies have shown that DSM-IV 
usually leads to lower prevalence rates, because the diagnostic criteria seem to 
be more stringent [36, 37], yet McCauley and colleagues have stated that there 
should be no clinical preference for any one of the diagnostic criteria.[38] In 
previous research, the variability in instruments used to diagnose mTBI has also 
been considered a difficulty. Depending on the diagnosis criteria used, different 
individuals will be classified as having mTBI, which may lead to inconsistencies and 
might influence the results.[22, 39-42] In our study, this could possibly mean that 
we have included patients who would not have been diagnosed with mTBI using 
other diagnostic criteria, which could affect the risk factors and functional outcome 
of this population.
In our study we used a relatively low threshold (p = 0.05) for the inclusion of predictors 
in the backward selection procedure. Higher levels (e.g., p = 0.20 or p = 0.157 
[43, 44]) as well as advanced statistical methods such as shrinkage and bootstrap 
validation are usually recommended to enhance the internal and external validity 
of prediction models.[43] Therefore, the results on predictors in our study should 
be interpreted as a proof of principle (there are different predictors associated with 
PCS according to different definitions) rather than considered applicable for clinical 
practice. Regarding the results of the regression, these could have been weakened 
by the fact that we looked at assault compared with all other injury mechanisms 
combined. More detailed information on the circumstances of the injury is essential 
to comprehend the real effect of the injury mechanism on the outcome. 
Additionally, lower education and comorbidity were considered significant risk 
factors for PCS, which could have been impacted by the large amount of imputed 
values. 
A final limitation of our study is that data were collected in one academic hospital, 
which limits the generalizability of the results, because of differences in the case 
mix and because patients with severe trauma are more likely to be admitted to the 
ED of an academic hospital.
During the last decade, a shift from identifying PCS and interpreting it as an 
exclusive syndrome to recognizing it as being a highly complex and ever-changing 
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condition in different settings/populations, can be observed. This development 
leads to more and more specific research in the area of PCS or, as now suggested, 
persistent post-concussive symptoms. This debate and inconsistency concerning 
definitions, diagnostic criteria, assessment and evaluation of PCS hampers its 
research and therapy. Standardizing and improving diagnosis and assessment of 
PCS will facilitate to identify opportunities for intervention when patients experience 
the disabling PCS symptoms, or even prevent mTBI patients from developing PCS. 
In addition, it is recommended to perform sensitivity and specificity analyses on the 
different classification methods for the RPQ to evaluate their classification accuracy.
[18]
Conclusion
Our study showed that prevalence rates of PCS 6 months after mTBI deviated 
considerably, depending on the classification method and rating score used. In 
addition, applying divergent classification methods resulted in a different set of 
predictors being statistically significantly associated with PCS, and a different 
percentage of overlap with functional impairment, measured with the GOSE.
These findings highlight the need for a universal guideline with respect to 
diagnostic criteria for PCS, and a gold standard for analysis of the RPQ, to enhance 
comparability of studies regarding PCS after mTBI. 
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Abstract
A subset of mild traumatic brain injury (mTBI) patients experience post-concussion 
symptoms. When a cluster of post-concussion symptoms persists for over three 
months, it is referred to as post-concussion syndrome (PCS). Little is known about 
the association between PCS and Health-Related Quality of Life (HRQoL) after 
mTBI. The aims of this study were to assess the implications of PCS on HRQoL 
six months after mTBI and the relationship between PCS and HRQoL domains. A 
prospective observational cohort study was conducted among a sample of mTBI 
patients. Follow-up postal questionnaires at six months after emergency department 
(ED) admission included socio-demographic information, the Rivermead Post-
Concussion Symptoms Questionnaire (RPQ), and HRQoL measured with the 36-
item Short-Form Health Survey (SF-36) and the Perceived Quality of Life Scale 
(PQoL). In total, 731 mTBI patients were included, of whom 38.7% were classified 
as suffering from PCS. Patients with PCS had significantly lower scores on all SF-36 
domains, lower physical and mental component summary scores and lower mean 
PQoL scores compared to patients without PCS. All items of the RPQ were negatively 
correlated to all SF- 36 domains and PQoL subscale scores, indicating that reporting 
problems on any of the RPQ symptoms was associated with a decrease on different 
aspects of an individual’s  HRQoL. To conclude, PCS is common following mTBI 
and patients with PCS have a considerably lower HRQoL. A better understanding 
of the relationship between PCS and HRQoL and possible mediating factors in this 
relationship could improve intervention strategies, the recovery process for mTBI 
patients and benchmarking.
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Introduction
Traumatic brain injury (TBI) represents a substantial burden worldwide and reported 
annual incidence rates vary from 47 to 849/100,000 in the European population.[1] 
TBI is defined as “an alteration in brain function, or other evidence of brain pathology, 
caused by an external force.”[2] The greater part (70-80%) of all TBI cases can be 
classified as mild TBI (mTBI). Despite the term ‘mild’, many patients experience 
post-concussion symptoms such as somatic symptoms (e.g. headaches, dizziness, 
blurred vision, fatigue and sleep disturbances), cognitive complaints (e.g. poor 
memory, attention and executive difficulties), and behavioral or emotional symptoms 
(e.g. depression, irritability, anxiety-related disorders, emotional lability).[3] When a 
subset of these symptoms persist for over three months,[4, 5] it is typically referred 
to as post-concussion syndrome (PCS). In previous literature, the prevalence 
rates of PCS vary considerably (5-43%), dependent on timing, measurement and 
classification method used.[4-8] Additionally, van der Naalt et al. have determined 
an incomplete recovery in almost half mTBI patients six months after injury.[9]
Generally, the International Classification of Diseases (ICD)-10[10] or Diagnostic 
and Statistical Manual of Mental Disorders (DSM)-IV[11] diagnostic criteria are used 
to determine the presence of PCS. In the literature, PCS continues to be a subject 
of discussion and remains controversial, because of diverging definitions and 
classification methods,[8] disagreement regarding etiology and no clear impartial 
neurologic results.
Health-related quality of life (HRQoL) has been acknowledged as an important 
outcome, reflecting to what degree a medical condition and its treatment affect the 
physical, mental and social aspects of someone’s life perceived from an individual’s 
perspective.[12] Previous studies have shown that many people suffering from 
mTBI experience a reduction in HRQoL, because of physical, cognitive and/or 
emotional impairments.[13, 14] Furthermore, PCS may result in loss of functional 
health, which prohibits return to work after injury and leads to additional economic 
and societal costs[15] and it may hamper someone’s psychosocial functioning.
[16] However, the topic of HRQoL and outcomes for people with PCS after mTBI 
is important and under-researched. Furthermore, to date no large comprehensive 
study has addressed the association between PCS and HRQoL and its subscales in 
the general adult mTBI population. This information could also add to the discussion 
concerning the clinical relevance of PCS; i.e. a strong association between PCS 
symptoms and a decreased quality of life may indicate that PCS is a clinical relevant 
syndrome.
More insight is needed in the relationship between PCS and HRQoL. Therefore, the 
objectives of this study were to assess the association between PCS and HRQoL 
six months after mTBI and the correlation between post-concussion symptoms and 
HRQoL domains. 
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Materials and Methods
Study design 
In this study, data were acquired through the Radboud University Brain Injury 
Cohort Study (RUBICS),[17-20] which is a prospective observational cohort study. 
Patients who attended the emergency department (ED) of the Radboud University 
Nijmegen Medical Center (RUNMC) between January 2003 and June 2010 with a 
diagnosis of mild, moderate or severe TBI were included in the RUBICS database. 
The clinical data registered in the ED by a neurologist and/or neurosurgeon were 
entered into the RUBICS databank by a research nurse. Demographic data 
(age, sex and education), trauma mechanism, hospital admission and length of 
hospitalization, clinical variables and comorbidities are reflected in the RUBICS 
databank and follow-up postal questionnaires were utilized to obtain this data. The 
clinical variables described are the Glasgow Coma Scale (GCS), abbreviated injury 
scale (AIS) and injury severity score (ISS). The AIS is used to classify and describe 
the severity of injury to trauma patients in every body region on a six-point ordinal 
scale[21] and the AIS head (AISH) is classified as the AIS score specific for the 
head. The ISS[22, 23] is derived from the AIS and represents the severity of the 
trauma. The questionnaires were self-rated by patients or guardians of patients 
six months after the injury. This study has been approved by the ethical standards 
committee of the RUNMC. For more details on the RUBICS dataset, see Scholten et 
al[13] and Haagsma et al.[20]
Study participants
In the current study, mTBI was diagnosed by a GCS score of 13-15 in the ED after 
initial resuscitation or followed by sedation and intubation during resuscitation for 
non-neurological cause. Exclusion criteria were: being 16 years and younger, no 
written informed consent given by patients/guardians, abusive use of drugs or 
alcohol, diagnosed with dementia, unknown address of the patient, and inability to 
speak or write Dutch. A total of 731 patients, which were classified as having mTBI 
and had completed all items of the RPQ at six-month follow-up, were selected for 
the current analyses.  
Post-concussion symptoms and diagnosis of PCS 
The RPQ was applied to identify the existence and severity of post-concussion 
symptoms at six-month follow-up. The RPQ describes 16 post-concussion symptoms 
frequently identified after TBI including headaches, dizziness, nausea/vomiting, 
noise sensitivity, sleep disturbance, fatigue, being irritable, feeling depressed or 
tearful, feeling frustrated or impatient, forgetfulness, poor concentration, taking 
longer to think, blurred vision, light sensitivity, double vision and restlessness. 
Patients were asked to assess the severity of these symptoms over the past 24 h 
compared with the pre-injury situation. The symptoms are rated on a 5-point Likert 
scale, which covers responses from 0 (not a problem) to 4 (severe problem). A 
higher total score, which ranges from 0 to 64, on the RPQ represents a higher and 
more severe number of symptoms to be in place.[24] Rating scores of one did not 
contribute to the total score of the RPQ as recommended by King et al.[24] 
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In this study, we mapped the symptoms of the ICD-10 diagnostic criteria[25] on the 
RPQ. Patients were classified as having PCS when they reported three or more of the 
following symptoms with a rating score of two (mild) or higher: headache, dizziness, 
fatigue, irritability, insomnia, concentration difficulty, and memory difficulty (Panel 
1). Additionally, the ICD-10 diagnostic criteria also requires reduced tolerance 
to stress, emotional excitement or alcohol as one of the criteria. However, this 
information is not available in the RPQ nor in the RUBICS database. 
Panel 1. Classification method regarding Post-Concussion Syndrome
Mapped ICD-10
At least 3 symptoms from the list below
Eligible symptoms from the RPQ Headache
Dizziness
Sleep disturbance
Fatigue
Being irritable, easily angered
Forgetfulness, poor memory
Poor concentration
Cut-off; rating score 2 Three items with score ≥ 2
Abbreviations. ICD, International Classification of Diseases; RPQ, Rivermead Post-Concussion 
Symptoms Questionnaire.
Health-related quality of life
The paper-and-pencil version of the 36-Item Short-Form (SF-36) Health Survey 
(Version 1)[26]  was self-rated by the patients included in the databank at six months 
post-injury. The SF-36 instrument has been validated in a TBI population and has 
demonstrated good internal consistency and validity,[27, 28] and is the most used 
generic HRQoL instrument in TBI research.[29] It is a 36 item multidimensional 
self-reported survey of patient’s health that reflects the physical, mental and social 
functioning. It consists of eight domains of health status: physical functioning (PF), 
role limitations related to physical functioning (RP), bodily pain (BP), general health 
perception (GH), vitality (VT), social functioning (SF), role limitations related to 
emotional problems (RE), and mental health (MH).[26] The weighted sums of the 
item responses for each domain are linearly transformed to a score ranging from 0 
to 100. The physical and mental health summary component scores are calculated 
by first standardizing the patients’ scores, specifically by subtracting the subscale 
means for the general Dutch population sample from each individual’s subscale 
scores and dividing the results by the standard deviation of the Dutch sample to 
generate Z-scores.[30] Second, to facilitate international comparison, Z-scores 
are multiplied by the subscale factor coefficients for physical and mental health 
summary component scores of the U.S. sample and summed over eight subscales 
into the physical and mental health summary component scores. Finally, both sums 
were re-scaled into T-scores, with a mean of 50 and standard deviation of 10 for the 
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U.S. norm.[31] Mean values of the respondents’ completed items in the same scale 
were used as replacement for the missing values at six months, under one condition 
that at least 50% of the items within that scale had been completed.[26] 
The Perceived Quality of Life Scale (PQoL) is also a generic HRQoL instrument, 
initially developed as a cognitive appraisal of life satisfaction for patients after 
intensive medical care.[32] The instrument has previously been used in adults 
with chronic neurologic disability and additionally in stroke and TBI.[33, 34] The 
PQoL showed good internal reliability in a TBI population.[35] The PQoL measures 
an individuals’ satisfaction with his or her functional status on an 11-point scale 
ranging from 0 (extremely dissatisfied) to 10 (extremely satisfied). It contains 
19 items in three different domains (physical health, cognitive health and social 
health), estimating the level of functioning in 10 different areas, including physical 
health, thinking and remembering, family relationships, community participation 
and leisure, work and income, and meaning and purpose of life. The overall PQoL 
score is established by the mean of the 19 item scores and seen as a measure of 
global life satisfaction, in which a score of < 7.5 is considered as “Dissatisfied” and 
a score > 7.5 as “Satisfied”.[32] For our analyses, the mean score (range 0 to 10) 
was chosen. Hot deck imputation per domain was used to estimate the missing 
values at six months, provided that at least 50% of the items within that domain 
had been completed, applying similar scores on the items in that specific domain. 
This was done because PQoL scores are only allowed to be computed in case of 
complete information on all items.[32]
The PQoL can be divided in physical, social and cognitive subscales. The physical 
subscale includes physical health (item 1), take care of yourself (item 2), amount of 
walking (item 4), getting outside the house (item 5) and amount and kind of sleep 
(item 19). The social subscale consists of see or talk to family and friends (item 
8), help from family and friends (item 9), help you give to family and friends (item 
10), contribution to community (item 11), work situation (item 12), kind and amount 
of recreation or leisure (item 13), level or lack of sexual activity (item 14), income 
meets your needs (item 15), respected by others (item 16), meaning and purpose 
of your life (item 17) and amount of variety in your life (item 18), and the cognitive 
subscale entails think and remember (item 3) and carry on a conversation (item 
6).[32]
Statistical analysis
Descriptive analyses were conducted on the demographic (age, sex and 
educational level), trauma mechanism, hospitalization, clinical injury variables and 
comorbidities. Patients diagnosed with mTBI and who had completed the entire 
RPQ were included in the analyses. To distinguish on socio-demographic and injury-
related variables between mTBI patients experiencing PCS and not experiencing 
PCS, chi-squared tests (dichotomous variables) and t-tests were applied. Mann 
Whitney U tests were used to evaluate the differences in SF-36 domain scores and 
PQoL scores between mTBI patients with and without PCS. Statistical significance 
was determined by a p-value of p<.05. Spearman’s correlation coefficients were 
utilized to evaluate the linear relationship and correlation between the RPQ and 
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the various SF-36 domains and PQoL subscales. Cohen’s Set Correlation and 
Contingency Tables were used to differentiate between strong, moderate and weak 
correlations. A correlation was considered strong when the coefficient was above 
0.5, moderate when the coefficient was between 0.3 and 0.5, and weak when the 
coefficient was below 0.3.[36] Missing data for the following variables: education 
(182 missing), comorbidity (237 missing), and hospital admission (2 missing) were 
imputed using multiple imputation technique with five datasets. Multiple regression 
was performed to adjust for differences in case-mix between patients with and 
without PCS. 
All statistical analyses were performed using SPSS version 24 for Windows (IBM 
SPSS Statistics, SPSS Inc, Chicago, IL). 
Results 
Patient characteristics
In total, 797 mTBI patients were selected from the RUBICS database, of which 731 
were included in this study. There were no significant differences in characteristics 
between the 731 patients with complete outcome data and the 66 patients with 
missing items on the RPQ, except that the median age of the 66 patients was 
significantly higher 54.5 (Interquartile range (IQR): 42.75‐68, p<.01). Table 1 shows 
the characteristics of our study sample. The median age of the respondents was 44 
years and 63% were male. Road traffic accidents (48%) and falls (33%) were the 
most reported causes of injury. The median ISS and AISH scores were respectively 
6 (IQR 4-14) and 2 (IQR 2-2). Forty-five per cent of the patients had no pre-existing 
disease and 81% received a computed tomography (CT) scan of the head in 
which no abnormalities were found. Approximately 51% of the mTBI patients were 
admitted to hospital with an average length of stay of 3 days (range 1 to 8 days). 
Furthermore, 35 patients (4.8%) were admitted to the intensive care unit (ICU).
The prevalence of PCS in this population according to our criteria was 38.7%, which 
defines a total of 283 patients as experiencing PCS six months after the injury. 
Patients with PCS were significantly more often female, had a lower education, 
were more likely to be injured by assault compared with other causes of injury, had 
higher ISS and AISH scores, were more likely to be hospitalized and had a higher 
RPQ total score (Table 1).
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Table 1. Characteristics of the study population 
Total PCS No PCS P-value
N 731 283 448
Gender (male) 463 (63.3%) 161 (56.9%) 302 (67.4%) <.01
Age1 (years) 44 (27-57) 45 (31-56) 43 (26-57) 0.14
Education <.01
Primary education 21 (2.9%) 6 (2.1%) 15 (3.3%)
Secondary education 336 (46.0%) 142 (50.2%) 194 (43.3%)
Higher professional 
education 108 (14.8%) 32 (11.3%) 76 (17.0%)
Academic education 84 (11.5%) 18 (6.4%) 66 (14.7%)
Unknown 182 (24.9%) 85 (30.0) 97 (21.7%)
Injury Mechanism 0.03
Road traffic accident 351 (48.0%) 139 (49.1) 212 (47.3%)
Fall 240 (32.8%) 96 (33.9%) 144 (32.1%)
Sports 77 (10.5%) 19 (6.7%) 58 (12.9%)
Assault 41 (5.6%) 22 (7.8%) 19 (4.2%)
Other/Unknown 22 (3.0%) 7 (2.6%) 14 (3.3)
Injury severity
ISS1 6 (4-14) 8 (5-16) 5 (4-13) <.01
AISH1 2 (2-2) 2 (2-3) 2 (1-2) <.01
Head AIS 3 93 (12.7%) 42 (14.8%) 51 (11.4%)
Head AIS 4 57 (7.8%) 30 (10.6%) 27 (6.0%)
Head AIS 5 11 (1.5%) 6 (2.1%) 5 (1.1%)
Comorbidity2 <.01
No pre-existing disease 329 (45.0%) 102 (36.0%) 227 (50.7%)
1 comorbid disease 92 (12.6%) 36 (12.7%) 56 (12.5%)
2 comorbid disease 33 (4.5%) 13 (4.6%) 20 (4.5%)
3 or more comorbidities 40 (5.5%) 24 (8.5%) 16 (3.6%)
Unknown 237 (32.4%) 108 (38.2%) 129 (28.8%)
CT scan 0.2
No CT scan 46 (6.3%) 18 (6.4%) 28 (6.3%)
CT scan, no abnormalities 591 (80.8%) 223 (78.8%) 368 (82.1%)
CT scan, abnormalities 94 (12.9%) 42 (14.8%) 52 (11.6%)
Hospitalization2
Hospital admission 373 (51.0%) 180 (63.6%) 193 (43.1%) <.01
Number of days 
hospitalized1 3 (1-8) 4 (1-9) 3 (1-6) 0.37
ICU admission 35 (4.8%) 22 (7.8%) 13 (2.9%) <.01
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PCS and Health-related quality of life 
SF-36 – Table 2 shows the median SF-36 and PQoL scores for mTBI patients with 
and without PCS six months post-injury. Patients with mTBI and PCS had significantly 
lower scores on all domains of the SF-36 compared to mTBI patients without PCS. 
The lowest mean score for mTBI patients with PCS compared to patients without 
PCS was reported on the role limitations related to physical functioning domain, 
which represents problems with work  ⁄ daily activities as a result of physical health 
(mean: 40, SD: 42 vs. mean: 82, SD: 33, p<.001). The median physical component 
summary score was 44 (IQR 35-53) and 56 (IQR 49-59), respectively for patients 
with PCS and without PCS (p<.001). Furthermore, the median mental component 
summary score was 43 (IQR 32-52) for patients experiencing PCS and 54 (IQR 50-
58) for patients without PCS (p<.001) (Appendix A). 
PQoL – The median PQoL score for patients with PCS was 6.7 (IQR 5.3-7.8) and 
significantly lower compared to the median PQoL of patients without PCS (8.6 (IQR 
7.7-9.5), p<.001) (Appendix B). Approximately, 45% of patients with PCS were 
dissatisfied with their functioning (PQoL< 7.5), whereas only 14% of patients without 
PCS were dissatisfied with their functioning. 
After adjusting for case-mix differences, there were still significant differences 
between patients with and without PCS.  
GCS1 15 (14-15) 15 (14-15) 15 (15-15) <.01
13 40 (5.5%) 22 (7.8%) 18 (4.0%)
14 152 (20.8%) 71 (25.1%) 81 (18.1%)
15 539 (73.7%) 190 (67.1%) 349 (77.9%)
RPQ total score1 4 (0-15) 18 (12-28) 0 (0-4) <.01
1 Data are displayed as median, with the first and third quartile given within parentheses.
2 Comorbidity was defined as the presence of any co-existing diseases or disease processes 
additional to injury that the TBI patients sustained. The following diseases were assessed 
as comorbid disease: asthma, chronic bronchitis, chronic non-specific lung disease (not 
questioned), heart disease, diabetes, back hernia or chronic backache, osteoarthritis, 
rheumatoid arthritis, and cancer.
3 Hospital or IC admission for one day or more after arrival at emergency department.
Abbreviations. PCS, Post-Concussion Syndrome; ISS, Injury Severity Score; AISH, Abbreviated 
Injury Scale of the Head; AIS, Abbreviated Injury Scale; CT, Computed Tomography; ICU, 
Intensive Care Unit; GCS, Glasgow Coma Scale; RPQ, Rivermead Post-Concussion Symptoms 
Questionnaire; TBI, traumatic brain injury.
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Correlation of RPQ with SF-36 
In Figure 1 the Spearman’s correlation coefficients of the RPQ items and the eight 
domains of the SF-36 are shown. All items of the RPQ were negatively correlated 
to the SF-36 domains, indicating that reporting problems on any of the RPQ items 
is associated with a decrease on different aspects of an individuals’ HRQoL. The 
strongest negative correlation (-0.671, p<.001) was found between fatigue and 
the vitality (VT) domain of the SF-36. Double vision was determined as having the 
weakest correlations with all domains. Moreover, fatigue was observed as having 
a strong negative correlation with all domains except for role limitations related to 
emotional problems (RE) and mental health (MH). All correlations were statistically 
significant on a p<.001 level.
Figure 1. Correlation RPQ items and SF-36 domains
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Correlation of RPQ with PQoL
The Spearman’s correlation coefficients of the RPQ items and the three PQoL 
subscales are shown in Figure 2. All the items of the RPQ were negatively 
correlated with the PQoL subscales. All correlations were statistically significant 
on a p<.001 level. The strongest correlation (-0.621, p<.001) was found between 
forgetfulness and the PQoL cognitive subscale. Double vision was observed as 
having the weakest correlation with all subscales, which is in line with the SF-36 
domain correlations. 
Figure 2. Correlation RPQ items and PQoL subscales
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Discussion
The objectives of this paper were to elucidate the association between PCS and 
HRQoL six months after mTBI and the correlation between the RPQ items with 
SF-36 domains and PQoL subscale scores. Almost 40% of our mTBI cohort were 
experiencing PCS six months post-injury and PCS was negatively associated 
with HRQoL as measured with both the SF-36 and PQoL. MTBI patients with PCS 
had a 20% lower HRQoL on average, compared with mTBI patients without PCS. 
Almost half of mTBI patients with PCS were dissatisfied with their functioning. When 
adjusting for possible confounding effects of baseline differences between the two 
groups, it was shown that PCS decreases HRQoL. Additionally, significant negative 
correlations between all RPQ items and SF-36 domains and PQoL subscale scores 
were found, indicating that reporting problems on any of the RPQ items was 
associated with a decrease on different aspects of an individual’s HRQoL.
These results are in line with previous literature, where Emanuelson et al. have 
found a significant correlation between higher rates of symptoms and low SF-36 
scores in patients 16-60 years of age living in western Sweden.[14] However, they 
did not use the RPQ to assess post-concussion symptoms. Patients could only 
rate each symptom as existing (yes) or non-existing (no), which meant they weren’t 
able to identify the severity of post-concussion symptoms and they didn’t use the 
term PCS throughout their paper. Patients with mTBI and PCS had lower SF-36 
scores on all domains compared to the Dutch population norm.[30] However, when 
looking at patients without PCS, mean SF-36 scores were higher on all domains 
compared to the Dutch population norm. This is in line with a previous study by 
Scholten at al. where it was reported that respondents with mTBI reached outcomes 
comparable to the Dutch population norm on all the SF-36 domains at one year 
follow-up.[13] In previous literature, a reduction of HRQoL was found for mTBI 
patients,[13] nevertheless there is a gap in the literature concerning the factors that 
cause this reduction. This study shows that a decrease in HRQoL for mTBI patients 
could be affected by PCS. We adjusted for the most important factors, however, 
there may also be an intricate role of other factors influencing the relationship 
between PCS and HRQoL. Both, the reporting of post-concussion symptoms with 
the RPQ and functional impairments with the SF-36 may be mediated by pre-injury 
psychological, personality, psycho-social factors and the severity of the injury.[29, 
37, 38] Additionally, 14% of patients without PCS demonstrated dissatisfaction with 
their functioning, which implies that other factors play a role.
Several limitations have been encountered during this study. Firstly, an abundance 
of information was requested from TBI patients to acquire the RUBICS database, 
which may have resulted in lower quality responses. Secondly, RPQ, SF-36 and 
PQoL were all reported through self-administration. For HRQoL self-report is inherent 
in the concept. However, as the general population already had difficulties to fill out 
the SF-36 in its entirety,[38] this might be even more complex for the TBI population; 
these patients may experience cognitive problems and may have more difficulties 
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answering complicated and extensive questions. Concerning the RPQ, previous 
research has revealed that self-report might lead to under- or over-reporting of 
symptoms.[39] By asking explicitly for the existence of symptoms patients might 
furthermore be made aware of a symptom they would have otherwise not reported 
or they may not understand the meaning of a symptom and may just simply endorse 
it anyway.[39] Researchers have questioned whether the sensitivity and specificity 
of most instruments (e.g. RPQ) are sufficient for mTBI patients, because they have 
been developed for more severe cases of TBI.[29] Stulemeijer et al. have shown 
that additional extracranial injuries could also have an impact on lowered SF-36 
scores.[40] Furthermore, even though questionnaires are very convenient in the 
clinical and research context, the RPQ alone cannot be used to diagnose PCS, a 
full clinical evaluation by a health professional is necessary. Lastly, the cohort data 
were collected in an academic hospital where it is more likely that patients with 
severe trauma have been admitted to the ED, which is shown in the high percentage 
of patients admitted to the hospital (51%). Additionally, no pre-injury data with the 
exception of pre-existing comorbidity was available in the dataset. Therefore, the 
cohort is likely to not be representative for the overall mTBI population.  
This study gives us more information on PCS and the association with HRQoL, which 
could ultimately lead to a better comprehension of recovery and burden of PCS after 
mTBI. A better understanding of the relationship between PCS and HRQoL and 
possible mediating factors in this relationship could improve intervention strategies 
and the recovery process. TBI outcome covers a broad spectrum of HRQoL[38] and 
more knowledge about the specific effects on the HRQoL domains will justify future 
decisions concerning quality of life measures and interventions. Nevertheless, the 
role of mediating factors in the relationship between PCS and generic and disease-
specific HRQoL is not clear. For future studies it would be interesting to look at the 
role of pre-injury psychological, personality and psychosocial factors which may 
influence both, the report of post-concussion symptoms and physical, mental and 
social functioning measured with the SF-36. 
Conclusions
To conclude, PCS is common after mTBI and patients suffering from PCS have a 
considerably lower HRQoL. These findings highlight that better assessment and 
intervention strategies for PCS are needed, because intervention and support 
strategies can be targeted more appropriately when mTBI patients with PCS are 
detected shortly after sustaining the injury.[40] More insight is needed in the role of 
pre-injury psychological, personality and psychosocial factors that may influence 
both the report of post-concussion symptoms and physical, mental and social 
functioning. 
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Appendix B. PQoL mean scores at six months after mTBI. 
PQoL: Perceived Quality of Life. 
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Appendix A. SF-36 mean scores at six months after mTBI. 
SF-36: Short-Form-36; PF: physical functioning; RP: role physical; BP: bodily pain; GH: general health; 
VT: vitality; SF: social functioning; RE: role emotional; MH: mental health; PCS: physical component 
score; MCS: mental component score. 
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Abstract
The aim of this study was to assess the occurrence of post-concussion symptoms 
and post-concussion syndrome (PCS) in a large cohort of patients after complicated 
and uncomplicated mild traumatic brain injury (mTBI) at three and six months post-
injury. Patients were included through the prospective cohort study: Collaborative 
European NeuroTrauma Effectiveness Research (CENTER-TBI). Patients enrolled 
with mTBI (Glasgow Coma Scale 13-15) were further differentiated into complicated 
and uncomplicated mTBI based on the presence or absence of computed 
tomography abnormalities, respectively. The Rivermead Post-Concussion Symptoms 
Questionnaire (RPQ) assessed post-concussion symptoms and PCS according 
to the mapped ICD-10 classification method. The occurrence of post-concussion 
symptoms and syndrome at both time points was calculated. Chi square tests were 
used to test for differences between and within groups. Logistic regression was 
performed to analyse the association between complicated versus uncomplicated 
mTBI and the prevalence of PCS. Patients after complicated mTBI reported slightly 
more post-concussion symptoms compared to those after uncomplicated mTBI. A 
higher percentage of patients after complicated mTBI were classified as having PCS 
at three (complicated: 46% vs. uncomplicated: 35%) and six months (complicated: 
43% vs. uncomplicated 34%). After adjusting for baseline covariates, the effect of 
complicated versus uncomplicated mTBI at three months appeared minimal: odds 
ratio 1.25 (95% confidence interval: 0.95-1.66). Although patients after complicated 
mTBI report slightly more post-concussion symptoms and show higher PCS rates 
compared to those after uncomplicated mTBI at three and six months, complicated 
mTBI was only found a weak indicator for these problems. 
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Introduction
In the European Union, around 2.5 million new cases of traumatic brain injury (TBI) 
occur each year.[1] The vast majority of patients presenting to hospital with a TBI 
are diagnosed as having mild TBI (mTBI; Glasgow Coma Score (GCS): 13-15).
[1] Some of these patients may have traumatic intracranial abnormalities on the 
computed tomography (CT) performed on presentation which could potentially be 
associated with worse outcomes compared to those who do not have any traumatic 
intracranial abnormalities. For this reason, Williams et al.[2] addressed a subgroup 
conceptualization of these injuries, which has been shown to provide more detail 
on level of outcome.[3] According to this approach a differentiation can be made 
between patients with a complicated (intracranial abnormalities present on CT) and 
uncomplicated (no intracranial abnormalities present on CT) mTBI. 
In addition to heterogeneity with regard to the manifestation of mTBI, outcome may 
also vary between patients. Many patients with mTBI experience post-concussion 
symptoms in the first couple of weeks and months following the brain injury. However, 
the type, amount and severity of these symptoms differ between patients and 
may fluctuate over time.[4] These post-concussion symptoms could be physical, 
cognitive, emotional and/or behavioural.[5] When a patient experiences a certain 
combination of symptoms for longer than three months, they may be diagnosed with 
post-concussion syndrome (PCS).[6, 7] Generally, the International Classification 
of Diseases (ICD)-10[8], or Diagnostic and Statistical Manual of Mental Disorders 
(DSM)-IV[9] criteria are used to diagnose PCS.[6, 10] PCS has been a critically 
debated topic and the question has been raised if we can, or even should, identify 
this as a unique syndrome for TBI,[4, 5, 11, 12] however, the concept is still used in 
the majority of post-concussion symptom research.
A certain percentage of patients (estimated between 5% and 43%)[13-18] after 
mTBI report and experience post-concussion symptoms for months and sometimes 
even longer  post-injury.[3, 19] However, the literature concerning similarities 
and dissimilarities of post-concussion symptoms between complicated mTBI 
and uncomplicated mTBI is inconclusive. McMahon et al. noted that patients 
after complicated mTBI reported significantly more post-concussion symptoms 
compared to patients after uncomplicated mTBI at both six and twelve months.
[20] On the contrary, Iverson et al. have determined that patients after complicated 
mTBI reported fewer depression and post-concussion symptoms compared to 
patients after uncomplicated mTBI.[21] When considering PCS, McCauley et al. 
demonstrated that abnormalities on CT were not associated with PCS at 3 months 
following injury.[22] Additionally, Iverson et al. have reported: ‘no significant 
difference in the percentages of patients in the uncomplicated versus complicated 
mTBI groups who met ICD-10 criteria for PCS.’[21] Furthermore, in previous research, 
limited information has been documented on the different care paths patients after 
complicated and uncomplicated mTBI may have followed and if reporting of post-
concussion symptoms differs between these care paths.
Despite a growing body of literature on complicated versus uncomplicated mTBI, 
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to date, most studies that compared self-reported symptoms following complicated 
and uncomplicated mTBI were limited in sample size, and there is a relative paucity 
of recent data. 
We hypothesize that patients after complicated mTBIs report more post-concussion 
symptoms and have higher prevalence rates of PCS at both time points compared 
to those with uncomplicated mTBI. Additionally, we anticipated a larger number 
of patients after complicated mTBI admitted to hospital ward compared to those 
discharged home from the emergency room (ER) stratum, and aimed to explore 
if such patients may constitute an “enriched” population in terms of occurrence of 
PCS and a higher number of post-concussion symptoms. This would be particular 
relevant when planning a clinical trial investigating efficacy of approaches to treat 
PCS symptoms.
The objectives of this study were to assess the occurrence of post-concussion 
symptoms and PCS in a large sample of patients after complicated and 
uncomplicated mTBI at three and six months post-injury. 
Methods
Study design 
Patients were included in the Collaborative European NeuroTrauma Effectiveness 
Research (CENTER-TBI) research project, which is a multicentre, prospective 
observational longitudinal cohort study, conducted in Europe and Israel.[1, 23] 
The core study enrolled patients with all severities of TBI who presented to centres 
between December 19, 2014 and December 17, 2017. Inclusion criteria were a 
clinical diagnosis of TBI, an indication for CT scanning, presenting to a centre 
within 24 hours of injury, and obtained informed consent adhering local and national 
requirements: prior to inclusion, either personally, or through a legally designated 
representative.[23] Participants were free to withdraw at any point in time during 
the study without stating a reason.[23] Patients were excluded when there was a 
severe pre-existing neurological disorder i.e., cerebrovascular accident, transient 
ischemic attacks, and epilepsy, which could potentially invalidate outcome 
assessments. Three strata were used to prospectively differentiate patients by 
care path: ER (patients evaluated in the ER and discharged afterwards), admission 
(patients admitted to hospital ward) and intensive care unit (ICU) (patients who 
were primarily admitted to the ICU).[23] The main descriptive findings of CENTER-
TBI have been published.[24]
Study participants 
In the current study, only patients with a mTBI diagnosis were included (Glasgow 
Coma Scale (GCS) 13-15). They were divided in complicated mTBI, which was 
defined as GCS 13-15 and presence of any intracranial injury on first CT and 
uncomplicated mTBI, which was defined as GCS 13-15 and absence of any 
intracranial injury on first CT. For analyses of post-concussion symptoms including 
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PCS, we performed a complete case analysis, selecting all patients after mTBI who 
completed the Rivermead Post-Concussion Symptoms Questionnaire (RPQ)[25] at 
three and six months follow-up (N =1,302) (Figure 1). 
Figure 1. Flowchart sample size
Patients after 
complicated 
mTBI 
N = 599
Patients after 
uncomplicated 
mTBI 
N = 648
Patients after 
mTBI
N = 2955
Patients after 
moderate and 
severe TBI
N = 1554
Patients after 
mTBI with 
incomplete RPQ
N = 1653Patients after mTBI with 
complete RPQ
N = 1302
Total number of 
patients in core 
study available 
for analysis
N = 4509
N, number; mTBI, mild traumatic brain injury; TBI, traumatic brain injury; RPQ, Rivermead Post-
Concussion Symptoms Questionnaire
Measurement-Instrument 
Post-concussion symptoms were assessed by the (RPQ),[25] which evaluates the 
frequency and severity of 16 post-concussion symptoms. Symptoms evaluated 
included headaches, dizziness, nausea/vomiting, noise sensitivity, sleep 
disturbance, fatigue, being irritable, feeling depressed or tearful, feeling frustrated 
or impatient, forgetfulness, poor concentration, taking longer to think, blurred vision, 
light sensitivity, double vision, and restlessness. Patients rated the severity of the 
post-concussion symptoms on a five-point Likert scale, where 0 represents a rating 
corresponding to “not experienced at all”, 1 “no more of a problem than before the 
TBI”, 2 “a mild problem”, 3 “a moderate problem” and 4 “a severe problem.”[25] 
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To obtain the total score, the ratings of all 16 items are summated, excluding the 
ratings of 1.[25] The RPQ was administered at three and six months following injury, 
and patients were asked to rate the severity of the symptoms over the last 24 hours.
Various approaches to defining PCS exist.[26] For this study, we primarily focussed 
on the mapped ICD-10 classification method, in which we defined patients as 
having PCS when they reported any three of the seven symptoms described in 
the ICD-10 criteria (e.g. headache, dizziness, sleep disturbance, fatigue, being 
irritable/ easily angered, forgetfulness/poor memory, and poor concentration).[8] 
As previous research is inconclusive concerning which severity rating should be 
applied as a cut-off,[26] two different cut-offs were assessed: rating score 2 (≥ 
2), corresponding to symptoms rated as mild or worse, and rating score 3 (≥ 3), 
corresponding to symptoms rated as moderate or worse. 
The RPQ was collected by telephone and face-to-face interviews, or per postal or 
web-based questionnaires (Appendix A). The questionnaire was translated into 18 
languages and linguistically validated.[23, 27] 
Ethical approval 
The CENTER-TBI study (EC grant 602150) has been conducted in accordance with 
all relevant laws of the EU if directly applicable or of direct effect, and all relevant laws 
of the country where the Recruiting sites were located, including, but not limited to, 
the relevant privacy and data protection laws and regulations (the “Privacy Law”), 
the relevant laws and regulations on the use of human materials, and all relevant 
guidance relating to clinical studies from time to time in force including, but not 
limited to, the ICH Harmonised Tripartite Guideline for Good Clinical Practice (CPMP/
ICH/135/95) (“ICH GCP”) and the World Medical Association Declaration of Helsinki 
entitled “Ethical Principles for Medical Research Involving Human Subjects”. Ethical 
approval was obtained for each recruiting site.  Informed Consent was obtained for 
all patients recruited in the Core Dataset of CENTER-TBI and documented in the 
e-CRF. The list of sites, Ethical Committees, approval numbers and approval dates 
can be found on the official Center TBI website (www.center-tbi.eu/project/ethical-
approval).
Statistical analysis
For all analyses, data was extracted from the INCF Neurobot tool (INCF, Sweden), a 
clinical study data management tool. Version 2.0 of the CENTER-TBI dataset (data 
frozen in January 2019) was used in this manuscript. The number and percentage 
of patients who were classified as having experienced mTBI (complicated and 
uncomplicated mTBI) were assessed by stratum and per GCS level. Descriptive 
analyses for demographic data (age, gender and education) injury mechanism, 
GCS at baseline, first CT scan, and RPQ total score were performed and examined 
for patients with mTBI, complicated and uncomplicated mTBI at 3 and 6 months 
post-injury. Chi-square tests for categorical variables and Student’s t tests for 
continuous variables were used to compare patients with mTBI who completed the 
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RPQ (filled in all items) with those with incomplete RPQ data (not all items filled in). 
Additionally, these tests were also performed to compare patients with complicated 
versus uncomplicated mTBI. To assess whether there was a relation between having 
a completed RPQ at three and/or six months, a McNemar test was performed.
At each time point, we computed the prevalence and percentages of post-
concussion symptoms and of patients who were classified as having PCS according 
to our mapped ICD-10 classification method, and we explored whether there were 
differences between the complicated and uncomplicated group. For all analyses, a 
p-value of p<0.05 was considered significant. 
For the analysis of the effect of complicated versus uncomplicated mTBI on PCS, 
data for the following predictor variables: age, GCS, stratum, education, gender, 
psychiatric medical history and cause of injury were first multiply imputed. We 
assumed missing at random as the mechanism of missingness. For the component 
variables considering psychiatric medical history (anxiety, depression, sleep 
disorders, schizophrenia, substance abuse disorder and other) missings were 
treated as absence of this diagnosis, since investigators could only enter components 
if the main category (e.g. psychiatric medical history” had been scored positive. All 
potential confounders, which were based on clinical relevance, the outcome (PCS) 
and exposure (complicated TBI) were included in the imputation model. Only the 
cases with observed outcomes were analysed in the main analysis. The Multivariate 
Imputation by Chained Equations (mice) package, which imputes incomplete 
multivariate data by chained equations,[28] was used to create five datasets.[29] 
Results of each imputed data set were combined according to Rubin’s rules.[30]
To analyse the association of complicated versus uncomplicated mTBI on the 
presence of PCS, logistic regression was performed. We adjusted for the following 
baseline covariates: age, gender, education, injury mechanism, GCS, complicated 
vs. uncomplicated, and stratum. The unadjusted and adjusted effects were 
displayed as odds ratios (OR) with 95% confidence intervals (95% CI).
All statistical analyses were performed using SPSS version 25 for Windows (IBM 
SPSS Statistics, SPSS Inc, Chicago, IL) and R (version 3.2.2 or higher, the R 
Foundation for Statistical Computing, Vienna, Austria).  
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Results
Study population 
Within CENTER-TBI, most patients were classified as mTBI (N=2,955; 65.5%), 
and these patients constituted the vast majority of patients in the ER (97%) and 
admission (93%) strata, but were also present in the ICU (34%) stratum (Table 
1). Complicated mTBI was identified in 12%, 45% and 73% of mTBI in the ER, 
admission and ICU strata, respectively. 
Figure 2 shows the total number of patients per stratum and provides additional 
differentiation by GCS score for complicated and uncomplicated mTBI. A larger 
number of patients with complicated mTBI were found in the admission and ICU 
strata compared to the ER stratum. Many patients had a significantly lower GCS 
score when looking at complicated versus uncomplicated mTBI (p < 0.01).
A total of 1,302 patients with mTBI and a completed RPQ from the CENTER-TBI 
database were included in this study (Figure 1). Table 2 shows the characteristics of 
our study sample. The median age of patients after mTBI was 53 years (interquartile 
range (IQR); 35-66) and 64% were male. The median number of years of education 
was 14 (IQR; 11-17) and almost half (47%) of the patients were injured due to an 
incidental fall, followed by road traffic incidents (39%). Approximately 46% showed 
any intracranial injury on the first CT and was defined as complicated mTBI. 
Patients after complicated mTBI were significantly older (p<0.01) and had a higher 
total RPQ score (p < 0.01: 11.8 vs. 9.4) compared to patients after uncomplicated 
mTBI. Patients after mTBI who completed the RPQ were not significantly different 
from those with incomplete RPQ data, except that they had a slightly higher number 
of education years (p < 0.01: 13.9 vs. 12.6) and more patients reported to have had 
a psychiatric medical history (p < 0.01) (Appendix B). Additionally, there was no 
statistically significant difference between patients who had a completed RPQ at 
three and/or six months (p = 0.17).
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Table 1. Number of mTBI, uncomplicated and complicated mTBI per stratum
Total mTBI Uncomplicated mTBI Complicated mTBI
ER N (%) 826 (97.4%) 699 (84.6%) 97 (11.7%)
Admission N (%) 1409 (92.5%) 686 (48.7%) 627 (44.5%)
ICU N (%) 720 (33.7%) 144 (20.0%) 527 (73.2%)
Total 2955 (65.5%) 1529 (51.7%) 1251 (42.3%)
Note: for 175 mTBI patients the CT scan was not available
Abbreviations. mTBI, mild traumatic brain injury; ER, emergency room; ICU, intensive care unit.
Figure 2. Number of uncomplicated and complicated mTBI patients with complete 
RPQ data per GCS level 13-15 per stratum
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Table 2. Characteristics of the study population 
Total mTBI with 
completed RPQ Uncomplicated Complicated P-value
N 1302 648 599
Gender (male) 827 (63.5%) 398 (61.4%) 396 (66.1%) 0.085
Age1 (years) 53 [35-66] 51 [31.25-64] 58 [39-68] <0.01
Education1 (years) 14 [11-17] 14 [12-17] 13 [11-17] 0.054
Injury Mechanism 0.394
Road traffic accident 504 (38.7%) 255 (39.4%) 227 (37.9%)
Incidental fall 616 (47.3%) 300 (46.3%) 289 (48.2%)
Other non-intentional 72 (5.5%) 41 (6.3%) 29 (4.8%)
Violence/assault 43 (3.3%) 22 (3.4%) 19 (3.2%)
Act of mass violence 1 (0.1%) - 1 (0.2%)
Suicide attempt 7 (0.5%) 2 (0.3%) 5 (0.8%)
Other 42 (3.2%) 23 (3.5%) 18 (3.0%)
Unknown 17 (1.3%) 5 (0.8%) 11 (1.8%)
Psychiatric Medical 
History 146 (11.2%) 68 (10.5%) 73 (12.2%) 0.329
Anxiety 36 (24.7%) 13 (19.1%) 22 (30.1%) 0.13
Depression 89 (61.0%) 46 (67.6%) 41 (56.2%) 0.161
Sleep disorders 19 (13.0%) 8 (11.8%) 10 (13.7%) 0.731
Schizophrenia 3 (2.1%) 1 (1.5%) 2 (2.7%) 0.602
Substance abuse disorder 17 (11.6%) 5 (7.4%) 9 (12.3%) 0.324
Other 19 (13.0%) 9 (13.2%) 9 (12.3%) 0.872
GCS baseline1 15 [15-15] 15 [15-15] 15 [14-15] <0.01
Computed Tomography
Any intracranial injury on 
first CT 599 (46.0%) 648 (0.0%) 599 (100.0%) <0.01
RPQ total score1  
3 months 6 [0-17] 4 [0-14] 7 [2-20] <0.01
6 months 5 [0-15] 4 [0-14] 7 [2-17] <0.01
1 Data are displayed as median, with the first and third quartile given within brackets.
Note: only completed RPQ (all items of the questionnaire filled out).
Abbreviations. mTBI, mild traumatic brain injury; RPQ, Rivermead-Post-Concussion Symptoms 
Questionnaire; CT, Computed Tomography.
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Post-concussion symptoms and PCS
The median RPQ score for patients after complicated mTBI at three and six months 
was 7 (IQR 3 months; 2-20/ IQR 6 months; 2-17), which was significantly higher 
than the median score for patients after uncomplicated mTBI (IRQ: 0-14) (p < 0.01). 
Figure 3.1 shows that patients after complicated mTBI reported significantly 
more feelings of dizziness, noise sensitivity, fatigue/tiring more easily, feeling 
depressed/tearful, feeling frustrated or impatient, forgetfulness/poor memory, poor 
concentration, taking longer to think, and restlessness compared to uncomplicated 
mTBI at three months (p < 0.05).
Additionally, when inspecting data at six months, patients in both groups reported 
a lower percentage of symptoms and less symptoms were found to be significant, 
compared to the 3-month time point (Figure 3.2). Nevertheless, differences in 
symptom reporting between complicated and uncomplicated remain.
PCS prevalence, when using rating score 2 as a cut-off, for patients after complicated 
mTBI were 45.6% (95% CI: 41.6 – 49.6) and 42.7% (95% CI: 38.7 - 46.7) at three and 
six months, respectively, which showed a significant decrease (p < 0.01) (Figure 
4). A significant difference was also found when comparing the prevalence rates 
for patients after uncomplicated mTBI, which were 35.3% (95% CI: 31.6 - 39.0) at 
3 months and 34.4% (95% CI: 30.7 - 38.1) at 6 months. Additionally, significant 
difference was found between the two groups at both follow up points (3 months: p 
< 0.01 and 6 months: p < 0.01).
When using rating score 3 as a cut-off, post-concussion symptom percentages 
(Appendix C.1 and C.2) and PCS prevalence rates were reduced by half for both 
complicated and uncomplicated mTBI. Furthermore, there was no significant 
difference anymore between patients with complicated and uncomplicated mTBI 
(3 months: p=0.055 and 6 months: p=0.303).
Since the absolute percentages within both groups did not differ much from three 
to six months, we looked more specifically into the patterns behind the significant 
difference, which could be explained by the transitioning of patients with PCS 
between three and six months. Figure 5 shows the trajectories of patients after 
complicated and uncomplicated mTBI classified with PCS over time. When looking 
at the complicated mTBI group, there are 272 patients who did not, and 202 patients 
who did meet the PCS criteria at 3 and 6 months. Seventy-one patients with PCS at 
3 month follow-up did not classify as having PCS at 6 month follow-up. 
Furthermore, 54 patients did not have PCS at 3 months, however, they did classify 
at 6 month follow-up. In general, the absolute number of patients transitioning 
between 3 and 6 month follow up for uncomplicated and complicated mTBI are 
almost even.
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Figure 3.1. Frequency of post-concussion symptoms with a severity rating of 2 
(mild problem) or higher at 3 months
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Figure 3.2. Frequency of post-concussion symptoms with a severity rating of 2 
(mild problem) or higher at 6 months
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Figure 4. Prevalence of PCS for patients after uncomplicated and complicated 
mTBI at 3 and 6 months
  
PCS, Post-Concussion Syndrome; mTBI, Mild Traumatic Brain Injury
Rating score 2 = mild or worse; Rating score 3 = moderate or worse
Figure 5. Trajectories of patients after uncomplicated and complicated mTBI with 
PCS at 3 and 6 month follow up
mTBI, Mild Traumatic Brain Injury; PCS, Post-Concussion Syndrome; n = number of patients
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Figure 6.1 shows the differentiation per stratum for patients after complicated and 
uncomplicated mTBI classified as having PCS. The PCS prevalence for patients 
after complicated mTBI were 43.6% and 51.1% for the admission and ICU strata, 
respectively. These percentages were higher than the 37.7% admission and 48.3% 
ICU PCS prevalence rates which were found for patients after uncomplicated mTBI. 
When looking at 6 months, the reported percentages of patients classified as having 
PCS for both groups were very similar within the admission stratum, however, the 
ER and ICU stratum stayed around the same (Figure 6.2).
Figure 6.1. Number and percentage of uncomplicated and complicated mTBI with 
PCS differentiated by strata at 3 months 
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Figure 6.2. Number and percentage of uncomplicated and complicated mTBI with 
PCS differentiated by strata at 6 months 
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Table 3 shows a summary of a covariate adjusted analysis for the association of 
complicated and uncomplicated mTBI on the presence of PCS. After adjusting for 
baseline covariates, the association of complicated versus uncomplicated mTBI 
at 3 month follow up was of only borderline significance with an odds ratio (OR) 
of 1.25 (95% CI: 0.95 – 1.66). This implies that the difference in PCS prevalence 
between complicated versus uncomplicated mTBI at 3 months can be influenced 
by differences in baseline characteristics. However, at 6 month follow up, the 
association was rendered insignificant (OR: 1.07, 95% CI: 0.80-1.42) (Appendix D).
Table 3. Summary of covariate adjusted analysis  for the association between 
complicated versus uncomplicated mTBI on the presence of PCS at 3 months and 
6 months
3 months 6 months
OR 95% CI OR 95% CI
Unadjusted 1.54 1.22 - 1.94 1.39 1.10 - 1.76
Adjusted 1.25 0.95 - 1.66 1.07 0.80 - 1.42
Baseline covariates adjusted for: age, gender, education, injury mechanism, GCS, complicated vs. 
uncomplicated, psychiatric medical history and stratum.
Abbreviations. mTBI, mild traumatic brain injury; PCS, post-concussion syndrome; OR, Odds Ratio; 95% 
CI, 95% confidence interval. 
Discussion
This study focussed on the three and six month prevalence rates of post-
concussion symptoms and PCS of patients after complicated and uncomplicated 
mTBI included in a large European database. Overall, we demonstrated that 
patients after complicated mTBI report significantly more symptoms and have 
higher prevalence rates of PCS at these points in time. The differences observed 
at three months (complicated: 45.6% vs. uncomplicated: 35.3%) and six months 
(complicated: 42.7% vs. uncomplicated 34.4%), were in line with a previous study 
done by McMahon et al.[20] However, we found a decrease in symptom reporting 
from three to six months for both groups, and this is in contrast with McMahon et al. 
since they determined that patients after uncomplicated mTBI were stable in their 
symptom reporting across the follow-up times, whereas patients after complicated 
mTBI reported significantly higher symptoms at six and 12 months compared to 
three months. Additionally, we found that complicated and uncomplicated mTBI 
patients transition between being classified with PCS at 3 and 6 month follow up, 
which meant that some patients with PCS ‘recover’ after 3 months and some enter 
the threshold of PCS from 3 to 6 months. Depending on the analysis approach taken, 
rating score 2 or rating score 3, we observed variability in results. However, our 
results confirm a higher prevalence of PCS in patients after complicated compared 
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to uncomplicated mTBI across both approaches. When looking at the association of 
complicated and uncomplicated mTBI on the presence of PCS, it became less clear 
after adjusting for baseline covariates, which suggests that the reported differences 
in this study may be explained by differentiations in baseline characteristics. Lastly, 
a larger number of complicated mTBI patients were found in the admission and ICU 
strata, and the percentages of patients classified as having PCS was also higher for 
both these strata when comparing patients after complicated and uncomplicated 
mTBI. In terms of PCS occurrence, patients in the admission and ICU strata would 
appear to represent an “enriched” population, but it is not clear if targeting patients 
with complicated mTBI would lead to substantial additional enrichment.  
In previous research, contradictions in reporting differences regarding post-
concussion symptom and syndrome following complicated and uncomplicated 
mTBI has led to a conundrum, which is based on the question if patients after 
complicated mTBI are similar or dissimilar based on symptom reporting compared 
to uncomplicated mTBI patients. Furthermore, the discussion still stands if post-
concussion symptoms are TBI specific[31] and regarding the existence of post-
concussion syndrome.[4, 32, 33] There is no gold standard regarding defining PCS 
and which severity rating should be used as a cut-off,[26] and different approaches 
to analysis, classification and quantification of PCS exist and lead to variability 
in results.[26] This has also been demonstrated in this study, where the different 
severity rating scores have shown to have a substantial impact on the results, since 
the symptom percentages and PCS prevalence drop down to half when using rating 
score 3 as a cut-off. 
The current study is unique compared to previous studies, because none of them 
have looked at a large sample such as in this study to compare self-reported 
symptoms from patients after complicated and uncomplicated mTBI nor did they 
assess both concepts, post-concussion symptoms and PCS alongside each other. 
A number of limitations of our study should be recognized. No information was 
available considering if patients were involved in a litigation. Lees-Haley et al. 
have accentuated the need for caution when relying on self-reported symptoms 
as evidence of brain damage in patients involved in litigation, since they are more 
likely to endorse post-concussion symptoms.[34] Additionally, response bias might 
also be portrayed in this study. Patients who did not complete the RPQ might be 
less likely to partake in the follow up than patients who did experience symptoms.
[26] There was no detailed information on pre-morbid personality traits [35, 36] 
and limited on the psychological distress of patients.[37] These factors could all 
potentially influence the reported outcome after mTBI. Furthermore, the RPQ was 
collected through various ways, and the method of administration could have 
influenced patients’ symptom reporting.[23, 38] Lastly, there is a broad spectrum of 
abnormalities within the complicated mTBI group and doctors might treat patients 
differently when objective evidence for the brain injury was found.[21] Moreover, 
the confirmation of structural damage to the brain provided by imaging studies 
showing traumatic abnormalities (e.g. complicated mTBI) might lead to a higher 
rate of self-reported symptoms.  
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For future research it would be recommended to look at the localization of 
abnormalities in CT or MRI data and see how this may effect post-concussion 
symptom reporting since in previous research CT abnormalities have been 
found to be related to outcome.[39] Additionally, brain imaging methods and 
technology are advancing and this could potentially help to revolutionize and 
improve our understanding and detection of small changes in the brain following 
mTBI.[3, 24] Furthermore, looking into the differences in treatment and treatment 
policies between complicated and uncomplicated mTBI would establish a better 
understanding considering the outcome. It would also be interesting to determine 
the occurrence of post-concussion symptoms and PCS at one year or even later 
follow-up times. Lastly, the DSM-V edition did not include PCS, but introduced the 
term mild neurocognitive impairment [MNI] due to TBI instead, which shows there 
is a move away from using PCS in mTBI research.
Conclusions 
This study showed that patients after complicated mTBI reported more post-
concussion symptoms and have higher PCS prevalence rates compared to patients 
with uncomplicated mTBI at three and six months, which presents complicated mTBI 
as an indicator for these problems. However, the differences between both patient 
groups are small, and after adjusting for baseline covariates, this association could 
be explained by differences in baseline characteristics. These findings highlight the 
need to take the long-term impact on outcome for patients diagnosed with mTBI into 
consideration, and both patient groups are in need of clinical follow-up.
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Appendix
Appendix A. Method of administration of the Rivermead Post-Concussion 
Symptoms Questionnaire
Telephone 
interview
Postal 
questionnaire
Web-based 
completion 
Face-to-face 
interview
Not completed/
missing
3 months 97 (3.3%) 784 (26.5%) 2 (0.07%) 418 (14.1%) 1653 (55.9%)
6 months 45 (1.5%) 594 (20.1%) 4 (0.14%) 659 (22.3%) 1653 (55.9%)
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Appendix B. Characteristics of mTBI patients with complete and incomplete RPQ
Complete RPQ Incomplete RPQ P-value
N 1302 1653
Gender (male) 827 (63.5%) 1076 (65.1%) 0.374
Age1 (years) 53 [35-66] 49 (29-69) 0.207
Education1 (years) 14 [11-17] 12 (10-15) <0.01
Injury Mechanism <0.01
Road traffic accident 504 (38.7%) 506 (30.6%)
Incidental fall 616 (47.3%) 825 (49.9%)
Other non-intentional 72 (5.5%) 91 (5.5%)
Violence/assault 43 (3.3%) 140 (8.5%)
Act of mass violence 1 (0.1%) 3 (0.2%)
Suicide attempt 7 (0.5%) 8 (0.5%)
Other 42 (3.2%) 50 (3.0%)
Unknown 17 (1.3%) 30 (1.8%)
Psychiatric Medical 
History 146 (11.2%) 249 (15.1%) <0.01
Anxiety 36 (24.7%) 77 (30.9%) 0.183
Depression 89 (61.0%) 146 (58.6%) 0.65
Sleep disorders 19 (13.0%) 34 (13.7%) 0.857
Schizophrenia 3 (2.1%) 2 (0.8%) 0.283
Substance abuse disorder 17 (11.6%) 62 (24.9%) <0.01
Other 19 (13.0%) 43 (17.3%) 0.262
GCS baseline1 15 [15-15] 15 (14-15) 0.037
Computed Tomography
Any intracranial injury on 
first CT 599 (46.0%) 652 (39.4%) <0.01
1 Data are displayed as median, with the first and third quartile given within brackets.
Abbreviations. mTBI, mild traumatic brain injury; RPQ, Rivermead-Post-Concussion Symptoms 
Questionnaire; CT, Computed Tomography.
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Appendix C.1 Frequency of post-concussion symptoms with a severity rating of 3 
(moderate problem) or higher at 3 months
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Appendix C.2 Frequency of post-concussion symptoms with a severity rating of 3 
(moderate problem) or higher at 6 months
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Appendix D. Significant predictors in a multivariable model on the association of 
complicated versus uncomplicated mTBI on the presence of PCS (with a severity 
rating of 2 (mild problem) or higher)
Post-Concussion Syndrome 3 months 6 months
Predictor OR 95% CI P-value OR
Age 0.995 0.989 - 1.001 0.083 1.002
Gender (male) 0.588 0.460 - 0.749 <0.01 0.617
Education 0.998 0.970 - 1.027 0.894 0.979
Stratum (ER)
Admission 1.517 1.127 - 2.044 <0.01 1.254
ICU 2.013 1.371 - 2.956 <0.01 2.128
GCS baseline 0.925 0.753 - 1.137 0.459 0.927
Injury Mechanism (other)
Road traffic accident 1.105 0.722 - 1.692 0.644 1.045
Incidental fall 1.252 0.967 - 1.620 0.088 1.623
Violence/assault/suicide 1.012 0.543 - 1.888 0.968 1.353
Psychiatric Medical 
History (yes) 1.592 0.698 - 3.632 0.269 2.8
Anxiety (yes) 1.198 0.516 - 2.783 0.674 0.687
Depression (yes) 1.146 0.513 - 2.559 0.74 0.832
Sleep disorders (yes) 1.631 0.557 - 4.782 0.372 0.817
Substance abuse disorder 
(yes) 1.272 0.414 - 3.915 0.674 2.092
Other 1.063 0.354 - 3.188 0.913 0.509
Any intracranial injury on 
first CT (yes) 1.252 0.945 - 1.658 0.117 1.084
N 1302 1302
Nagelkerke R2 0.072 0.085
Note: schizophrenia was taken out of the analyses due to limited number of patients; violence/assault, 
act of mass violence and suicide attempt were grouped together into ‘violence/assault/suicide’; other 
non-intentional and other were grouped together into ‘other’.
Abbreviations. mTBI, mild traumatic brain injury; PCS, post-concussion syndrome; OR, Odds Ratio; 95% 
CI, 95% confidence interval; PCS, post-concussion syndrome; ER, emergency room; ICU, intensive 
care unit; RTA, road traffic accident; CT, computed tomography.
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Abstract
The objective of this study was to provide a comprehensive examination of the 
relation of complicated and uncomplicated mild traumatic brain injury (mTBI) 
with multidimensional outcomes at three and six months after TBI. We analyzed 
data from the Collaborative European NeuroTrauma Effectiveness Research 
(CENTER-TBI) research project. Patients after mTBI (Glasgow Coma scale (GCS) 
score of 13-15) enrolled in the study were differentiated into two groups based on 
computed tomography (CT) findings: complicated mTBI (presence of any traumatic 
intracranial injury on first CT) and uncomplicated mTBI (absence of any traumatic 
intracranial injury on first CT). Multidimensional outcomes were assessed using 
seven instruments measuring generic and disease-specific health-related quality 
of life (HRQoL) (SF-36 and QOLIBRI), functional outcome (GOSE), and psycho-
social domains including symptoms of post-traumatic stress disorder (PTSD) 
(PCL-5), depression (PHQ-9), and anxiety (GAD-7). Data were analyzed using a 
multivariate repeated measures approach (MANOVA-RM), which inspected mTBI 
groups at three and six months post injury. Patients after complicated mTBI had 
significantly lower GOSE scores, reported lower physical and mental component 
summary scores based on the SF-36 version 2, and showed significantly lower 
HRQoL measured by QOLIBRI compared to those after uncomplicated mTBI. There 
was no difference between mTBI groups when looking at psychological outcomes, 
however, a slight improvement in PTSD symptoms and depression was observed 
for the entire sample from three to six months. Patients after complicated mTBI 
reported lower generic and disease-specific HRQoL and worse functional outcome 
compared to individuals after uncomplicated mTBI at three and six months. Both 
groups showed a tendency to improve on outcome from three to six months after 
TBI. The complicated mTBI group included more patients with impaired long-
term outcome than the uncomplicated group. Nevertheless, patients, clinicians, 
researchers, and decisions-makers in health care should take account of the 
short and long-term impact on outcome for patients after both uncomplicated and 
complicated mTBI.
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Introduction
In the European Union 1.5 million hospitalizations result from traumatic brain injury 
(TBI) annually [1, 2]. Approximately 70-90% of patients presenting to hospital are 
diagnosed with mild TBI (mTBI), which is generally classified with a Glasgow Coma 
Scale (GCS) score of 13 to 15 [1]. Williams et al. have elaborated further on this 
description of mTBI and proposed that intracranial abnormalities on the computed 
tomography (CT) on presentation should be taken into account. This resulted in 
distinguishing patients after complicated (presence of trauma-related intracranial 
abnormalities and/or depressed skull fracture on CT) and uncomplicated (absence 
of intracranial abnormalities and/or depressed skull fracture on CT) mTBI[3]. The 
sensitivity of CT has improved over the years, and an abnormal scan may no longer 
have the same significance.
Previous research concerning the impact of complicated and uncomplicated mTBI 
on outcome has been contradictory. On the one hand, the presence or absence of 
intracranial abnormalities is seen as relevant to prognosis, since complicated mTBI 
has been associated with cognitive and functional outcome comparable to patients 
after moderate TBI (GCS 9-13) [3-6]. In contrast, other studies have shown no 
relationship between complicated mTBI and cognitive and functional outcome [7-9]. 
Additionally, previous research reported divergent results concerning longitudinal 
outcome after complicated and uncomplicated mTBI. In some studies, patients after 
complicated mTBI reported worse outcome than individuals after uncomplicated 
mTBI [7, 10, 11]. While others observed improvement in patients after complicated 
mTBI over time and showed slower recovery in the uncomplicated mTBI group [12]. 
A few studies even found no significant differences between the two groups [7, 9]. 
In previous research, the focus in complicated and uncomplicated mTBI research 
has mainly been on neurocognitive and functional outcome, and post-concussion 
symptoms [4, 5, 7, 11, 13-15]. However, nowadays, generic and disease-specific 
health-related quality of life (HRQoL) have been acknowledged as an important 
outcome after TBI [16, 17] for both patients and clinicians. HRQoL reflects an 
individual’s perception of how an illness and its treatment affect the physical, 
mental, cognitive and social aspects of someone’s life [16, 18, 19].
Despite an abundance of studies and decades of research on complicated and 
uncomplicated patients after mTBI, only few studies have examined HRQoL 
outcomes in patients after complicated and uncomplicated mTBI [20] and 
differences regarding outcome between these groups remain poorly understood. 
There has not yet been a study with a large sample size, taking longitudinal changes 
into account, and the ability to compare patients on different outcome domains: 
generic and disease specific HRQoL, functional outcome and symptomatology, 
such as post-traumatic stress, depression and anxiety. Moreover, the authors of 
the present study are not aware of any studies using a multivariate approach when 
exploring HRQoL, functional and psychological outcomes in adult patients [21]. As 
(m)TBI may affect different areas simultaneously, it is important to investigate the 
differences between groups by using multidimensional approaches [22]. 
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We hypothesize that patients after complicated mTBI report lower generic and 
disease-specific HRQoL and worse functional outcome compared to uncomplicated 
mTBI at three and six months. Additionally, we do not expect considerable 
improvement in outcome from three to six months.   
More insight is needed regarding the impact of complicated mTBI compared to 
uncomplicated mTBI on outcome from a longitudinal perspective. Therefore, the 
objective of this study was to provide a comprehensive multidimensional approach 
in analyzing the effects of complicated and uncomplicated mTBI on outcome in a 
large sample of individuals at three and six months post-injury.
Materials and Methods
Study design
In this study we analyzed patients who were enrolled in the Collaborative European 
NeuroTrauma Effectiveness Research (CENTER-TBI) research project. This is 
a multicenter, prospective, observational, longitudinal cohort study, which was 
conducted in Europe and Israel [1, 23]. Patients with all severities of TBI who 
presented to hospital were included between 19 December 2014 and 17 December 
2017. A clinical diagnosis of TBI, an indication for a CT scan, presenting to a center 
within 24 hours after the injury, and informed consent were used as inclusion criteria. 
Informed consent, adhering to local and national requirements, had to be obtained 
prior to inclusion, either personally or through a legally acceptable representative. 
At any point in time during the study patients were free to withdraw without stating 
a reason. Patients with severe pre-existing neurological disorders, which could 
invalidate assessment of outcomes, were excluded. Patients were recruited in 
three strata: emergency room (ER; patients evaluated at the ER and discharged 
afterwards), admission (ADM; patients admitted to hospital ward), and intensive 
care unit (ICU; patients who were primarily admitted to the ICU) [23]. The main 
descriptive findings of CENTER-TBI can be found in Steyerberg et al. [24].  
Study participants
In the current study analysis, participants were included if they had mTBI (GCS 
13-15). They were differentiated in two groups: complicated and uncomplicated 
mTBI. Complicated mTBI was specified as presence of any traumatic intracranial 
abnormalities on first CT scan and uncomplicated was specified as absence of 
any traumatic intracranial abnormality on first CT. The presence of intracranial 
abnormality was defined as the detection of at least one of the following twelve 
findings on the CT scan: mass lesion, extra axial hematoma, epidural hematoma, 
acute or chronic subdural hematoma, one or multiple subdural collections/
mixed density hematomas, contusion, traumatic axonal injury (TAI), traumatic 
subarachnoid hemorrhage, intraventricular hemorrhage, midline shift, or cisternal 
compression. In the current study, a linear or depressed skull fracture, in the 
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absence of structural intracranial abnormalities, was not considered as a criterion 
for complicated mTBI, however, this has been used as a determinant of intracranial 
abnormalities in previous research. Furthermore, participants had to be ≥ 16 years 
of age and classified as GOSE ≥ 3. 
The American Society of Anesthesiologists Physical Status Classification System 
(ASA-PS) was used to assess individuals’ health status before the injury[25].  
For all analyses, a complete case analysis for the following variables at three and 
six months was performed: SF-36, QOLIBRI, GOSE, PCL-5, PHQ-9 and GAD-7. For 
more details, see Figure 1.
Figure 1. Flowchart sample size
N = 4509
Recruited into the core 
CENTER-TBI study
Not meeting inclusion 
criteria (N = 2232):
Age < 16 (n = 149)
GOSE < 3 (n = 1185)
Moderate or severe TBI (n = 1554)
Not meeting inclusion 
criteria (N = 1173):
mTBI groups (n = 124)
Absent outcomes at three months:
SF-36 PCS (n = 731)
SF-36 MCS (n = 737)
QOLIBRI (n = 720)
GOSE (n = 720)
PCL-5 (n = 738)
PHQ-9 (n = 735)
GAD-7 (n = 737)
Absent outcomes at six months:
SF-36 PCS (n = 697)
SF-36 MCS (n = 696)
QOLIBRI (n = 709)
GOSE (n = 429)
PCL-5 (n = 711)
PHQ-9 (n = 713)
GAD-7 (n = 719)
N = 2277
Age ≥ 16, GOSE ≥ 3, mTBI
N = 1104
Participated at 3 and 6 
months and completed 
outcomes (final sample)
Abbreviations. N = number; mTBI = mild traumatic brain injury; GOSE = Glasgow Outcome Scale 
Extended; TBI = traumatic brain injury; SF-36 PCS = Short Form (36) Health Survey (physical component 
score); SF-36 MCS = Short Form (36) Health Survey (mental component score); QOLIBRI = Quality 
of Life after Brain Injury; PCL-5 = Posttraumatic Stress Disorder Checklist; PHQ-9 = Patient Health 
Questionnaire; GOSE = Glasgow Outcome Scale - Extended; GAD-7 = Generalized Anxiety Disorder 
questionnaire.
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Instruments
Outcome was assessed as a multidimensional construct by using seven instruments 
measuring generic and disease-specific HRQoL, functional outcome, and psycho-
social domains including post-traumatic stress, depression and anxiety. The 
following measures were analyzed: 
Health-related quality of life (HRQoL)
Generic HRQoL. The 36-item Short Form (SF-36v2) Health Survey is a multidimensional 
self-report questionnaire measuring the subjective health state including physical, 
mental, and social functioning [26]. The questionnaire comprises 36 items 
covering eight domains and applies different response scales from a dichotomous 
(“yes”/”no”) to a polytomous five-point Likert scale. For more information see Ware 
et al.[26]. For our analyses, we used the two summary component scores: physical 
component summary (PCS) and mental component summary (MCS) score, which 
measure physical functioning and mental health, respectively. The total score of the 
SF-36 ranges from 0 to 100, whereby higher values indicate higher HRQoL, and 
total scores below 40 are considered impaired [27].
Disease specific HRQoL. The Quality of Life after Brain Injury (QOLIBRI) is a 37-
item self-report instrument which measures level of satisfaction with various aspects 
of TBI-specific HRQoL [28]. It entails six scales evaluating key aspects of life: the 
first four scales assess ‘satisfaction’ with cognition, self, daily life and autonomy 
and social relationships and the last two scales measure ‘feeling bothered’ with 
emotions and physical problems. Responses are given on a five-point Likert scale 
which extends from 0 (“not at all”) to 4 (“very”). The total score was transformed 
linearly to range from 0-100; higher values indicate better HRQoL[28]. For the 
QOLIBRI, scores below 60 are considered impaired [29].
Functional outcome
Glasgow Outcome Scale Extended (GOSE) measures functional outcome after TBI. 
Functional outcome is rated by a clinician on an eight point scale: 1 (dead), 2 
(vegetative state), 3 (lower sever disability), 4 (upper severe disability), 5 (lower 
moderate disability), 6 (upper moderate disability), 7 (lower good recovery) and 
8 (upper good recovery) and is derived from eight questions [30]. In the present 
study, functional impairment was classified as a GOSE score ≤ 6 [31]. Structured 
interviews and self-report questionnaires were used to collect the GOSE. A multistate 
model was used to impute the 180-day GOSE when patients scores were outside 
the 5 to 8 month window (msm R package) [32]. Patients with GOSE 1 (dead) were 
excluded from analyses, and GOSE levels 2 and 3 were collapsed into one. 
Post-traumatic stress, depression and anxiety
The Posttraumatic Stress Disorder Checklist-5 (PCL-5) [33] measures 20 symptoms 
of post-traumatic stress disorder (PTSD) based on the Diagnostic and Statistical 
Manual of Mental Disorders, 5th edition (DSM-V) [34] by using a five-point scale 
(from 0 “not at all” to 4 “extremely”). The total score ranges from 0 to 80, whereby 
higher values indicate greater impairment and a score of ≥ 33 is considered 
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indicative of clinically relevant PTSD[35]. 
The Patient Health Questionnaire (PHQ-9) [36] is a nine item self-assessment 
instrument evaluating depression symptoms in the past two weeks using a four-
point Likert scale (from 0 “not at all” to 3 “nearly every day”) based on DSM-IV 
criteria [37]. The maximum score is 27 and the higher the score, the greater the 
indication for depressive symptoms. A score of ≥ 10 is seen as a strong indication 
for clinically relevant depressive symptoms and cutoffs of 5, 10 and 15 and 20 
indicate mild, moderate, and moderately severe to severe depressive symptoms, 
respectively [36, 38].
The Generalized Anxiety Disorder questionnaire (GAD-7) [39] measures anxiety 
symptoms in the past two weeks by using seven items with a four-point scale (from 
0 “not at all” to 3 “nearly every day”). The total score ranges from 0 to 27. A score 
of ≥ 10 is generally seen as an indicator for the presence of anxiety disorder and 
cutoffs 5, 10 and 15 indicate mild, moderate, and severe anxiety, respectively[39].
Ethical approval 
The CENTER-TBI study (EC grant 602150) has been conducted in accordance with 
all relevant laws of the EU if directly applicable or of direct effect, and all relevant laws 
of the country where the Recruiting sites were located, including, but not limited to, 
the relevant privacy and data protection laws and regulations (the “Privacy Law”), 
the relevant laws and regulations on the use of human materials, and all relevant 
guidance relating to clinical studies from time to time in force including, but not 
limited to, the ICH Harmonised Tripartite Guideline for Good Clinical Practice (CPMP/
ICH/135/95) (“ICH GCP”) and the World Medical Association Declaration of Helsinki 
entitled “Ethical Principles for Medical Research Involving Human Subjects”. Ethical 
approval was obtained for each recruiting site. Informed Consent was obtained for 
all patients recruited in the Core Dataset of CENTER-TBI and documented in the 
e-CRF. The list of sites, Ethical Committees, approval numbers, and approval dates 
can be found on the official Center TBI website www.center-tbi.eu/project/ethical-
approval. 
Statistical analyses
For all analyses, data was extracted from the INCF Neurobot tool (INCF, Solna, 
Sweden), a clinical study data management tool. Core data set version 2.1 (data 
frozen in January 2019) was used for all analyses in this manuscript. Descriptive 
analyses for care paths, demographic and socio-economic characteristics, pre-
injury health status and medical history, cause of injury, clinical presentation, CT 
characteristics, SF-36 MCS and SF-36 PCS, PCL-5, PHQ-9, GAD-7, QOLIBRI, 
and GOSE were performed and analyzed for patients with complicated and 
uncomplicated mTBI at three and six months post-injury. Descriptive statistics 
show the number (N) and percentages (%) for categorical variables and median 
and interquartile range (IQR) for continuous and ordinal variables. To compare 
individuals after complicated mTBI to uncomplicated mTBI, Chi-square tests 
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and Mann-Whitney U-tests were used for categorical and continuous variables, 
respectively. 
We compared individuals with a least one impaired outcome with those classified 
as not impaired at all (i.e., each outcome value did not exceed respective cut-off 
value). For analyses of individuals who were classified as impaired according to 
the cut-off values of unfavorable outcome for each outcome variable, new variables 
with classification (impaired vs. not impaired) were calculated for each dependent 
variable separately. See the instrument descriptions for the respective selected 
cut-off values. Distributions of individuals classified as reporting impaired outcome 
within mTBI groups were compared by using Chi-square tests for both three and 
six months after TBI. 
Data were analyzed using a multivariate repeated measures approach (MANOVA-
RM), suitable for non-normal data with covariance heterogeneity, to provide robust 
test statistics [40, 41]. The outcome construct (dependent variables) consisted of 
seven instruments assessing outcomes (SF-36 MCS and SF-36 PCS, PCL-5, PHQ-
9, GAD-7, QOLIBRI, and GOSE). The between effect was defined by complicated 
and uncomplicated mTBI groups. The within effect was defined by time points 
(three and six months after mTBI). 
For post hoc comparisons, we used repeated measures ANOVAs for non-normal 
data and significance was assessed at α < 0.007 applying a Bonferroni-adjustment 
( ).
All analyses were conducted using R version 3.6.1 [42] with application of the 
MANOVA-RM package [40] for both MANOVA-RM and post-hoc repeated 
measures ANOVAs. Appendix A gives a detailed overview of the methodology. The 
significance level was determined as α < 0.05 for Chi-square tests, Mann-Whitney 
U-tests, and multivariate analysis and α < 0.007 for post hoc comparisons between 
groups.
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Results
Study sample
The total CENTER-TBI cohort included 2,955 patients after mTBI and our study 
sample consisted of 1104 patients (37.4%) who were interviewed at both time 
points (3 and 6 months after mTBI) and completed all seven outcomes. Included 
patients were admitted to the ER (30.6%), ADM (47.6%), or the ICU (21.8%) and 
had sustained either uncomplicated mTBI (48.5%) or complicated mTBI (51.5%). 
The mean age of individuals after mTBI was 52.3 years (SD = 18.8) and 63.4% 
were male. The majority were injured by a fall (47%) or traffic incident (39%) and 
approximately 11% reported having experienced a TBI previously. Patients after 
complicated mTBI were significantly older (mean age: 54.5 vs. 50.3) compared to 
those after uncomplicated mTBI and were less likely to be classified as ‘working’, 
however, they less often reported a previous TBIs (p < 0.01). Patients after 
complicated mTBI were more often classified with a GCS score of 13 and 14. For 
more details, see Table 1.
Table 1. Characteristics of the study sample
Study sample Uncomplicated Complicated P-value
N 1104 569 (51.5%) 535 (48.5%)
Care paths < 0.01
ER 338 (30.6%) 286 (50.3%) 52 (9.7%)
Admission 525 (47.6%) 236 (41.5%) 289 (54.0%)
ICU 241 (21.8%) 47 (8.3%) 194 (36.3%)
Demographic characteristics
Gender (male) 700 (63.4%) 352 (61.9%) 348 (65.0%) 0.272
Age1 (years) 54 [37.25-67] 51 [35-65] 58 [40-68] < 0.01
Socio-economic characteristics
Education1 (years) 14 [12-17] 14 [12-17] 14 [11-17] 0.054
Employment status before 
injury
Working2 593 (53.7%) 331 (58.2%) 262 (49.0%) < 0.01
Pre-injury health status and 
medical history
Pre-injury ASA-PS classification 0.175
A patient with mild systemic 
disease 377 (34.1%) 181 (31.8%) 196 (36.6%)
A patient with severe systemic 
disease 106 (9.6%) 60 (10.5%) 46 (8.6%)
Previous TBI 129 (11.7%) 84 (14.8%) 45 (8.4%) < 0.01
Cause of injury
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Injury Mechanism 0.409
Road traffic accident 429 (38.9%) 222 (39.0%) 207 (38.7%)
Incidental fall 517 (46.8%) 265 (46.6%) 252 (47.2%)
Other non-intentional 60 (5.4%) 36 (6.3%) 24 (4.5%)
Violence/assault 38 (3.4%) 19 (3.3%) 19 (3.6%)
Act of mass violence 1 (0.1%) - 1 (0.2%)
Suicide attempt 7 (0.6%) 2 (0.4%) 5 (0.9%)
Other 36 (3.3%) 20 (3.5%) 16 (3.0%)
Unknown 16 (1.4) 5 (0.9%) 11 (2.1%)
Clinical presentation
GCS baseline1 15 [15-15] 15 [15-15] 15 [14-15] < 0.01
13 65 (5.9%) 9 (1.6%) 56 (10.5%)
14 155 (14.0%) 53 (9.3%) 102 (19.1%)
15 884 (80.1%) 507 (89.1%) 377 (70.5%)
CT characteristics
Computed Tomography
Any intracranial injury on first CT 535 (48.5%) 0 (0.0%) 535 (100%) < 0.01
1 Data are displayed as median, with the first and third quartile given within brackets.
2 Working = working 35 hours or more per week; working 20-34 hours per week; working less than 20 
hours per week and/or special employment/sheltered employment
Abbreviations. mTBI, mild traumatic brain injury; ER, emergency room; ICU, intensive care unit; ASA-PS, 
The American Society of Anaesthesiologists (ASA) Physical Status Classification System; TBI, traumatic 
brain injury; GCS, Glasgow Coma Scale; CT, Computed Tomography.
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Descriptive statistics of outcomes
Figure 2 provides an overview on outcome instruments and uncomplicated and 
complicated mTBI groups and time points. Patients after complicated mTBI reported 
both lower generic (PCS and MCS scores) and lower disease-specific HRQoL 
(QOLIBRI), lower functional outcome (GOSE), higher PCL-5, PHQ-9, and GAD-7 
scores compared to individuals after uncomplicated mTBI at both time points. In 
general, small differences were observed for both groups between 3 and 6 months. 
Figure 2. Boxplots for outcomes by time points and uncomplicated and complicated 
mTBI groups
Note. The Y-axis of the boxplots are adapted to the scales of the outcomes. Red dots within boxplots 
indicate the mean value.
Abbreviations. mTBI, mild traumatic brain injury; SF-36 PCS, Short Form (36) Health Survey (physical 
component score); SF-MCS, Short Form (36) Health Survey (mental component score); PCL-5, 
Posttraumatic Stress Disorder Checklist; PHQ-9, Patient Health Questionnaire; GAD-7, Generalized 
Anxiety Disorder questionnaire; QOLIBRI, Quality of Life after Brain Injury; GOSE, Glasgow Outcome 
Scale – Extended; 3mo, 3 months; 6mo, 6 months.  
118
Chapter 5
Appendix B provides mean values (M) and standard deviations (SD) for the seven 
outcomes clustered in the two mTBI groups and time points. 
Patients were considered impaired when the corresponding cut-offs were reached. 
The percentage of impaired individuals (i.e., with at least one of the seven outcomes 
being impaired) in the total sample was 53% at three months and 49% at six months 
after TBI. In the uncomplicated mTBI group, 51% and 49% were classified as 
impaired at three and six months, respectively. In the complicated mTBI group, 
53% at three months and 48% at six months had at least one impaired outcome. 
For development of impaired outcomes in individuals after uncomplicated and 
complicated mTBI at three and six months see Appendix C.
For both mTBI groups, there were patients included in our study sample who could 
be considered as reporting impaired outcomes. Therefore, these individuals with 
impaired outcomes were inspected separately. Table 2 gives an overview for each 
dependent variable by uncomplicated and complicated mTBI groups at three and 
six months post-injury.  
Table 2.  Percentages of impaired individuals according to the respective cut-off 
values
Outcome Time points
Uncomplicated mTBI 
(n = 569)
SF-36 PCS
3mo 24%
6mo 21%
SF-36 MCS
3mo 22%
6mo 21%
PCL-5
3mo 10%
6mo 8%
PHQ-9
3mo 16%
6mo 16%
GAD-7
3mo 11%
6mo 8%
QOLIBRI
3mo 19%
6mo 19%
GOSE
3mo 23%
6mo 16%
Note. Cut-off values: SF-36 PCS and SF-36 MCS < 40, PCL-5 ≥ 33, PHQ-9 ≥ 10, GAD-7 ≥ 10, QOLIBRI 
< 60, GOSE ≤ 6.
Abbreviations. mTBI, mild traumatic brain injury; 3mo, 3 months; 6mo, 6 months; SF-PCS, Short Form (36) 
Health Survey (physical component score); SF-MCS, Short Form (36) Health Survey (mental component 
score); PCL-5, Posttraumatic Stress Disorder Checklist; PHQ-9, Patient Health Questionnaire; GAD-7, 
Generalized Anxiety Disorder questionnaire; QOLIBRI, Quality of Life after Brain Injury; GOSE, Glasgow 
Outcome Scale - Extended; n, number of cases.
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At three months post TBI, there were significantly more individuals with impaired 
outcomes after complicated mTBI according to SF-36 MCS score, QOLIBRI, and 
GOSE (p < 0.05). Concerning the GOSE scale, 41% of patients after complicated 
mTBI were considered to be impaired (cut-off value ≤ 6) and 23% of the individuals 
after uncomplicated mTBI. Additionally, more patients with impaired generic (SF-36 
MCS < 40) and disease-specific (QOLIBRI < 60) HRQoL were observed within the 
complicated mTBI group (for details, see Table 2).
At six months after TBI, we observed significantly more individuals with impaired 
outcomes after complicated mTBI according to the GOSE scale (p < 0.05). More 
than one third of the patients after complicated mTBI showed impairments on the 
GOSE, compared to 16% of individuals after uncomplicated mTBI. Among the other 
outcomes, the distribution within mTBI group was equal. 
MANOVA-RM
MANOVA-RM showed significant differences between complicated and 
uncomplicated mTBI groups as well as between time points. No significant 
interaction was found between both main effects. There were significant differences 
between mTBI groups in three (generic and disease-specific HRQoL and functional 
outcome) out of seven outcomes. All but one domain (i.e., anxiety) differed between 
both time points (see Table 3 for test statistics).
Table 3. Results of repeated measures MANOVA and repeated measures ANOVA
Analysis Dependent variable(s) Independent variable (M)ATS df1 df2 p
M
AN
O
VA
 R
M Multiple mTBI 197.538 - - < 0.001
outcomes* Time points 34.708 - - < 0.001
mTBI : Time points 2.932 - - 0.158
AN
O
VA
 R
M
SF-36 PCS
mTBI 5.897 1 1365.422 0.015
Time points 61.133 1 - < 0.001
mTBI : Time points 4.361 1 - 0.037
SF-36 MCS
mTBI 7.879 1 1399.985 0.005
Time points 10.502 1 - 0.001
mTBI : Time points 3.058 1 - 0.08
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PCL-5
mTBI 5.481 1 1366.071 0.019
Time points 16.902 1 - < 0.001
mTBI : Time points 0.653 1 - 0.448
PHQ-9
mTBI 2.632 1 1386.136 0.114
Time points 9.075 1 - 0.005
mTBI : Time points 0.032 1 - 0.848
GAD-7
mTBI 3.216 1 1425.187 0.073
Time points 3.137 1 - 0.077
mTBI : Time points 0.026 1 - 0.872
QOLIBRI
mTBI 12.25 1 1337.174 < 0.001
Time points 8.588 1 - 0.003
mTBI : Time points 2.98 1 - 0.084
GOSE
mTBI 80.944 1 1444.067 < 0.001
Time points 26.15 1 - < 0.001
mTBI : Time points 1.057 1 - 0.304
Note. TBI severity = between effect (uncomplicated and complicated mTBI); Time = within effect (time 
points 3 and 6 months after TBI); p = p-value based on parametric bootstrapping ((M)ATS). Bold 
p-values are significant on α = 0.05 for MANOVA-RM and αadj = 0.007 for ANOVA-RM, respectively.
* Multiple outcomes = all seven outcomes combined as a dependent variable
Abbreviations. (M)ATS, (multivariate) ANOVA-type statistic; df1/df2, degrees of freedom; p, p-value; 
TBI, traumatic brain injury; SF-PCS, Short Form (36) Health Survey (physical component score); SF-
MCS, Short Form (36) Health Survey (mental component score); PCL-5, Posttraumatic Stress Disorder 
Checklist; PHQ-9, Patient Health Questionnaire; GAD-7, Generalized Anxiety Disorder questionnaire; 
QOLIBRI, Quality of Life after Brain Injury; GOSE, Glasgow Outcome Scale - Extended.
Post-hoc comparisons
Table 4 provides an overview on differences between mTBI groups, time points, 
and interaction between both effects according to the results of ANOVA-RM.
Post hoc comparisons revealed, in contrast to the multivariate results, a more 
detailed insight into differences between the main effects and their interaction for 
each dependent variable. Therefore, differences between mTBI groups and time 
points for the seven outcomes are reported separately. It is important to note that, 
with the exception of the mean depression score in the complicated mTBI group, all 
other outcomes were on average above the clinically relevant cut-off points.
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Table 4. Overview of differences between mTBI groups, time points, and interaction 
between both effects
Outcome mTBI Time points Interaction
SF-36 PCS -- ++ --
SF-36 MCS ++ ++ --
PCL-5 -- ++ --
PHQ-9 -- ++ --
GAD-7 -- -- --
QOLIBRI ++ ++ --
GOSE ++ ++ --
Note. ++ = significant on α = 0.007, -- not significant
Abbreviations. mTBI, mild traumatic brain injury; SF-PCS, Short Form (36) Health Survey (physical 
component score); SF-MCS, Short Form (36) Health Survey (mental component score); PCL-5, 
Posttraumatic Stress Disorder Checklist; PHQ-9, Patient Health Questionnaire; GAD-7, Generalized 
Anxiety Disorder questionnaire; QOLIBRI, Quality of Life after Brain Injury; GOSE, Glasgow Outcome 
Scale - Extended.
Health-related quality of life
Generic HRQoL. The PCS (SF-36) showed a significant within effect with an increase 
in HRQoL from three (M = 46.52, SD =10.43) to six months (M = 48.10, SD = 10.21) 
after TBI. 
The MCS (SF-36) revealed significant differences between both the mTBI groups 
and the observed time points. Individuals after uncomplicated mTBI (M = 48.43, SD 
= 11.01) reported significantly higher HRQoL compared to those after complicated 
mTBI (M = 46.61, SD = 12.07). There was a slight but significant increase of MCS 
score from three (M = 47.14, SD = 11.57) to six months (M = 47.95, SD = 11.56) 
after mTBI. 
Disease-specific HRQoL. For the QOLIBRI significant differences between both 
mTBI groups and time points were reported. HRQoL was significantly higher in the 
uncomplicated mTBI group (M = 74.97, SD = 16.82) compared to the complicated 
mTBI group (M = 71.56, SD = 17.33). In addition, an increase of HRQoL was 
observed between three (M = 72.84, SD = 17.05) and six months (M = 73.79, SD = 
17.24) following mTBI for both groups.
Functional outcome
For the GOSE, significant differences in both the between and the within effects 
were detected. Patients after complicated mTBI showed significantly higher 
disability levels (M = 6.63, SD = 1.37) compared to those with uncomplicated mTBI 
(M = 7.24, SD = 1.08). A significant increase concerning recovery was observed for 
both groups from three (M = 6.86, SD =1.301) to six months (M = 7.02, SD = 1.23).
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Post-traumatic stress, depression and anxiety
Results showed a significant decrease of PTSD related symptoms (PCL-5) from 
three (M = 12.54, SD = 13.44) to six months (M = 11.41, SD = 12.98) after mTBI. 
Depression related symptoms measured by the PHQ-9 were slightly but significantly 
higher for three (M = 4.93, SD = 5.04) compared to six months (M = 4.61, SD = 5.01) 
after mTBI. Anxiety measured by GAD-7 revealed no significance neither between 
mTBI groups nor between time points. 
Discussion
This study focused on outcome of patients after complicated and uncomplicated 
mTBI at three and six month post-injury, included in a large European database. 
Results may contribute significantly to existing literature concerning this topic. 
A better understanding of the relation between complicated and uncomplicated 
mTBI and different outcomes may improve intervention strategies and the recovery 
process of patients after mTBI.
When comparing individuals after complicated and uncomplicated mTBI, patients 
after complicated mTBI reported lower generic and disease-specific HRQoL 
and worse functional outcome at both time points. Nevertheless, we did not find 
considerable improvement in outcomes from three to six months as mean scores 
on all outcome measures were within average range and not classified as impaired. 
The mean PHQ-9 score for patients after complicated mTBI at three months post-
injury reached the cut-off for mild depressive symptoms, which indicates the need 
for an appropriate follow-up and early treatment. It is noteworthy that the number of 
individuals with impaired functional and psychological outcomes was considerably 
higher in the complicated mTBI group than in the uncomplicated group, especially 
three months post-injury. Therefore, one should ensure that these patients are 
detected early and their health status should be monitored longitudinally, to 
provide targeted and timely treatment. Ultimately, the differences between some 
measures were small and significant baseline differences between the groups 
might contribute to the reported findings. Especially, when keeping in mind that 
patients after complicated mTBI were often more severely injured according to the 
GCS score. 
In previous research, nearly 40% of patients with mTBI reported depressive symptoms 
within three to six months post-injury[43]. In addition, 33% of patients with mTBI were 
functionally impaired three months post-injury[13]. When specifically focusing on 
individuals after complicated and uncomplicated mTBI, contradictory results have 
been reported regarding the impact of complicated and uncomplicated mTBI on 
outcome. Ponsford et al. found that the majority of individuals after uncomplicated 
mTBI make a good recovery on average 7 months post-injury, when focusing on 
post-concussion symptoms, depression/anxiety and mental and physical quality of 
life scores [44]. In various studies, complicated mTBI is seen as a key component 
when predicting outcome [3-6]. However, other research did not find any relation 
between functional outcome and complicated mTBI [7-9]. Furthermore, HRQoL has 
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been under-investigated in previous research and a multidimensional approach to 
outcome assessment such as in this study has been lacking.
The present study is novel because there has not yet been a study with such a 
large sample size and simultaneously having the ability to compare patients on 
different outcome levels such as generic and disease-specific HRQoL, functional 
outcome, and symptomatology. Moreover, the methodology used in this study 
strengthened the results, since a multivariate statistical approach suitable for non-
normal distributed data with less assumptions and restrictions as in most other 
research was applied. In particular, the method combines information from multiple 
outcome measures and is also be suitable for non-normal data.
Several limitations concerning this study should be taken into account. It is important 
to note that the effects sizes were small for the PCS and MCS scores and PHQ-9, 
statistical significance was most likely due to the sample size used in this study. 
Resilience and coping, which was not measured in this study, might have impacted 
outcome. Maestas et al. reported that pre-injury coping in the sense of strengthening 
resilience could impact outcome after uncomplicated and complicated mTBI as 
coping may impact resilience [20]. Williams’ classification of complicated versus 
uncomplicated may underestimate the presence and type of TBI abnormalities as 
routine magnetic resonance imaging was proven to be far more sensitive and is 
the preferable tool [45]. Generalizability of the results presented in this study is 
restricted since adjustment for baseline covariates between the two groups was not 
provided. In the current study implications of treatment after mTBI have not been 
accounted for, which could influence the course of recovery after mTBI. Lastly, 
patients who are still experiencing lower HRQoL and lower functional outcome 
might have been more likely to participate, resulting in response bias [46]. 
For future research it would be interesting to look at outcome at later follow-up 
times such as five to ten years post-TBI. In addition, return to work or school 
after complicated and uncomplicated mTBI should be assessed since this could 
influence subjective well-being [47], and has major impact on societal costs [1]. 
Furthermore, research into biomarkers and localization of the abnormality on the CT 
or magnetic resonance imaging scan can could refine the conclusions drawn in this 
study [1, 10]. Lastly, to establish a better understanding considering outcome after 
complicated and uncomplicated mTBI, outcomes in this study should be compared 
to patients with non-brain injured trauma as well as the general population, and 
complicated and uncomplicated mTBI groups should be further differentiated by 
GCS score.
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Conclusions
To conclude, the present results indicate that patients after complicated mTBI 
reported lower generic and disease-specific HRQoL and worse functional outcome 
compared to patients after uncomplicated mTBI at three and six months. However, 
differences between some measures were small and there were significant 
baseline differences between the groups that might contribute to the findings. 
Both groups showed a tendency to improve on outcome from three to six months 
after TBI. Additionally, the complicated mTBI group comprised more patients with 
impaired outcomes than the uncomplicated group. Considering this, patients, 
clinicians, researchers, and decisions-makers in health care should be taking the 
short and long-term effects on outcome for patients after both uncomplicated and 
complicated mTBI into account. At the same time, individually tailored therapy 
should be provided early on for those who show deficiencies in recovery, HRQoL, 
psychological and psychosocial outcomes.
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Appendix
Appendix A. Statistical Model and Methods (available per request)
Appendix B. Descriptive statistics on outcomes by uncomplicated and complicated 
mTBI groups
Uncomplicated mTBI Complicated mTBI 
(n = 569) (n = 535)
Outcome Time points M SD M SD
SF-36 PCS
3mo 47.41 10.56 45.56 10.22
6mo 48.58 10.37 47.59 10.01
SF-36 MCS
3mo 48.24 10.89 45.98 12.14
6mo 48.62 11.12 47.24 11.98
 PCL-5
3mo 11.8 13 13.33 13.86
6mo 10.45 12.39 12.42 13.51
PHQ-9
3mo 4.69 4.9 5.17 5.18
6mo 4.4 4.92 4.84 5.1
GAD-7
3mo 3.35 4.25 3.77 4.65
6mo 3.15 4.02 3.61 4.64
QOLIBRI
3mo 74.77 16.46 70.79 17.45
6mo 75.17 17.18 72.32 17.2
GOSE
3mo 7.17 1.1 6.53 1.42
6mo 7.3 1.06 6.73 1.32
Abbreviations. mTBI, mild traumatic brain injury; 3mo, 3 months; 6mo, 6 months; SF-PCS, Short Form (36) 
Health Survey (physical component score); SF-MCS, Short Form (36) Health Survey (mental component 
score); PCL-5, Posttraumatic Stress Disorder Checklist; PHQ-9, Patient Health Questionnaire; GAD-7, 
Generalized Anxiety Disorder questionnaire; QOLIBRI, Quality of Life after Brain Injury; GOSE, Glasgow 
Outcome Scale - Extended; n, number of cases; M, mean; SD, standard deviation.  
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Appendix C. Development of impaired outcomes in individuals after uncomplicated 
and complicated mTBI at three and six months
N
o.
 (%
) o
f p
at
ie
nt
s
(A) Uncomplicated mTBI
Not impaired (n = 310, 54%)
Not impaired (n = 204, 38%)
Impaired (n = 259, 46%)
Impaired (n = 331, 62%)
Impaired (n = 247, 43%)
Impaired (n = 290, 54%)
Not impaired (n = 322, 57%)
Not impaired (n = 245, 46%)
3 months 6 months
Not impaired: no impaired outcomes (according to the cut-off values)
Impaired: at least one impaired outcome (according to the cut-off values)
3 months 6 months
(B) Complicated mTBI
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Abstract
Objectives: To evaluate the frequency of post-concussion symptoms and prevalence 
and risk factors of post-concussion syndrome (PCS) in the general population, 
investigate the association between the Rivermead Post-Concussion Symptoms 
Questionnaire (RPQ) and self-perceived health, and evaluate differences between 
three European countries.
Methods: A web-based survey including the RPQ and EQ-5D was conducted 
among representative samples in three European countries.
Results: A total of 11,759 respondents completed the questionnaire. The most 
frequently reported symptom was fatigue (49.9%). Almost half (45.1%) of the 
respondents were classified as having PCS considering rating score 2 (three 
RPQ items with score ≥ 2) as a cut-off. Chronic health complaints were found as a 
significant risk factor for PCS. All items of the RPQ were positively correlated with 
the EQ-5D and the strongest positive correlation (0.633, p<0.001) was between 
RPQ item ‘feeling depressed or tearful’ and EQ-5D domain ‘anxiety/depression’.
Conclusions: We found a high frequency of post-concussion-like symptoms and 
PCS in the general population, indicating that these symptoms are not specific 
for patients with traumatic brain injury (TBI), and PCS is not a unique syndrome 
after TBI. Therefore, the use of post-concussion symptoms and PCS as outcome 
following mild TBI should be interpreted with caution. 
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Introduction
Post-concussion symptoms following a traumatic brain injury, and especially mild 
traumatic brain injury (mTBI), are very common.[1] Post-concussion symptoms can 
be categorized in physical symptoms, cognitive deficits and behavioral/emotional 
symptoms.[2] In general, many patients with mTBI make a full recovery within one 
year after injury,[3] but when several post-concussion symptoms persist over time, 
patients are considered as having a post-concussion syndrome (PCS). One of 
the most prominent diagnostic criteria of PCS is the International Classification of 
Diseases (ICD-10).[4] The Rivermead Post-Concussion Symptoms Questionnaire 
(RPQ) is a frequently applied instrument to assess the existence and severity of 
post-concussion symptoms.[5]
Over the last decennia, the concept of PCS has been debated in an abundance of 
studies. The prevalence rates of PCS throughout the literature vary greatly[6] and 
depend on the definition used[7] as well as the applied classification method.[8] 
Researchers and clinicians who have performed extensive research concerning 
the etiology of PCS have still not been able to successfully identify the pre- and 
post-injury-related factors as well as the underlying structure of post-concussion 
symptoms.[9] All controversy[10] and uncertainty leads to a growing concern 
whether PCS really does exist and if post-concussion symptoms are unique for 
patients with mTBI. Multiple studies have concluded that the etiology of the post-
concussion symptoms and/or syndrome might probably not resort back to the 
brain damage itself.[11-13] Moreover, self-reported symptoms may be nonspecific 
symptoms, which are not exclusively associated with patients with mTBI.[14] Post-
concussion symptoms can be caused by various factors, and it is complex to 
interpret which components may be linked specifically to the brain injury and to which 
extent symptoms already existed before the injury. Additionally, previous studies 
have shown that post-concussion-like symptoms exist in healthy populations[13, 
15-19] as well as in patients with a non-head injury trauma,[11, 14] patients with 
chronic pain[12] and personal injury claimants.[20] However, all previous studies 
had relatively small sample sizes and samples were not representative for general 
populations, since the populations studied mainly consisted of university students 
or patient groups.[11-18, 21] Furthermore, all studies were only conducted in one 
country at a time and most research was done in North-America,[12, 13, 16, 18-21] 
with exceptions of China,[15] France[14] and Australia.[11, 17]
Wang and colleagues have suggested that the differences in frequency of post-
concussion symptoms could be due to cultural differences.[15] Additionally, 
Zakzanis and colleagues[16] have shown that the influence of culture and language 
should be taken into consideration in PCS research. Consequently, prevalence 
rates in healthy populations may differ between countries. Apart from culture and 
language, a linkage between post-concussion symptoms and lower levels of life 
satisfaction[22] and lower health-related quality of life (HRQoL)[23] have been 
reported. Nonetheless, the patient populations in both these researches consisted 
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of patients with TBI. A strong link between post-concussion symptoms and HRQoL 
may suggest that PCS is debilitating. However, a weak association could point out 
that PCS consists of common symptoms that everyone experiences at some time 
which do not explicitly have a major effect on HRQoL. Whether this linkage also 
exists in healthy populations remains to be investigated.
The aims of this paper were to (a) evaluate the frequency of post-concussion 
symptoms and prevalence of PCS in general healthy populations, (b) assess the 
risk factors for PCS, (c) compare the RPQ with general HRQoL (EQ-5D), and (d) 
inspect the differences between three European countries.
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Methods
Participants
A web-based survey was conducted among a representative sample in three 
European countries, namely the United Kingdom (UK), the Netherlands and Italy. 
The respondents were recruited by Survey Sampling International (SSI), a market 
research agency, who distributed and launched the questionnaires. Existing large 
internet panels were used and these samples were designed to be representative 
of the population aged 18 to 70 in the selected countries with regard to age, gender 
and education. Data were obtained between June 29th and July 31st 2017. A total 
of 11,759 respondents filled out the questionnaire, which was comprised of 4,646 
respondents in UK, 3,564 respondents in the Netherlands and 3,549 respondents 
in Italy.
Patient consents
All participants, as members of a web-based panel, had already provided informed 
consent to participate in online surveys. Informed consent for the present survey 
was obtained from all those agreeing to complete the survey. Participants were 
informed on the welcome page that the survey aimed to better understand the 
consequences of traumatic brain injury, that it would take approximately 20 min to 
complete, and that all responses were confidential and anonymous. Consent was 
obtained when respondents clicking the ‘Go to Survey’ button from this page. This 
study was part of the CENTER-TBI study (EC grant 602150) and ethical approval 
was obtained from the Leids Universitair Centrum – Commissie Medische Ethiek 
(approval P14.222/NV/nv).
Measures
Prevalence and severity of post-concussion symptoms were evaluated by the use 
of the RPQ. A total of 16 different post-concussion symptoms are described in the 
RPQ, which include headaches, dizziness, nausea/vomiting, noise sensitivity, sleep 
disturbance, fatigue, being irritable, feeling depressed or tearful, feeling frustrated 
or impatient, forgetfulness, poor concentration, taking longer to think, blurred 
vision, light sensitivity, double vision and restlessness. During the questionnaire 
respondents were asked to assess the severity of the symptoms over the last 24 
h on a 5-point Likert scale: 0 (not experienced at all), 1 (no more of a problem), 2 
(a mild problem), 3 (a moderate problem) and 4 (a severe problem).[5] The RPQ 
total score is the sum of all 16 items excluding ratings of 1.[5] During this study, the 
criteria described in the ICD-10 are mapped onto the RPQ scale and respondents 
were classified as having PCS when they reported at least three out of the following 
symptoms: headaches, dizziness, fatigue, irritability, impaired memory, impaired 
concentration, and insomnia.[4] There is not a set standard available in the literature 
for which severity rating to uses as a cut-off, which resulted in two possible cut-offs; 
mild or higher (≥ rating score 2) and moderate or higher (≥ rating score 3) (Panel 
1).[8] In this study, we looked at both cut-offs separately.
HRQoL was measured by the EQ-5D. The EQ-5D constitutes of two parts: the 
EQ-5D descriptive system and the EQ visual analog scale (EQ VAS). The EQ-
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5D descriptive system encompasses five dimensions (mobility, self-care, usual 
activities, pain/discomfort, and anxiety/depression). The EQ-5D-5L was introduced 
in 2009 and gives respondents the opportunity to score the dimensions on five 
levels (no problems, slight problems, moderate problems, severe problems and 
extreme problems). The EQ-VAS consists of a vertical VAS rating scale, where 0 
is labeled as “The worst health you can imagine” and 100 as “The best health you 
can imagine” and documents the respondent’s self-rated health. The EQ-5D utility 
scores, which are on a scale from 0 (dead) to 1 (full health), for each country were 
calculated by the use of the Dutch value set.[24]
Panel 1. Severity rating cut-offs regarding Post-Concussion Syndrome
Cut-off rating score 2 Cut-off rating score 3 Eligible symptoms
Three RPQ items with 
score ≥ 2
Three RPQ items with 
score ≥ 3
Headache
Dizziness
Sleep disturbance
Fatigue
Being irritable, easily angered
Forgetfulness, poor memory
Poor concentration
Abbreviations. RPQ, Rivermead Post-Concussion Syndrome Questionnaire
Risk factors
Age, gender, education level, work status, income level, the experience of serious 
illness in respondents themselves; or their immediate family, whether respondents 
cared for others, and the experience of chronic health complaints were considered 
risk factors. This selection was based on the available data in our dataset and by 
looking at risk factors in previous literature.[25-27] The categorizations for the risk 
factors can be found in Appendix B.
Statistical analysis
Descriptive analyses were performed for demographic data (age, gender, 
education, work status, annual household income, the experience of serious illness 
in yourself, immediate family and caring for others, and chronic health complaints). 
The frequency of post-concussion-like symptoms was assessed by computing 
the percentages for respondents, and the prevalence of PCS was calculated by 
identifying the percentage of respondents that complied with our classifications.
Differences in mean EQ-5D utility and EQ-5D VAS scores per country were assessed 
by the use of the Kruskal Wallis H test, followed by post-hoc analyses where the 
significance values were adjusted by the Bonferroni correction for multiple tests. 
Statistical significance was determined by a p-value of p<0.05.
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By the use of Mann Whitney U tests, we inspected the difference for respondents 
with and without PCS in mean EQ-5D utility and mean EQ-5D VAS. To evaluate 
the correlation between the various EQ-5D dimensions and EQ-5D total score and 
the RPQ items, which were not normally distributed, the Spearman’s correlation 
coefficients were administered. Strong, moderate and weak correlations were 
differentiated between by Cohen’s Set Correlation and Contingency Tables: a 
coefficient above 0.5 the correlation was considered strong, a coefficient between 
0.3 and 0.5 moderate, and when the coefficient was below 0.3 it was considered 
as weak.[28]
The survey was translated from English into Dutch and Italian using translation 
software and subsequently translated back into English. Bilingual native speakers 
verified the translations independently.
All analyses were done for the complete database and per country. SPSS version 
24 for Windows (IBM SPSS Statistics, SPSS Inc, Chicago, IL) was used to perform 
all statistical analyses.
Data availability
The data that support the findings of this study are available from the corresponding 
author, [DV], upon reasonable request. Anonymized data will be shared.
Results
Study population
In total 11,759 respondents were included in this study. The characteristics of our 
study sample are shown in Table 1. The median age of the respondents was 44 
years (interquartile range (IQR); 32–57 years) and women and men were evenly 
represented. The educational level of the respondents can be divided up in 28.3% 
(low), 47.2% (middle) and 25.3% (high). Approximately 50% was employed and 
just over a half (52.2%) had experienced serious illness in their immediate family. 
One in two (50.9%) respondents has reported to have one or more chronic health 
complaints.
Frequency of post-concussion-like symptoms and prevalence of PCS
The most frequently reported symptom was fatigue (49.9%) followed by sleep 
disturbance (42.4%) (Figure 1). The least reported symptom was double vision 
(10.7%). The patterns for the reported post-concussion symptoms in the individual 
countries were quite similar. Fatigue was also the most frequently reported symptom 
in each country (UK: 52.6%, the Netherlands: 48.4% and Italy: 48.1%), followed 
by sleep disturbance (UK: 47.0%, the Netherlands: 40.1%), except for Italy where 
being irritable was the second most reported symptom (Italy: 44.0%). When using 
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rating score 3 as a cut-off the same pattern is detected (Appendix A).
Almost half (45.1%) of the respondents were classified as having PCS considering 
rating score 2 (three RPQ items with score ≥ 2) as a cut-off (Table 2). When using 
rating score 3 (three RPQ items with score ≥ 3) as a cut-off, this prevalence 
rate dropped substantially to 17.5%. When we inspected all respondents with 
chronic health complaints, higher PCS prevalence rates were found for every 
single complaint compared to the sample as a whole. Furthermore, respondents 
with memory problems due to a neurological disease/dementia had the highest 
percentage of PCS prevalence for rating score 2 (81.9%) and rating score 3 
(53.4%). The prevalence of PCS differed per country with the UK (47.8%) having the 
highest prevalence rates. When using rating score 3 as a cut-off, the biggest drop 
in prevalence rate is seen in Italy, which implies that Italians report less frequently 
moderate problems.
Figure 1. Frequency of post-concussion symptoms with a severity rating of 2* or 
higher per country
0
10
20
30
40
50
60
Fa
tigu
e
Sle
ep
 Di
stu
rba
nc
e
Fe
elin
g F
rus
tra
ted
 or
 Im
pa
tien
t
Be
ing
 Irr
itab
le,
 ea
sily
 an
ge
red
Fe
elin
g D
ep
res
sed
 or
 Te
arf
ul
He
ad
ac
he
s
Re
stle
ssn
es
s
Po
or 
Co
nc
en
tra
tio
n
Fo
rge
tfu
lne
ss,
 po
or 
me
mo
ry
Ta
kin
g L
on
ge
r to
 Th
ink
Fe
elin
gs
 of
 Di
zzi
ne
ss
No
ise
 Se
nsi
tivi
ty
Blu
rre
d V
isio
n
Lig
ht 
Se
ns
itiv
ity
Na
us
ea
 an
d/o
r V
om
itin
g
Do
ub
le 
Vis
ion
Cumulative percentages per symptom
UK
NL
IT
Cumulative percentages per symptom
139
1
9
5
13
3
11
7
4
12
8
2
10
6
14
Table 1. Characteristics of the study population
All respondents UK The Netherlands Italy
(N=11759)
N (%)
(N=4646)
N (%)
(N=3564)
N (%)
(N=3549)
N (%)
Age1 (years) 44 [32-57] 44 [31-57] 45 [32-57] 45 [33-57]
Gender (male) 5840 (49.7%) 2288 (49.2%) 1782 (50.0%) 1770 (49.9%)
Education2 
Low 3330 (28.3%) 1066 (22.9%) 1064 (29.9%) 1200 (33.8%)
Middle 5555 (47.2%) 1986 (42.7%) 1601 (44.9%) 1968 (55.5%)
High 2874 (24.4%) 1594 (34.3%) 899 (25.2%) 381 (10.7%)
Work status3 
Employed 6038 (51.3%) 2428 (52.3%) 1891 (53.1%) 1719 (48.4%)
Unemployed 1648 (14.0%) 417 (9.0%) 384 (10.8%) 847 (23.9%)
Looking after others4 601 (5.1%) 313 (6.7%) 149 (4.2%) 139 (3.9%)
Student 772 (6.6%) 287 (6.2%) 245 (6.9%) 240 (6.8%)
Retired 1743 (14.8%) 733 (15.8%) 452 (12.7%) 558 (15.7%)
Unable to work 957 (8.1%) 468 (10.1%) 443 (12.4%) 46 (1.3%)
Annual household 
income5
Low 2722 (23.1%) 999 (21.5%) 648 (18.2%) 1075 (30.3%)
Middle 2853 (24.3%) 1409 (30.3%) 614 (17.2%) 830 (23.4%)
High 4325 (36.8%) 1735 (37.3%) 1525 (42.8%) 1065 (30.0%)
Do not know/do not 
want to tell 1859 (15.8%) 503 (10.8%) 777 (21.8%) 579 (16.3%)
Experience of serious 
illness 
In you yourself (yes) 3115 (26.5%) 1640 (35.3%) 917 (25.7%) 558 (15.7%)
In your immediate 
family (yes) 6138 (52.2%) 2845 (61.2%) 2484 (69.7%) 809 (22.8%)
In caring for others 
(yes) 2822 (24.0%) 1520 (32.7%) 795 (22.3%) 507 (14.3%)
Chronic health 
complaints (yes)6 5983 (50.9%) 2487 (53.5%) 1887 (52.9%) 1609 (45.3%)
RPQ total score1 8 [0-20] 8 [0-22] 6 [0-18] 8 [2-18]
1 Data are displayed as median, with the first and third quartile given within brackets.
2 Education was divided up in low (junior school), middle (comprehensive school) and high (college 
and university).
3 Work status was categorized as employed (employee and self-employed), unemployed (consisting 
out of work for more than and less than 1 year), looking after others (e.g. a carer or parent), a student, 
retired and unable to work.
4 E.g. carer or parent.
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5 Income was grouped as follows low (UK; less than £14.000, Italy and the Netherlands; less than 
€20.000), middle (UK; £14.000-£27.999, Italy and the Netherlands; €20.000-€39.999) and high (UK; 
more than £27.999, Italy and the Netherlands; more than €39.999).
6 Chronic health complaints were defined as: asthma, chronic bronchitis, severe heart disease, 
consequences of a stroke, diabetes, severe back complaints, arthrosis, rheumatism, cancer, memory 
problems due to neurological disease/dementia, memory problems due to ageing, depression or anxiety 
disorder, and other chronic health complaints.
Table 2. Prevalence of Post-Concussion Syndrome in the general population
Rating score 2   Rating score 3 
Country PCS No, PCS PCS No, PCS
All respondents 5301 (45.1%) 6458 (54.9%) 2057 (17.5%) 9702 (82.5%)
UK 2221 (47.8%) 2425 (52.2%) 971 (20.9%) 3675 (79.1%)
NL 1442 (40.5%) 2122 (59.5%) 581 (16.3%) 2983 (83.7%)
IT 1638 (46.2%) 1911 (53.8%) 505 (14.2%) 3044 (85.8%)
Abbreviations. UK, United Kingdom; NL, the Netherlands, IT, Italy; PCS, Post-Concussion Syndrome.
Risk factors
Lower age, female gender, low education, unable to work, low-income level and 
when respondents indicated they experienced serious illness in respondents 
themselves, their immediate family, and when they cared for others, and chronic 
health complaints are all significantly associated with PCS (Appendix B). The most 
pronounced effects on PCS are “being a student” or “retired” compared to being 
“unable to work” and chronic health complaints. Multivariable prediction models 
explained 26% (rating score 2) and 24% (rating score 3) (Nagelkerke R2) of the 
variance in PCS.
EQ-5D utility
The mean EQ-5D utility score was 0.81. The lowest utility measured in this sample 
was −0.45% and 33.5% of the respondents reported no problems on any of the 
EQ-5D domains. As expected, the mean utility score was significantly lower for 
respondents with PCS compared to respondents without PCS (0.70 vs. 0.90; 
p<0.001) (Table 3). The mean EQ-5D VAS score was 74.7 (Table 4) and was also 
found to significantly differ between respondents with and without PCS (66.8 vs. 
81.2; p<0.001).
The highest mean utility score was found for Italian respondents (μ = 0.86, SD = 0.16), 
followed by Dutch respondents (μ = 0.83, SD = 0.21) and lastly British respondents 
(μ = 0.77, SD = 0.28). The lowest mean utility score was found for respondents from 
the UK with PCS according to rating score 3. There were statistically significant 
differences in EQ-5D utility and total scores between countries (p<0.05), except for 
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the utility between the Netherlands and Italy (p=0.051). Tables 3 and 4 also show 
the mean utility scores for respondents with and without PCS according to the two 
cut-offs and per country. The biggest difference in utility was determined for British 
respondents without PCS and with PCS according to rating score 3.
For the EQ-5D VAS scores, the same order was found as for the mean utility score, 
which means Italian respondents rate their own health the highest and British 
respondents the lowest, with the Dutch respondents in between both of them. The 
EQ-5D-VAS was determined to be significantly different for respondents with and 
without PCS in all countries (p<0 .001).
RPQ and EQ-5D
Figure 2 shows Spearman’s correlation coefficients between RPQ items and EQ-5D 
dimensions indicating that all items of the RPQ are positively correlated with the 
EQ-5D dimensions. The strongest positive correlation (0.633, p< .001) was found 
between ‘feeling depressed or tearful’ and the anxiety/depression dimension. The 
weakest correlation was between ‘headache’ and the mobility dimension. Fatigue 
has a moderate correlation with all EQ-5D dimensions, with the exception of the 
self-care dimension. All correlations were statistically significant on a p<0.001 level. 
Lastly, when looking at correlations between the EQ-5D total score and all RPQ 
items separately, fatigue (0.546, p<0.001) was determined as the strongest positive 
correlation and double vision (0.278, p<0.001) showed the weakest correlation with 
the EQ-5D total score.
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Figure 2. Correlation between RPQ items and EQ-5D domains.
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Discussion
This study provides the first examination of the frequency of post-concussion-like 
symptoms and the prevalence of PCS in a large and representative sample of the 
general population, and within and across three European countries. We found a 
high base rate of post-concussion-like symptoms and respondents with memory 
problems due to a neurological disease/dementia had the highest prevalence rate 
for PCS. The use of post-concussion symptoms and PCS as outcome following 
mTBI should be interpreted with caution.
Our findings correspond to those of preceding studies. Wang and colleagues 
investigated a group of university students, in which they found fatigue as the 
highest reported symptom with a frequency of 38.1%.[15] During this study, we also 
determined fatigue (49.9%) as the highest reported symptom for all respondents in 
the database. The prevalence rate of PCS was 45.1% considering rating score 2 as 
a cut-off, however; when using rating score 3 the prevalence for PCS decreased to 
17.5%, which is comparable to prevalence rates found by Lagarde and colleagues 
in patients with head injuries (28.7%) and patients with non-head injuries (22.9%).
[14]
The following risk factors were all significantly associated with PCS: lower age, 
female gender, low education, work status, low-income level, chronic health 
complaints, and when respondents experienced serious illness in themselves, their 
immediate family, and when they cared for others, and chronic health complaints. 
These findings are in line with previous studies.[25-27] Being a “student” or “retired” 
compared to being “unable to work” and chronic health complaints had the most 
noticeable effect on PCS. Statistically significant differences in EQ-5D utility, total 
scores, and EQ-5D VAS scores were found for patients with and without PCS. This 
indicates that being classified with PCS had a strong impact on the respondent’s 
HRQoL. In addition, correlations between all RPQ items and EQ-5D dimensions 
were high.
The current study is unique compared to previous studies, because none of 
them have looked at large samples such as in this study nor did they compare 
three different countries at the same time. Additionally, the database used is 
also representative for the general population with regards to age, gender, and 
educational level, where in previous studies mostly healthy university students were 
used.[13, 15-19]
Limitations include that for the calculation of the utility scores of the EQ-5D, Dutch 
value sets were used for all countries included in the analysis, mainly because there 
is no value set available yet for Italy. Using the same tariff for each country could 
potentially limit the representativeness of these scores in the separate countries, as 
the relative value of dimensions and levels may differ from those in the Netherlands. 
However, it does substantiate the comparability across the three countries. When 
comparing the population norms with the mean EQ-5D utility and VAS scores, the 
reported mean scores were comparable for the Netherlands and Italy. However, the 
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mean UK scores, 0.77 and 71.3, respectively, are lower than the population norms; 
0.86 and 82.8.[29]
Our study was conducted by the use of a web-based checklist, which might have 
led to ‘over’ reporting of symptoms, because according to Edmed & Sullivan, the 
method used to assess PCS symptoms influences the number and type of symptoms 
reported.[17] On the other hand, the RPQ is the most frequently applied instrument 
to classify PCS. By also incorporating this method in our study, our prevalence rates 
are comparable with previous mTBI studies. Another limitation is based on the fact 
that there were no questions asked if respondents had experienced a concussion, 
TBI or brain injury in their life or trauma’s in general. However, the expected TBI 
prevalence is 639.2 (UK), 278.6 (the Netherlands) and 214.5 (Italy), extrapolated 
from reported country-specific age-adjusted hospital discharge rates per 100.000 
due to TBI by Majdan and colleagues.[30] This is considerably lower than the found 
prevalence rates for PCS in this population. Nevertheless, the found pattern is similar 
to PCS distribution, where the UK was the highest and IT the lowest. Additionally, 
previous literature has determined that respondents suffering from depression and/
or burn-out or PTSD, or being involved in a litigation at the time of the questionnaire 
assessment are factors that could be associated with PCS.
However, in the current study, there is no information representing these aspects.[1, 
13] There is also no information available if respondents are enduring intolerance of 
stress, emotion or alcohol, which is the last criterion described in the ICD-10 criteria.
[4] Furthermore, we do not know to what extent our samples are representative for 
the population in the three countries with regards to characteristics other than age, 
gender, and educational level. Additionally, the people who partake in a market 
research panel might not be illustrative of the general population.
We were able to look at the representativeness of the sample with regards to HRQoL 
by comparing our scores with the population norms. However, it could be that our 
sample is not representative with regards to other factors and characteristics that 
impact the likelihood of developing PCS, and which should be taken into account 
when pooling representative samples. Moreover, the maximum age in our study 
sample was 70, whereas the TBI epidemiology is changing with a greater deal of 
patients aged 70 and older.[31]
More research is needed into which cut-off point is sufficient for PCS research, 
because the current literature is inconclusive concerning the severity rating score 
that should be used as a cut-off when the RPQ is applied to classify PCS. As shown 
during this study, and previous studies, the results change considerably depending 
on the cut-off.[8] Rating score 2 seems to be less discriminating as healthy adults 
are also being diagnosed with PCS, which points towards a high percentage of 
false-positives. Additionally, to correctly diagnose people with PCS, a clinical 
examination should take place rather than basing it on self-report of symptoms by 
the patient. Clinicians should be aware of the high post-concussion-like symptom 
endorsement and prevalence of PCS in the healthy population and the possible 
contributing risk factors in a specific country, and take this into consideration during 
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their clinical examination.[13] Considering the issues with current PCS assessment 
tools, more and more research is being done into new methods that may be better 
suited in the assessment of PCS (e.g. ocular motor assessment[32] and robotic 
technology[33]). It is very clear that a high base rate of PCS symptoms is present 
in the general population, so when looking at patients with TBI, one should wonder 
which part of the reported symptoms are actually due to the injury. There is a 
plethora of research being performed in the field of PCS, however, this study shows 
that there is no clear view on what is really being researched. Furthermore, this is 
supported by the fact that the prevalence rates of PCS halved when we looked at the 
respondents without any chronic health complaints and that prevalence depended 
substantially on the distribution of risk factors in a population that are not specific 
for TBI. The terminologies post-concussion symptoms and PCS should be modified 
as they are deceptive, since they incorrectly assume that the underlying principle 
of the symptoms and/or syndrome is a brain injury.[11]
Conclusions
This study showed that post-concussion-like symptoms are frequently reported, 
and the prevalence of PCS is prominent in the general population, indicating that 
post-concussion-like symptoms are not specific for patients with TBI, and PCS is not 
a unique syndrome after TBI. Post-concussion-like symptoms are highly correlated 
with EQ-5D dimensions. This suggests that post-concussion-like symptoms are 
debilitating and that also in the healthy population these symptoms have a major 
effect on HRQoL.
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Appendix
Appendix A. Frequency of post-concussion symptoms with a severity rating of 3* 
or higher per country 
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Post-Concussion 
Syndrome Rating Score 2* Rating score 3**
Predictor OR 95% CI OR 95% CI
Age 0.98 0.98 - 0.98 0.98 0.97 - 0.98
Gender (male) 0.58 0.53 - 0.64 0.664 0.59 - 0.75
Education (high)
Low 1.34 1.18 - 1.53 1.306 1.11 - 1.54
Middle 1.25 1.12 - 1.40 1.085 0.94 - 1.26
Work status (unable to 
work)
Employed 0.49 0.40 - 0.60 0.417 0.35 - 0.50
Unemployed 0.67 0.54 - 0.83 0.553 0.45 - 0.68
Carer 0.54 0.41 - 0.70 0.44 0.33 - 0.58
Student 0.36 0.27 - 0.48 0.275 0.20 - 0.38
Retired 0.39 0.32 - 0.49 0.333 0.26 - 0.43
Income level (low) 1 1.34 1.22 - 1.47 1.267 1.12 - 1.44
Have you experienced 
serious illness in
you yourself (yes) 1.78 1.60 - 1.99 2.13 1.88 - 2.41
in your immediate family 
(yes) 1.15 1.04 - 1.27 1.234 1.09 - 1.40
in caring for others (yes) 1.31 1.17 - 1.46 1.35 1.18 - 1.53
Chronic health 
complaints (yes) 3.67  3.33 - 4.04 3.94 3.41 - 4.55
N 9900 9900
Nagelkerke R2 0.26 0.24
1 Income was categorised in low (UK; less than £28.000, Italy and the Netherlands; less than €20.000 
and high (UK; £28.000 and more, Italy and the Netherlands; €20.000 and more).
*Two different rating scores were used as cut-off: rating score 2 (* ≥ mild) and rating score 3 (** ≥ 
moderate)
Abbreviations. PCS, Post-Concussion Syndrome.
Appendix B. Significant predictors in a multivariable model of PCS using two cut-
offs
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Abstract
Objective: To evaluate the prevalence of post-concussive symptoms and their 
relation to health-related quality of life (HRQoL) in pediatric and adolescent 
patients with mild traumatic brain injury (mTBI) and that received head computed 
tomography (CT) imaging during initial assessment.
Methods: Patients aged between 5-21 years with mTBI (GCS 13-15) and available 
Rivermead Post-Concussion Questionnaire (RPQ) at six months followup in the 
multi-center, prospectively collected CENTER-TBI study were included. Prevalence 
of post-concussive symptoms was assessed and the occurrence of post-
concussive syndrome (PSC) based on the ICD-10 criteria, was analyzed. HRQoL 
was compared in patients with and without PCS using the Quality of Life after Brain 
Injury (QOLIBRI) questionnaire.
Results: A total of 196 adolescent or pediatric mTBI patients requiring head CT 
imaging were included. High-energy trauma was prevalent in more than half of 
cases, abnormalities on head CT scans were detected in 44% and admission to the 
regular ward or intensive care unit was necessary in 78%. Six months post-injury, 
36% of included patients had experienced at least one moderate or severe symptom 
of the RPQ. PCS was present in 13% of adolescents and children when considering 
symptoms of at least moderate severity and those patients had significantly lower 
QOLIBRI total scores, indicating lower HRQoL, compared to young patients without 
PCS.
Conclusions: Adolescent and pediatric mTBI patients requiring head CT imaging 
show signs of increased trauma severity. Post-concussive symptoms are present 
in up to one third of those patients and PCS can be diagnosed in 13% six months 
after the injury. Moreover, PCS is significantly associated with decreased HRQoL.
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Introduction
Mild traumatic brain injury (mTBI) is a common injury in children and adolescents 
that frequently leads to clinical presentation. An epidemiological study including 
children from 0-17 years requiring medical contact reported an estimated incidence 
of 304 cases per 100.000 child-years.[1] Ninety-seven percent of included patients 
in that study were classified as mTBI,[1] which is defined according to the American 
Congress of Rehabilitation Medicine (ACRM) by a Glasgow Coma Scale (GCS) of 
13-15, a maximum loss of consciousness (LOC) of 30 minutes and post-traumatic 
amnesia (PTA) less than 24 hours after the brain impact.[2, 3] Acute post-concussive 
symptoms after mTBI can be severe and might include somatic symptoms such 
as headaches, cognitive symptoms such as difficulty concentrating, and affective 
symptoms such as irritability. In a considerable fraction of patients, symptoms 
can chronically persist for weeks, months, or even years.[4] The prevalence of 
prolonged post-concussive symptoms in young patients varies depending on the 
diagnostic criteria used and the population studied, but has been reported to be as 
high as 31%.[5] Although the knowledge about such post-concussive symptoms 
in the pediatric and adolescent population has considerably increased over the 
past years and now includes insights from large, multi-center studies,[5, 6] there 
remains an important subgroup of patients that has not been studied in detail: 
Young mTBI patients requiring a head computed tomography (CT) during initial 
assessment following the brain injury. While the majority of adolescents and children 
do not receive CT imaging after mTBI in order to avoid radiation exposure, it might 
be nevertheless indicated when e.g. a history of high-energy injury mechanisms, 
suspicious clinical findings, or other risk factors are present. In such patients, a 
more severe subtype of mTBI might therefore be present. Mild TBI in general can 
already have profound negative impacts on the lives of affected adolescents and 
children.[7] Moreover, young patients experiencing a combination of persistent post-
concussive symptoms of somatic, cognitive and affective nature can be diagnosed 
with post-concussion syndrome (PCS), a diagnosis encoded in the ICD-10.[8] 
Between 11% and 55% of adolescents and children have been reported to develop 
PCS following mTBI.[9] In those patients, the persistent post-concussive symptoms 
can have serious consequences and could significantly decrease their overall 
health-related quality of life (HRQoL).[10] The objectives of this study, therefore, 
were to examine the prevalence of such persistent post-concussive symptoms, to 
analyze the occurrence of PCS and to assess its association with HRQoL in the 
potentially more complicated subgroup of adolescent and pediatric patients who 
were classified as mTBI but who required head CT imaging after presenting to the 
emergency department (ED).
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Methods
Study design and patient selection
For the present study, data from the Collaborative European NeuroTrauma 
Effectiveness Research in TBI (CENTER-TBI) core study was analyzed. CENTER-TBI 
is a multi-center, observational, longitudinal cohort study of patients with a clinical 
diagnosis of TBI (all severities) and, notably, the indication for head CT imaging 
(defined at the discretion of each study center), who presented to a participating 
study center within 24 hours after the injury. Patients for the CENTER-TBI core study 
were enrolled from December 2014 to December 2017 in 59 centers across Europe 
and Israel.[11, 12] The study protocol was approved by national and local ethics 
committees for each recruiting site and informed consent was obtained by the legal 
representative or next of kin for all enrolled patients. For this analysis, we included 
all pediatric and adolescent patients between the age of 5 and 21 years from the 
CENTER-TBI core study database that presented with mTBI (Glasgow Coma Scale 
[GCS] 13-15) and had completed the Rivermead Post-Concussion Questionnaire 
(RPQ) at six months post-injury.
Data collection
Data was accessed through the clinical study data management tool Neurobot 
(INCF-Neurobot, RRID:SCR_017004). The CENTER Core version 2.1 was used for 
this study. The variables age, sex, GCS at admission, presence of any intracranial 
abnormality on initial CT brain imaging (CT abnormalities), post-traumatic amnesia 
(PTA), loss of consciousness (LOS), major extracranial injury, admission to the 
intensive care unit (ICU), high-energy trauma as well as RPQ and Quality of Life 
after Brain Injury (QOLIBRI) scores at six months were collected. Major extracranial 
injury was defined as an abbreviated injury scale (AIS) of at least 3 in any body 
region. High-energy trauma was defined as an accelerating/decelerating trauma of 
high velocity or falls > 1m.
Outcome measurements
Rivermead Post-Concussion Questionnaire
The RPQ was used to assess the presence and severity of post-concussive 
symptoms following mTBI.[13] This assessment instrument evaluates 16 different 
symptoms that can be divided into three categories: somatic symptoms (headaches, 
blurred vision, double vision, noise sensitivity, light sensitivity, dizziness, nausea, 
sleep disturbances, fatigue), affective symptoms (irritability, depression, frustration, 
restlessness), and cognitive symptoms (forgetfulness, poor concentration, slowed 
thinking). Patients rate the severity of each symptom on a 5-point Likert scale (not 
experienced at all (0), no more of a problem (1), a mild problem (2), a moderate 
problem (3), a severe problem (4)). Patients were specifically instructed to rate the 
severity of their symptoms over the last 7 days in comparison to the pre-injury levels, 
thus giving the instrument a time and an event anchor.[14] For the analysis, scores 
0 and 1 were comprised into one category as proposed in previous works,[13, 
15, 16] yielding a 4-point scale ranging from currently absent symptoms (0), mild 
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symptoms (2), moderate symptoms (3) to severe symptoms (4). The total RPQ 
score was calculated by adding the scores of each RPQ symptom to a sum with 
a maximum total score of 64. Presence of PCS was defined according to ICD-10 
criteria, which meant that patients had to experience at least three of the following 
symptoms: headaches, dizziness, sleep disturbance, fatigue, being irritable/
easily angered, forgetfulness/poor memory, and poor concentration.[8] As there is 
currently no consensus on whether to include only symptoms of at least moderate 
severity (rating score ≥3) or even of mild severity (rating score ≥2) when assessing 
patients for PCS, the prevalence of PCS was analyzed for both definitions in this 
study. 
Health-related Quality of Life (HRQoL)
To assess HRQoL, the QOLIBRI questionnaire was used, which consists of 37 
items covering six aspects of disease-specific HRQoL after TBI (cognition, self, 
daily life & autonomy, social relationships, emotions, and physical problems).[17] 
The QOLIBRI instrument is a health-related, disease specific and internationally 
validated instrument to assess HRQoL in patients following brain injury.[17, 18] The 
responses to each questionnaire item were summed to the QOLIBRI total score 
ranging from 0, meaning worst, to 100, meaning best possible HRQoL (https://
qolibrinet.com/scoring/). A QOLIBRI total score of 60 or greater represents good 
HRQoL; a score below 60 indicates an unsatisfactory outcome with an increased 
risk for one or even two psychiatric disorders.[18]
Statistical analysis
Baseline demographical and clinical variables are presented as median and 
interquartile ranges (IQR) for continuous variables and numbers and percentages 
for categorical variables. Correlation between total RPQ scores and QOLIBRI 
total scores were tested with Spearman’s rank sum test. Differences in QOLIBRI 
total scores between patients with and without PCS were tested using the non-
parametric Mann-Whitney U test. The level of significance was set at p < 0.05. All 
analyses were conducted with the statistical software R (version 3.6.1).[19] 
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Results
Patient characteristics
Among recruited CENTER-TBI core study participants, 324 mTBI patients were 
between the age of 5 and 21 at the time of enrollment of which 196 patients (60%) 
completed the RPQ at six months after the brain impact and were included in this 
study (Figure 1). Those patients were enrolled at 32 different centers across Europe 
and by definition of the CENTER-TBI core study inclusion criteria had received a 
head CT scan during initial assessment in the ED. The median age was 17 years 
(IQR: 14-19; range: 6-21) and 72% of included patients were males. A GCS score 
of 15 was recorded for 144 patients (73%). LOC and PTA were very common in 
this cohort with 52% and 58% of patients, respectively. A total of 54% of patients 
were involved in a high-energy trauma, and 19% additionally suffered from major 
extracranial injuries with an AIS ≥ 3. Finally, CT abnormalities were detected in 44% 
of patients on brain CT imaging. Of all patients, 22% were discharged home from 
the ED, while 49% and 29% were admitted to the regular ward or intensive care unit, 
respectively (Table 1).
Figure 1. Flowchart of patient selection
Total number of 
patients in core study 
available for analysis
n = 4509
Patients after mTBI
n = 2955
Patients after mTBI
aged 5-21 years
n = 342
Patients after mTBI
aged 5-21 years with 
complete RPQ
n = 196
Patients after 
moderate or severe 
TBI
n = 1554
Patients after mTBI 
< 5 years (n = 11) or 
> 21 years (n = 2602)
Incomplete RPQ
n = 146
159
1
9
5
13
3
11
7
4
12
8
2
10
6
14
Table 1. Characteristics of the study population
 
Characteristic n=196
Demographic characteristics
Age1 (years) 17 [14-19] 
Sex (male) 142 (72%)
Stratum
ER 44 (22%)
Admission 96 (49%)
ICU 56 (29%)
Trauma energy
High-energy trauma 106 (54%)
Pre-injury health status
Previous history of headaches 10 (5%)
Previous psychiatric history 8 (4%)
Previous TBI 24 (13%)
Clinical presentation
GCS = 15 144 (73%)
PTA 102 (52%)
LOC 114 (58%)
Major extracranial injury 37 (19%)
CT characteristics
CT abnormalities 80 (44%)
Influence of alcohol and drugs
Blood alcohol >80 mg/dL 6 (3%)
Drug abuse 5 (3%)
1 This variable is displayed as median, with the first and third quartile given within brackets.
Abbreviations. ER, Emergency room; ICU, Intensive Care Unit; TBI, traumatic brain injury; GCS, Glasgow 
Coma Scale; PTA, post-traumatic amnesia; LOC, loss of consciousness; CT, computed tomography.
160
Chapter 7
Prevalence of post-concussive symptoms and occurrence PCS
Prevalence of mild, moderate or severe post-concussive symptoms were assessed 
at six months after mTBI in our adolescent and pediatric patient cohort (Figure 
2). More than one third of patients (36%) reported having at least one of the 16 
symptoms assessed in the RPQ with at least moderate severity. When including 
symptoms of mild severity, this number exceeded 60% (Figure 3). The most 
commonly reported symptoms were headaches, fatigue, poor concentration, and 
forgetfulness, i.e. poor memory. At least one of the nine somatic symptoms of 
at least moderate severity were reported by 30% of patients, while 20% had at 
least one of the three cognitive and four psychological symptoms. Those numbers 
increased to 54% for any somatic symptom, 40% for any cognitive symptom, and 
37% for any psychological symptom when including also mild symptoms. Among 
patients reporting post-concussive symptoms at six months, the median number 
of moderate or worse symptoms was 2 (IQR: 2-4) and 5 (2-7) for mild or worse 
symptoms. By our definition requiring at least three moderate RPQ symptoms on 
the basis of ICD-10 criteria, 26 patients (13%) were classified as having PCS six 
months after the injury. Notably, this number substantially increased to 34% when 
applying the definition that at least three symptoms of at least mild severity were 
required.
Figure 2. Prevalence of mild, moderate or severe post-concussive symptoms
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Figure 3. Symptoms assessed in the RPQ with at least mild or moderate severity
PCS and quality of life 
A total of 172 patients (88%) included in this study completed a QOLIBRI assessment 
at six months follow-up. The median QOLIBRI total score was 82 (IQR: 68-91), 
representing good quality of life. In 67 patients (34%) with PCS considering at least 
mild severity, the median QOLIBRI total score was 66 (IQR: 53-76). Of those, 23 
patients (34%) had a QOLIBRI total score < 60, representing unsatisfactory HRQoL. 
Patients without PCS following this classification (n=129, 66%) reported a median 
QOLIBRI total score of 86 (IQR: 79-94) which was significantly higher compared 
to the patients with PCS considering at least mild severity (p<0.001). As opposed 
to patients with PCS, only 4 patients (3%) without PCS had a QOLIBRI rating <60. 
When applying the definition of at least three symptoms of moderate severity, 
similar results were obtained: Patients classified as suffering from PCS (n=26) had 
a median QOLIBRI total score of 57 (IQR: 49-72) and 14 of those 26 patients (54%) 
reported a QOLIBRI total score < 60. Patients without PCS following this classification 
(n=170, 87%) showed a median QOLIBRI total score of 83 (IQR: 73-92) which was 
significantly higher compared to the patients with PCS) in patients without PCS, 
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displaying a significant difference between these two groups (p<0.001). Only 13 
patients (8%) without PCS reported a QOLIBRI total score < 60. For both severity 
cut-offs, this means that patients with PCS have lower HRQoL compared to patients 
without PCS. Moreover, total RPQ scores and QOLIBRI total scores showed a 
significant, moderately strong negative correlation (r=-0.62, p<0,001).
Discussion
Mild Traumatic brain injury represents one of the most common injuries in the young 
population but only a small minority of patients will receive CT scans in an effort to 
avoid potentially harmful radiation in this particular patient population. The analysis 
of patient characteristics in our cohort showed that adolescents and children who 
require CT imaging indeed form a more severe and complex subgroup of mTBI 
patients. More than half of the patients in this study were involved in high-energy 
trauma and abnormalities on CT imaging were detected in 44%.  Nearly 30% of 
patients were primarily admitted to the ICU in this cohort which is notable because 
the TBI was at presentation classified as mild in all patients. This might reflect the 
higher injury severity in this particular group of patients and possible explanations for 
the high ICU admission rate despite mTBI include the high prevalence of concurrent 
extracranial injuries. While previous reports of post-concussive symptoms focused 
on young mTBI patients in general and thus included only a small portion of patients 
who received head CT scans (and/or excluded them altogether when detecting 
abnormalities on CT imaging), with head CT imaging as an inclusion criterion, the 
CENTER-TBI study offers the unique possibility to analyze this particular subgroup 
of adolescents and children as a separate entity.
For young mTBI patients who require head CT-imaging during initial post-injury 
assessment, we report high prevalence numbers of post-concussive symptoms: 
One third of patients reported at least one symptom of at least moderate severity six 
months after brain injury. Thirteen percent of patients met the criteria for our more 
demanding definition of PCS that considered only at least moderate symptoms, 
which falls well into the range of results from previous studies that included pediatric 
mTBI patients in general.[4, 20, 21] Especially somatic symptoms were very 
common in our study (30% of children and adolescents) and this number increased 
to more than 50% when including also mild symptoms. Naturally, when including 
mild symptoms, the results are likely to be less specific and more susceptible to 
confounding influences, as mild somatic symptoms such as mild headaches and 
fatigue are also common in non-injured individuals.[22-24] The high prevalence of 
symptoms of moderate and severe severity in adolescents and children with mTBI 
and an indication for head CT imaging, however, emphasizes the presumption that 
mTBI in this subgroup might not be so “mild” after all but can have serious long-
term sequelae.
In our study, adolescent and pediatric patients with PCS had significantly lower 
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QOLIBRI total scores indicating lower or even unsatisfactory HRQoL compared to 
young patients without PCS. Those findings are in line with results from previous 
studies showing that HRQoL is influenced across several domains (physical, 
emotional, social, school etc.) in patients with PCS.[10] In addition, the reported 
significant correlation between the RPQ and QOLIBRI total scores in our study 
illustrates the close association between post-concussive symptoms and HRQoL, 
and therefore demonstrates the clinical importance of recognizing post-concussive 
symptoms in this particular subgroup of adolescents and children who obtained 
CT imaging after mTBI. While there are some preliminary promising therapeutic 
approaches such as brief cognitive therapy and other medical and non-medical 
interventions that could be effective and beneficial in children and adolescents 
with persistent post-concussive symptoms,[25, 26] further high-quality studies are 
needed to closer investigate the possible impact and efficacy of these interventions.
[25]
We note several limitations to our study. First of all, while CENTER-TBI included 
patients of all ages, pediatric and adolescent patients were underrepresented as 
participating centers were mainly general hospitals and not specialized pediatric 
centers. Therefore, the sample size is relatively small when compared to the older 
patient cohort in the CENTER-TBI study. 
Furthermore, a non-response bias limiting external validity is possible as a 
considerable proportion of patients were lost to follow-up (40%). Results from our 
study also need to be interpreted with caution when considering the assessment 
tool used. The RPQ was initially validated in adolescents and adults aged equal or 
above 16 years.[13] It has been suggested to remain a basic common data element 
in TBI research as it correlates with cognitive impairment,[13, 14, 27] although it 
remains a controversial assessment tool that might, amongst other concerns, be 
prone to recall bias as patients might underestimate post-concussive-like symptoms 
they experienced before the injury. Lastly, the use and utility of simple change 
scores for diagnosis of post-concussive symptoms in children have recently been 
questioned.[28] Therefore, the results from this study should merely be seen as 
an exploratory analysis. However, our results support the fact that further studies 
designed to acquire a better understanding of post-concussive symptoms are 
needed, as those symptoms might be highly prevalent in mTBI patients and directly 
affect patients’ HRQoL. 
In conclusion, this analysis of the multi-center, prospectively collected CENTER-TBI 
dataset, we found a high prevalence of 30 to 60% of post-concussive symptoms 
at six months post-injury in adolescents and children with mTBI who received CT 
imaging upon presentation to the hospital. Depending on the definition, 13-34% 
were classified as experiencing a PCS. Those patients had a significantly decreased 
HRQoL compared to patients without PCS. 
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Abstract
Objective: Post-concussion syndrome (PCS) occurs following mild traumatic brain 
injury (mTBI). Patients with mTBI are often assessed using self-report instruments 
that rely on perception of current symptoms compared to how they felt and 
functioned pre-injury. The objective was to examine reliability of patients’ post-injury 
reporting of their pre-injury symptoms. 
Methods: We included two control groups (trauma patients without brain injury 
history and healthy controls) who were recruited at an outpatient surgical clinic and 
among the working and social environment of the researchers, respectively. The 
Head Injury Symptom Checklist (HISC) was used to assess pre-injury and current 
symptoms at four time points post injury. We included 836 patients with mTBIs, 191 
trauma patients without brain injury history, and 100 healthy controls. 
Results: Patients with mTBI reported significantly more pre-injury symptoms than both 
control groups (p<.001). Forty-five percent of patients with mTBI were inconsistent 
in their pre-injury ratings across four assessments. Patients with post-injury PCS 
reported much greater pre-injury symptoms and were more often inconsistent. 
Conclusion: Accurately assessing PCS by comparing pre with post-injury 
complaints is difficult, and may have implications for diagnosis when using self-
report instruments. Therefore, post-injury PCS diagnosis should be interpreted with 
caution and PCS should ideally be examined using clinical examination.
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Introduction
Traumatic brain injury (TBI) is a leading cause of death and disability worldwide 
and half of the world’s population will experience one or more TBIs over their 
lifetime.[1] The large majority of TBIs (70-90%) can be classified as mild (mTBI),[1] 
which is often indicated by a Glasgow Coma Scale (GCS) score between 13 and 
15 at admission to the emergency department. Most patients report complete 
symptom resolution following mTBI;[2, 3] however, a subset of patients report post-
concussion symptoms, which can be defined as somatic, cognitive, and emotional 
symptoms that may last for months or even years.[4-6] When three or more post-
concussion symptom categories are present, a patient can be diagnosed with 
‘postconcussional syndrome’ (PCS) according to the definition by the International 
Classification of Diseases (ICD)-10.[7] The diagnosis of PCS is highly controversial 
because symptoms do not always cluster in a consistent and predictable manner.[8] 
In addition, post-concussion symptoms, such as fatigue, concentration difficulties, 
and headaches, are not specific to TBI and are also reported among trauma 
patients without brain injury history [9-11] and healthy adults.[12, 13] The method 
of assessment of post-concussion symptoms and PCS, such as using a clinical 
interview versus a self-reported questionnaire, is another topic of controversy.[14, 
15] Nevertheless, post-concussion symptoms are generally examined with self-
report questionnaires. 
The use of self-report may have several limitations in a mTBI population, because 
symptom endorsement on self-report questionnaires might be influenced by 
expectation bias; i.e. following mTBI, patients may expect that they will experience 
some post-concussion symptoms and may therefore be more likely to endorse 
these symptoms.[16] Additionally, it might be difficult to make a distinction between 
the two, considering PCS could also be a part of or a result from emotional distress, 
which commonly occurs in the aftermath of TBI.[10, 17, 18] Furthermore, some 
self-report instruments (e.g., the Rivermead post-concussion questionnaire (RPQ)
[19]) investigate a comparison of current symptoms with symptoms experienced 
before injury. The reliability and validity of pre-injury symptom ratings might be 
complicated because patients may not remember symptoms that occurred months 
earlier in an accurate manner.[20] Moreover, following a negative event, patients 
may have the tendency to underestimate past problems and to view oneself as 
healthier in the past, which is referred to as the ‘good-old-days’ bias.[21] Previous 
studies examined the occurrence of the ‘good-old-days bias’ in patients with mTBI.
[20-24] They consistently found that patients with mTBI remembered their pre-
injury functioning as better compared to healthy controls. As a consequence of this 
cognitive bias, patients may misattribute the experience of common symptoms to 
the mTBI, and thereby increase the possibility of an incorrect PCS diagnosis[25]. 
These previous studies assessing the reliability and validity of pre-injury symptom 
ratings are, however, limited by small sample sizes[20, 23, 24] and the use of non-
representative patient groups.[21, 22] In addition, previous studies assessed the 
pre-injury symptom-level only once or twice,[24] whereas repeated measurements 
may provide further insight into the test-retest reliability of pre-injury ratings. 
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Especially since test-retest reliability was noted as less than optimal for most 
common and emerging concussion assessment tools.[26, 27]
This study aimed to assess the reliability and validity of post-injury ratings of 
symptoms compared with pre-injury symptoms in a large and representative 
sample of patients with mTBI at several time points during the first year following 
injury. Additionally, these ratings of patients with mTBI were compared to both 
trauma patients without brain injury history and healthy controls. We specifically 
tested the three hypotheses, based on previous research and clinical experience, 
listed below.
1. Both patients with mTBI and trauma patients without brain injury history 
 will underestimate their pre-injury symptom level (i.e., ‘good-old-days bias’) 
 by reporting fewer symptoms than healthy controls.
2. The consistency (i.e., test-retest reliability[28]) of ratings of pre-injury 
 symptoms at different time points will be low in patients with mTBI.
3. Patients with mTBI who have post-injury PCS will be more likely to 
 underestimate their pre-injury symptoms and will be less consistent in their 
 ratings compared to patients with mTBI without post-injury PCS.
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Methods
Study population
Data from patients with mTBI were obtained from the prospective UPFRONT study, 
which collected baseline, clinical, and outcome data across three level I trauma 
centers in the Netherlands between 2013 and 2015.[29] Patients were included if 
they presented to the emergency department of one of the participating centers 
with an admission GCS score of 13-15.
Trauma patients without brain injury history were recruited at the outpatient surgical 
clinic of the University Medical Center Groningen between June and October 2013. 
Patients were included if they sustained minor injury to one of the extremities, for 
which they had visited the emergency department. Patients were excluded if they 
completed the questionnaire more than six months (> 185 days) after the injury. 
Healthy controls were recruited among the working and social environment of the 
investigators involved with the UPFRONT study. They were included if they were at 
least 16 years old and they had sufficient comprehension of the Dutch language. 
Patients were excluded if they were addicted to drugs or alcohol, homeless, or 
diagnosed with dementia. The study was approved by the medical ethics committee 
of the University Medical Center in Groningen and all participants provided written 
informed consent. For more information on the UPFRONT study or the study 
population, see previous publications.[18, 29, 30]
Assessment of post-concussion symptoms and PCS
Post-concussion symptoms and PCS were assessed using the Head Injury Symptom 
Checklist (HISC).[18] The HISC consists of 21 frequently reported symptoms after 
a TBI, which can be rated on a 3-point scale (never, sometimes, often). Eight 
symptoms from the ICD-10 are included in the checklist: headache, dizziness, 
fatigue, irritability, sleep problems, concentration problems, memory problems, 
and intolerance of alcohol or stress. Stress intolerance is not a symptom included 
in the HISC, so for this we used the more anxious symptom. For each patient, we 
recorded the total number of ICD-10 symptoms endorsed as ‘sometimes’ or ‘often’. 
In addition, we classified patients as having PCS if they indicated that at least three 
out of eight symptoms were experienced ‘sometimes’ or ‘often’. Because it has 
not been established whether symptoms should be included if they are endorsed 
as ‘sometimes’ or only when they are endorsed as ‘often’,[31] we also estimated 
prevalence rates of post-concussion symptoms and PCS including only those 
symptoms that were endorsed as ‘often’. For this study, we defined screening 
positively for ICD-10 PCS as endorsing any 3 of the 8 symptoms.
For patients with mTBI, the HISC was administered two weeks, three months, six 
months, and twelve months following injury. At each time period, patients were 
asked to rate both their current and pre-injury symptoms. The trauma patients 
without brain injury history completed the HISC once for both their current and pre-
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injury symptoms at approximately three weeks post injury. The healthy controls 
completed the HISC twice with a two-week interval and were asked to rate their 
current symptoms. 
Statistical analyses
Baseline characteristics of patients with mTBI, trauma patients without brain injury 
history, and healthy controls were reported by frequencies and percentages, 
or medians and interquartile range for continuous variables. At each time point, 
we presented the number and percentage of participants who endorsed post-
concussion symptoms and screened positively for the ICD-10 diagnosis of PCS, 
on both their retrospective pre-injury and current symptom ratings. Analyses were 
performed using SPSS statistics version 24.0.
Hypothesis 1: Both patients with mTBI and trauma patients without brain injury 
history will underestimate their pre-injury symptom level (i.e., show the ‘good-old-
days bias’) by reporting fewer post-concussion symptoms than healthy controls. 
We used a chi-square test to compare the number of patients with three or more 
pre-injury post-concussion symptoms among patients with mTBI, trauma patients 
without brain injury history, and healthy controls. Non-parametric Kruskall-Wallis 
tests were used to compare the total number of ICD-10 symptoms across groups. 
For the patients with mTBI, we used the two-week assessment because this was most 
comparable to the assessment of the trauma patients without brain injury history (3 
weeks). For the healthy controls we used their first rating (random selection). Post-
hoc tests were performed to assess which of the three groups differed statistically 
significantly. A p-value of 0.02 (0.05/3) was considered statistically significant in the 
post-hoc analyses.
Hypothesis 2: The consistency (i.e., test-retest reliability) of pre-injury ratings will be 
low in patients with mTBI. 
We performed chi-square tests to compare the number of patients with three or 
more pre-injury post-concussion-like symptoms across all four time points (2 weeks, 
3 months, 6 months, and 12 months) in patients with mTBI. Because this comprises 
six related comparisons, a p-value of 0.008 (0.05/6) was considered statistically 
significant. Spearman’s correlation was used to compare the total number of ICD-
10 symptoms across four time points. A correlation <0.5 can be interpreted as a 
weak correlation, a correlation 0.5-0.7 as a moderate correlation, and a correlation 
>0.7 as a high correlation. In addition, we calculated the number and percentage 
of patients with mTBI who consistently reported three or more symptoms over all 
four time points. Inconsistency was defined as reporting three or more symptoms 
on one or more of the pre-injury ratings but not on the preceding questionnaires. 
Multivariable logistic regression analysis was used to explore whether baseline 
characteristics and pre-injury comorbidities were predictive of inconsistency.
Hypothesis 3: Patients with mTBI who have post-injury PCS will be more likely to 
underestimate their pre-injury symptoms and will be less consistent in their ratings 
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compared to patients with mTBI without post-injury PCS.
We used the chi-square test to examine whether patients with and without PCS at 
six months differed on their pre-injury rating (also assessed at six months). The 
Mann-Whitney U test was used to examine whether the total number of pre-injury 
symptoms differed among patients with and without a diagnosis of PCS at six 
months post injury. Ratings at six months were chosen for this purpose because 
this is a common time point to evaluate persistent PCS. We additionally performed 
multivariable logistic regression analysis to adjust the effect of post-injury PCS 
diagnosis for age, sex, education, and pre-injury physical and psychological 
comorbidities. Patients were classified in the following four groups: persistent PCS 
(PCS present at two weeks and six months),[32] late-onset PCS (PCS not present 
at two weeks, but present at six months), resolved PCS (PCS present at two weeks, 
but not at six months), and no PCS (no PCS at both two weeks and six months). 
A chi-square test was performed to compare pre-injury ratings among these four 
groups. 
To examine whether post-injury PCS was associated with inconsistency in pre-injury 
ratings, we used the chi-square test to check whether inconsistency (see hypothesis 
2) was different for those with versus without PCS at six months. In addition, we 
also checked for differences between the four patient groups described above 
(no PCS, persistent PCS, late-onset PCS, and resolved PCS). Multivariable logistic 
regression analysis was performed to adjust the effect of post-injury PCS for age, 
sex, education, and pre-injury physical and psychological comorbidities.
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Results
Study population
A total of 1,151 patients with mTBI were included in the UPFRONT study, of whom 
836 completed either the retrospective pre-injury or the current rating of symptoms 
at two weeks post injury. Patients included in this study were older (46 years) 
than those who were not included (38 years). Patients’ median age was 48 years 
(interquartile range (IQR): 27-62) and 61% were male. Patients were most often 
injured by a fall (n = 550, 66%) and the majority experienced loss of consciousness 
(n = 710, 85%) and/or posttraumatic amnesia (n = 682, 87%). A total of 509 patients 
(61%) were admitted to the hospital (Table 1).
The non-brain-injured trauma control group consisted of 206 patients, among 
whom 204 completed the HISC. Thirteen patients were excluded from the analyses 
because they completed the questionnaire more than six months (> 185 days) after 
the injury, which ultimately left 191 trauma patients without brain injury history. These 
patients had a median age of 35 years (IQR: 23-52) and 54.5% were male. Fall was 
the most common cause of injury (n = 92, 48.2%), and 35 patients (18.3%) were 
admitted to the hospital ward. The healthy control group consisted of 100 healthy 
volunteers, who all completed the HISC at two different time points. Healthy controls 
had a median age of 29 years (IQR: 24-48) and half of them were male. More than 
half of the healthy volunteers (n = 65, 65%) had a high education level (Table 1). 
Post-concussion symptoms in mTBI and trauma patients without brain injury 
history during the first year post injury
Post-concussion symptoms were often endorsed among patients with mTBI during 
the first year post injury. Fatigue was the most commonly reported symptom at 
all time points (79% at 2 weeks, 66% at 3 months, 68% at 6 months, and 66% 
at 12 months). The majority of patients endorsed three or more out of eight post-
concussion symptoms, and thereby fulfilled our criteria for the ICD-10 diagnosis 
of PCS (84% at 2 weeks, 72% at 2 months, 78% at 6 months, 75% at 12 months; 
Table 2). Among the trauma patients without brain injury history, 38% (n = 73) were 
classified as having PCS approximately three weeks post injury. The most often 
reported symptoms included sleep problems (n = 90, 47%) and fatigue (n = 84, 
44%). 
Including only those symptoms that were endorsed as ‘often’ rather than ‘sometimes 
or often’, resulted in substantially lower prevalence rates (median number of 
symptoms among patients with mTBI=1, median number of symptoms among 
trauma patients without brain injury history =0). Among the patients with mTBI, 22-
32% fulfilled our criteria for ICD-10 PCS post injury, whereas only a minority of the 
trauma patients without brain injury history (6%) met the criteria (Table 2). 
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Table 1. Characteristics of the study sample.
 ‡ Includes cerebrovascular accident, heart diseases, hypertension, diabetes, asthma or other respiratory 
diseases, epilepsy, or any malignant disorder. 
 Ɫ Includes any psychiatric disorder necessitating treatment by a psychologist or psychiatrist or use of 
psychotropic medication, or both.
*All patients with mild TBIs that have either a pre-injury or a current rating at 2 weeks post injury
Abbreviations. mTBI, mild traumatic brain injury.
Patients with mTBI 
(n = 836)*
Trauma patients 
without brain injury 
history (n = 191)
Healthy controls 
(n = 100)
Age (median, interquartile 
range)
48 (27-62) 35 (23-52) 29 (24-48)
Male sex 512 (61%) 104 (54.5%) 50 (50%)
Education level
     - Low
     - Middle 
     - High
158 (19%)
329 (40%)
342 (41%)
Not measured 6 (6%)
29 (29%)
65 (65%)
Pre-injury physical 
disorders ‡
257 (31%) 71 (37.2%) Not measured
Pre-injury psychiatric 
disorders Ɫ
94 (11%) 10 (5.2%) Not measured
Cause of injury
    - Motor vehicle accident
    - Fall
    - Violence
    - Other
193 (23%)
550 (66%)
40 (5%)
53 (6%)
5 (2.6%)
92 (48.2%)
7 (3.7%)
87 (45.5%)
NA
Loss of Consciousness 710 (85%) Not present by 
definition
NA
Post-Traumatic Amnesia 682 (82%) Not present by 
definition
NA
Hospital admission 509 (61%) 35 (18.3%) NA
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Hypothesis 1: Both patients with mTBI and trauma patients without brain injury 
history will underestimate their pre-injury symptom level (i.e., ‘good-old-days bias’) 
by reporting fewer symptoms than healthy controls
Patients with mTBI reported more pre-injury symptoms and more often indicated 
having experienced three or more pre-injury symptoms compared to both trauma 
patients without brain injury history and healthy controls (p < .001). There were 
no statistically significant differences between trauma patients without brain injury 
history and healthy controls in the total number of ICD-10 symptoms (p = 0.343) or 
the number of patients experiencing three or more symptoms (p = 0.322). 
Hypothesis 2: The consistency (i.e., test-retest reliability) of pre-injury ratings will be 
low in patients with mTBI
All four pre-injury ratings of post-concussion-like symptoms (2 weeks, 3 months, 6 
months, and 12 months) differed significantly from each other (all p < .001; Table 
3). As seen in Table 3, there were weak to moderate correlations between the total 
number of pre-injury symptoms across the four time points. A total of 444 patients 
completed all four pre-injury ratings. Among these patients, only half (n = 242, 55%) 
consistently reported three or more symptoms across all time points. The remaining 
202 patients (45%) endorsed three or more pre-injury symptoms at some of the time 
points but not at other time points, and thus showed inconsistent pre-injury ratings. 
Inconsistency was not associated with demographic or pre-injury characteristics 
(Table 4).
Table 3. A comparison of pre-injury ratings of patients with mTBI among the four 
different time points.
Rating 3 months 6 months 12 months
2 weeks Similar rating: 75%
PCS at 2w, not at 3m: 16%
PCS at 3m, not at 2w: 9%
p < .001
r* = 0.66
Similar rating: 74%
PCS at 2w, not at 6m: 12%
PCS at 6m, not at 2w: 14%
P < .001
r = 0.64
Similar rating: 71%
PCS at 2w, not at 12m: 15%
PCS at 12m, not at 2w: 14%
P < .001
r = 0.49
3 months - Similar rating: 75%
PCS at 3m, not at 6m: 9%
PCS at 6m, not at 3m: 16%
P < .001
r = 0.67
Similar rating: 75%
PCS at 3m, not at 12m: 11%
PCS at 12m, not at 3m: 14%
P < .001
r = 0.54
6 months - Similar rating: 77%
PCS at 6m, not at 12m: 14%
PCS at 12m, not at 6m: 9%
P < .001
r = 0.59
*r = the Spearman correlation between the number of ICD-10 symptoms across different time periods. 
Abbreviations. w, weeks; m, months.
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Hypothesis 3: Patients with mTBI and post-injury PCS will be more likely to 
underestimate their pre-injury symptoms and be less accurate compared to patients 
with mTBI without post-injury PCS
Patients with PCS at six months reported substantially more pre-injury symptoms 
(median = 3, IQR = 2-5, mean = 3.3) compared to patients without PCS at six 
months (median = 1, IQR = 0-2, mean = 0.94, p< .001). Additionally, three or more 
pre-injury symptoms were also reported more often by patients with PCS at six 
months (62% vs. 3%, p < .001). Comparing patients with persistent PCS (PCS at 
both 2 weeks and 6 months), late-onset PCS (no PCS at 2 weeks, PCS at 6 months), 
resolved PCS (PCS at 2 weeks, no PCS at 6 months), and no PCS (no PCS at 
both 2 weeks and 6 months) also revealed statistically significant differences (p < 
.001). The percentage of patients that reported three or more pre-injury symptoms 
was highest among those with late onset PCS (65%) and those with persistent 
PCS (62%). Patients without PCS or those with resolved PCS both had very low 
percentages pre-injury symptoms (2% and 4%, respectively). In multivariable 
analyses, PCS at six months remained a strong predictor of reporting three or more 
pre-injury symptoms (Odds ratio (OR) = 43.2, 95% Confidence Interval (CI) 15.5 
– 119.8). In addition, reporting three or more pre-injury symptoms was associated 
with older age (OR = 1.01, 95% CI 1.00 – 1.03) and pre-injury psychiatric disorders 
(OR = 4.05, 95%CI 1.89 – 8.67; Table 4). 
Table 4. Exploratory analysis of factors associated with inconsistency of pre-injury 
ratings and reporting three or more pre-injury symptoms (measured at six months 
post injury) in patients with mild TBI.
Variable Inconsistency of pre-
injury ratings
OR (95% CI)
Three or more pre-injury 
symptoms
OR (95% CI)
PCS diagnosis at 6 
months
43.2 (15.5-119.8)
Female sex 1.15 (0.78 – 1.70) 1.37 (0.92-2.05)
Age (per year) 1.01 (0.99 – 1.02) 1.01 (1.00-1.03)
Education
Low
Middle
high
Reference
0.84 (0.48 – 1.45)
0.80 (0.46 – 1.39)
Reference
1.18 (0.68-2.07)
1.23 (0.70 – 2.17)
Pre-injury physical 
disorders‡
1.12 (0.70 – 1.80) 0.93 (0.60 – 1.60)
Pre-injury psychiatric 
disordersⱢ
0.68 (0.35 – 1.32) 4.05 (1.89-8.67)
‡Includes cerebrovascular accident, heart diseases, hypertension, diabetes, asthma or other respiratory 
diseases, epilepsy, or any malignant disorder. 
ⱢIncludes any psychiatric disorder necessitating treatment by a psychologist or psychiatrist, use of 
psychotropic medication, or both.
Note: OR, 95% CIs that do not cross 1 are bolded.
Abbreviations. OR, Odds ratio; 95% CI, 95% Confidence interval; PCS, post-concussion syndrome.
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We also assessed whether PCS at six months was associated with inconsistency. 
patients with PCS at six months were more often inconsistent in their pre-injury 
assessment than patients without PCS (50% vs. 31%, p = .001). The association 
between PCS at six months and inconsistency remained statistically significant 
after correcting for sex, age, education, and pre-injury physical and psychiatric 
complaints (OR = 2.33, 95% CI 1.40 – 3.87). Comparing the four different groups 
revealed that patients with late-onset PCS were most often inconsistent (69%), 
followed by patients with persistent PCS (48%) and resolved PCS (45%). Patients 
without post-injury PCS had the lowest inconsistency (10%, p < .001). 
Discussion
Post-concussion symptoms, and PCS, are usually conceptualized by the patient 
or health care provider by comparing current symptoms with how the person felt 
and functioned prior to the injury. This is done by having the person think back, 
and retrospectively conceptualize or rate, pre-injury symptoms. During this study, 
we investigated the reliability and validity of such retrospective ratings of pre-injury 
symptoms among a representative sample of patients with mTBI in the Netherlands, 
and we compared their ratings to those of trauma patients without brain injury history 
and healthy controls. The accuracy of pre-injury ratings is critically important, 
because some self-report instruments (e.g., the RPQ[19] and the HISC[18]) require 
patients to compare their current symptom level with their symptom level pre injury. 
When patients do not remember their pre-injury status accurately or demonstrate 
cognitive bias (e.g., the good-old-days bias), this may increase the possibility of an 
incorrect PCS diagnosis after injury. Interestingly, we did not find evidence for the 
good-old-days bias in our sample. In fact, we found almost the opposite—those 
people who endorsed the greatest number of symptoms at six months following 
their injury were also most likely to endorse greater symptoms before their injury. 
We found that approximately half of the patients with mTBI were inconsistent in their 
retrospective assessment of symptoms over different time periods following injury, 
and a post-injury diagnosis of PCS was strongly associated with inconsistency in 
retrospective ratings of pre-injury symptoms. 
In this study, we included post-concussion symptoms and post-concussion-like 
symptoms endorsed as ‘sometimes’ or ‘often’, resulting in a very high prevalence 
in reporting a constellation of symptoms among all groups, both before and after 
injury. Nevertheless, prevalence rates were on the high end of the spectrum, 
particularly for studies in which compensation is not involved. However, they were 
in line with previous studies performed in patients with mTBI using the RPQ with 
the cut-off of ‘mild or worse’.[4, 6, 33, 34] It is open to question whether all patients 
identified or ‘diagnosed’ with PCS in these studies truly reflect a subgroup with 
clinically significant symptomatology. Possibilities to reduce the potential high rate 
of false-positives include the calculation of difference scores between pre- and 
post-injury assessment, which was performed in a previous investigation using the 
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UPFRONT data.[35] Another possibility might be to restrict analyses to symptoms 
endorsed as ‘often’ on the HISC or ‘moderate or worse’ on the RPQ. In this study, 
we found preliminary evidence that this cut-off may better discriminate between 
patients with mTBI and both control groups, and also between the pre- and post-
injury assessments of patients with mTBI. The fact that the HISC was used in this 
study instead of the RPQ, which is the most applied questionnaire for both research 
and clinical purposes, should not be seen as a limitation, because we focused on 
certain symptoms that fit the diagnosis of PCS and did not look at the total number 
of symptoms, for which the RPQ is normally used.[19] 
Based on previous research, we hypothesized that both patients with mTBI and 
trauma patients without brain injury history would report fewer pre-injury symptoms 
than healthy controls, congruent with the ‘good-old-days’ bias theory. In contrast, 
however, we found that patients with mTBI reported significantly more pre-
injury symptoms than both control groups, whereas the trauma patients without 
brain injury history did not differ significantly from the healthy controls. Thus, we 
did not find evidence of the good-old-days bias in this large cohort of patients 
with mTBI. There might be several reasons for this. The patients with mTBI in 
the UPFRONT study were older in comparison to both control groups and one-
third of the sample reported pre-existing physical comorbidities. Because post-
concussion-like symptoms are non-specific, the endorsement of a large number 
of pre-injury symptoms in our sample might be the direct consequence of physical 
comorbidities, other age-related symptoms, or life stressors that were experienced 
pre injury. Notwithstanding, the age of the patients with mTBI in our sample (median 
age = 48 years) was comparable to the age of the patients with mTBI included in 
the study by Iverson et al.[21] (mean age = 41.5 years). Iverson and colleagues[21] 
report, however, that only 20% of the patients with mTBI endorsed three or more 
pre-injury symptoms as ‘mild or worse’, while we found a percentage of 43-49%. A 
major difference between the two cohorts is that we included a sample of patients 
with mTBI who presented to the emergency department of level I trauma centers, 
whereas Iverson et al.[21] included injured workers who received compensation 
benefits. Such a population might be more vulnerable to a true good-old-days 
bias[20] or might distort or misrepresent their pre-injury symptoms and functioning 
in relation to their compensation claim. 
Another reason for the significant difference between the pre-injury ratings of the 
patients with mTBI and the healthy controls is that the healthy controls in this study 
might not be representative of the general population. They are relatively young and 
highly educated, and therefore, they may have endorsed fewer symptoms. Previous 
research in healthy adults or trauma patients without brain injury history showed 
higher rates of post-concussion symptoms,[10, 21] comparable to those found in 
our sample of patients with mTBI. 
Similar to the study by Silverberg et al.,[20] we found that patients with post-injury 
PCS reported substantially more pre-injury symptoms compared to those without 
post-injury PCS. Pre-injury symptom ratings among patients with PCS were also 
substantially higher than reported in the general population.[21] The endorsement of 
pre-injury symptoms was also associated with older age and pre-injury psychiatric 
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disorders. Because post-concussion-like symptoms are non-specific,[10] it is likely 
that pre-existing mental health problems or age-related complaints have influenced 
both the pre-injury and current symptom ratings in this group.
In this study, we also assessed the consistency of pre-injury ratings over time. In 
concordance with our hypothesis, we found that approximately half of the patients 
with mTBI inconsistently reported their pre-injury symptom level during the first year 
following injury. Our results are in line with the study by Yang et al.[24] who studied 
pre-injury ratings at both one and three months post injury. They found a trend 
towards an increase in pre-injury symptoms reported at three months compared to 
one-month following injury. Inconsistency of pre-injury ratings might be influenced 
by the fact that memories have to be reconstructed and might be influenced by 
subjective beliefs and perception. Some people may have simply forgotten whether 
they experienced certain symptoms in the past or they may have reframed them.
[36] Inconsistency was especially apparent for patients with post-injury PCS; even 
those with resolved PCS (i.e., PCS at 2 weeks but not at 6 months) had a higher 
rate of inconsistency than those who never fulfilled the criteria for PCS post injury. 
It is possible that patients with post-injury PCS are dealing with recall bias, which 
means that they have difficulties remembering when the symptoms first occurred 
(i.e., did the symptoms start pre injury or post injury?). In addition, some of the post-
concussion symptoms themselves (e.g., fatigue, concentration problems, memory 
problems) may directly influence the ability to accurately complete a self-report 
questionnaire and thereby may have influenced the consistency of the pre-injury 
assessment. It is possible that some people in this study who reported the greatest 
symptoms at six months following injury are more likely to conceptualize those 
symptoms as longstanding and due to factors separate from their mTBI.
Strengths of our study include the large number of patients with mTBI and the 
representativeness of the study sample. In addition, pre-injury symptoms were 
assessed at four different time points and ratings were compared to both trauma 
patients without brain injury history and healthy controls. Therefore, the current 
study represents the most up to date and comprehensive study in assessing the 
reliability of pre-injury symptom reporting among patients with mTBI. The main 
limitation of our study was that the healthy control group was not comparable to 
both patient groups. Therefore, the relatively low number of symptoms reported 
might be the direct consequence of the younger age and the higher education level 
in this group. Healthy controls were recruited via the personal and occupational 
network of the investigators of the UPFRONT study, which could have introduced 
bias. An alternative approach might be to include ‘friend controls’, a method that 
is currently used by the TRACK-TBI study.[37] A second limitation concerns the 
number of patients that were lost to follow-up during the 12-month period. A total of 
806 patients completed the two-week assessment, whereas 586 were still involved 
at 12 months. All pre-injury ratings were completed by 444 patients. Although 
attrition is common in mTBI studies,[4, 6, 38] it might have resulted in selection bias 
that could have influenced our study results; i.e. if patients with post-injury PCS are 
more likely to participate in the follow-up assessment and these patients are less 
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consistent in their pre-injury assessment, it is possible that the large percentage 
of inconsistent ratings in our study is in fact an overestimation. Additionally, the 
confidence interval for PCS diagnosis at six months as a predictor of three or more 
pre-injury symptoms was wide. Lastly, the RPQ is the most often used questionnaire 
to assess PCS and is recommended in the common data elements[39]. However, 
in this study we used the HISC, which could make the results of this study more 
difficult to compare with previous literature although it was possible to delineate 
patients with PCS based on the available symptoms. 
Our study reveals the difficulty in accurately obtaining pre-injury ratings of 
symptoms among patients with mTBI. More than half of the patients inconsistently 
reported their pre-injury functioning over time. Patients with post-injury PCS had 
strikingly high ratings of pre-injury symptoms and were also more likely to report 
symptoms inconsistently over time. This has implications for the accuracy of self-
report measurements designed to assess post-concussion symptoms and PCS in 
patients with mTBI. When patients are not able to accurately recall their pre-injury 
status, the validity of their perceived post-injury status could also be doubted. 
Another problem is that the overlap with psychiatric disorders is not captured in a 
self-report questionnaire. Patients with pre-injury PCS more often had psychiatric 
premorbidity and this premorbidity also showed a strong association with post-
injury PCS. Therefore, some of the post-injury PCS diagnoses might actually be 
the consequence of pre-existing psychiatric problems rather than the sustained 
mTBI. For clinical purposes, we recommend assessing post-concussion symptoms 
in a more comprehensive way by using a semi-structured or structured interview. 
In such an interview, a clinician may investigate the frequency and severity of 
symptoms and whether these symptoms influence functioning and quality of life. 
A clinician may also examine when the symptom first occurred and whether there 
is overlap with psychological factors such as emotional distress. For research 
purposes, however, such an approach might not be feasible.
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Abstract
Purpose: The Quality of Life after Brain Injury overall scale (QOLIBRI-OS) measures 
health-related quality of life (HRQoL) after traumatic brain injury (TBI). The aim of 
this study was to derive value sets for the QOLIBRI-OS in three European countries, 
which will allow calculation of utility scores for TBI health states.
Methods: A QOLIBRI-OS value set was derived by using discrete choice experiments 
(DCEs) and visual analogue scales (VAS) in general population samples from the 
Netherlands, United Kingdom and Italy. A three stage procedure was used: (1) A 
selection of health states, covering the entire spectrum of severity, was defined; 
(2) General population samples performed the health state valuation task using a 
web-based survey with three VAS questions and an at random selection of sixteen 
DCEs; (3) DCEs were analysed using a conditional logistic regression and were 
then anchored on the VAS data. Utility scores for QOLIBRI-OS health states were 
generated resulting in estimates for all potential health states.
Results: The questionnaire was completed by 13,623 respondents. The biggest 
weight increase for all attributes is seen from “slightly” to “not at all satisfied”, resulting 
in the largest impact on HRQoL. “Not at all satisfied with how brain is working” 
should receive the greatest weight in utility calculations in all three countries.
Conclusion: By transforming the QOLIBRI-OS into utility scores we enabled the 
application in economic evaluations, and in summary measures of population 
health, which may be used to inform decision-makers on the best interventions and 
strategies for TBI patients.
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Introduction
Traumatic Brain Injury (TBI) is generally defined as “an alteration in brain function 
or other evidence of brain pathology, caused by an external force”.[1] TBI is one 
of the leading causes of death and disability worldwide.[2] Annually, TBI costs 
approximately $US 400 billion worldwide and imposes a massive burden on society.
[3] Economic evaluations in health care interventions are increasingly being used to 
inform governments, healthcare funders and policy makers and to prioritize resource 
allocation.[4] Nonetheless, for economic evaluations, preference-based measures 
(PBMs) are a requirement[5] and values have to be assigned to the health states 
these measures describe.[6] Many popular PBMs are generic. However, generic 
instruments do not always adequately assess specific aspects of health-related 
quality of life (HRQoL) that are affected by a disease, such as for example cognition.
[7] Therefore, generic measures, such as the EuroQol-5D (EQ-5D) and Short Form-
36 (SF-36), are often combined with condition-specific questionnaires. A TBI-
specific instrument is the Quality of Life after Brain Injury overall scale (QOLIBRI-
OS).[8] The QOLIBRI-OS instrument is a disease-specific tool for assessing HRQoL 
after sustaining TBI, which covers areas that are typically affected by TBI.[9] It was 
developed in 2012 and since then has been widely applied in TBI[8]. By generating 
a condition-specific preference based measure (CSPBM) for TBI, it will potentially 
provide a more accurate assessment of the impact of heterogeneous outcomes 
after TBI and a more sensitive measure of the benefit of interventions. 
The QOLIBRI-OS is a non-preference-based instrument that yields ordinal data, and 
therefore has limitations for economic evaluation studies. Transforming QOLIBRI-
OS into utility scores will enable the application in economic evaluations, and in 
summary measures of population health (e.g. quality-adjusted life years (QALYs)). 
Furthermore, a value set for the QOLIBRI-OS will introduce the ability to summarize 
general population preferences for health states that could be experienced by 
TBI patients and the HRQoL of TBI patients can be compared with other (patient) 
groups. 
To be able to use  health state values in QALYs calculations,[10] they have to be 
anchored on a scale from 0 (dead) to 1 (full health). A less than 0 value is given 
to health states which are reported to be worse than dead. Ultimately, a value set 
can be generated, which means that each item level of the QOLIBRI-OS has a 
weight (utility) assigned to it. A lower utility means a higher impact on HRQoL. Each 
QOLIBRI-OS health state can be converted into a single summary index value with 
a value set.  
Value sets for generic instruments (e.g. EQ-5D and Health Utility Index 2 (HUI2))
[11] are widely available and are being used extensively in economic evaluations.
[12] However, the QOLIRBI-OS currently does not have utilities, which means 
the instrument cannot be used for QALY calculations.[13] To make the QOLIBRI-
OS suitable for use in economic evaluations, the health states need to be valued 
with a preference-elicitation method. Widely used methods are discrete choice 
experiments (DCE)[14, 15] and visual analogue scales (VAS).[16] The DCE and 
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VAS technique are used to quantify health outcomes.[17-21] DCEs are based on 
stated preferences and are seen to be a simpler method than the conventional 
methods such as time trade off (TTO) and standard gamble (SG).[22] The DCE 
approach makes it possible to predict values for alternatives in hypothetical 
situations or conditions that cannot be judged in the real world.[23] The VAS is 
a valuation technique that records participants’ views about hypothetical health 
states on a scale from 0 (worst imaginable health state) to 100 (best imaginable 
health state).[16]
The objective of this study was to develop health utility indices for the QOLIBRI-OS 
health states. In order to do this we aimed to develop value sets for the QOLIBRI-
OS in three European countries by the use of a web-based DCE and VAS valuation 
study, which will allow calculation of utility values for the health states measured 
with the QOLIBRI-OS.
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Methods
The QOLIBRI-OS is a short, six-item version of the Quality of Life after Brain Injury 
(QOLIBRI), which provides a profile of HRQoL in domains typically affected by brain 
injury. It addresses wellbeing and functioning and the psychometric properties 
have been determined satisfactory to good.[8] The QOLIBRI-OS assesses a 
single overall score, which provides a brief summary measure of HRQoL.[8] The 
six items are satisfaction with physical condition; how brain is working, in terms of 
concentration, memory and thinking; feelings and emotions; ability to carry out day 
to day activities; personal and social life; current situation and future prospects. 
Responses are on a 5-point Likert scale ranging from “not at all satisfied” to “very 
satisfied”. Ultimately, the current situation and future prospects item from the 
QOLIBRI-OS was excluded because a general sample might answer this item too 
subjectively, which may hamper the use of the QOLIBRI-OS value set in populations 
other than TBI patients. By use of Rasch analysis, the psychometric validity of the 
QOLIBIR-OS scale was tested and well-functioning items of the QOLIBRI-OS were 
identified, which ultimately resulted in measures of item difficulty and fit of the 
QOLIBRI-OS. The scale was examined for redundancy and removing the current 
situation and future prospects item did not change the properties of the scale 
(Appendix A). In the end, the QOLIBRI-OS scale included 5 items, each with 5 
levels, which are shown in Table 1. 
Developing value sets for the QOLIBRI-OS required three methodological steps 
(Figure 1). Each of these steps is described in more detail in the following sections. 
Table 1. Five selected items of QOLIBRI-OS$
QOLIBRI-OS
1. Satisfied with physical condition
2. Satisfied with how brain is working, in terms of  
    concentration, memory and thinking
3. Satisfied with feelings and emotions
4. Satisfied with ability to carry out day to day activities
5. Satisfied with personal and social life
$ Item levels: 1-Not at all; 2-Slightly; 3-Moderately; 4-Quite; 5-Very
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Figure 1. Steps taken to yield a QOLIBRI-OS value set which enables calculation of 
utility weights for the health states measured with this instrument.
Step 1
Health state selection
Using level balanced design
Step 2
Health state valuation
• Discrete choice experiment (DCE)
• Visual analogue scale (VAS)
• Data survey general population 
sample (N = 13,623)
Step 3
Modelling
• Generate a value set for the 
QOLIBRI-OS
Step-by-step
Step 1: Health state selection
Even after reducing the items from the QOLIBRI-OS from 6 to 5, the selected items 
can generate a large number of possible health states. The 5-item QOLIBRI-OS can 
generate 3125 (55) possible health states, since each dimension has five levels, 
and this makes it impossible to ask the respondents for a valuation all of them.
[13] We therefore made a selection of health states to be used in the health state 
valuation task. For the DCE valuation of the QOLIBRI-OS, 392 health states were 
selected, which were presented in 196 pairs, based on a method devised by Oppe 
and van Hout.[24] These health states cover the spectrum of severity. For this we 
used a level-balanced design,[13] meaning that all levels of each item occurred 
with the same frequency. The same 392 states were used in the EuroQol EQ-5D-5L 
value set valuation study.[24-26]  The best and worst health states plus death were 
selected for the visual analogue scale (VAS) valuation.
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Step 2: Health state valuation – study design 
During this step a panel of judges evaluated the selected health states. The 
general population was asked to evaluate the possible QOLIBRI-OS health states 
by assuming what they would consider their quality of life to be, if they were in one 
of these specific health states. The responses from the general population sample 
were used to generate the health state values. 
Health state valuation – survey
The web-based questionnaire included questions regarding the demographics 
of the respondent (e.g. age, sex, educational and income level, chronic health 
complaints), sixteen DCE questions and three VAS questions. The DCE pairs were 
randomly assigned to the participants. During this study, no DCE or VAS data was 
excluded. The survey and description of health states were translated from English 
into Dutch and Italian using translation software and subsequently translated back 
into English. Bilingual native speakers verified the translations independently. 
The panel of judges consisted of members of the general public aged 18 to 75 
years from the United Kingdom (UK), Italy and the Netherlands, which provided 
an international spread. The samples were also representative of the population in 
the countries with regard to age, gender and education. A total number of 13,623 
respondents filled out the questionnaire (Italy: 5,270 respondents; Netherlands 
4,183 respondents; UK 4,170 respondents). The questionnaires were distributed 
by a market research agency (Survey Sampling International (SSI), nowadays 
called Dynata) via internet during the period June 29th till July 31st 2017. A second 
round of data collection took place between February 3rd and February 16th 2018 
to collect some more responses for the VAS data, especially for the health state 
‘dead’, and these were all respondents who had already completed the survey the 
first round (recontacts). 
Valuation techniques
The responses from the general population sample reflect preferences between 
different health states[10] and these were used to generate and model the value 
sets.
One of the methods used to evaluate the health states was a DCE,[27-29] which is 
an ordinal measurement method. With this method, a pair of health states (labelled 
A and B, Figure 2), with no reference to the duration of the states, is presented, 
and respondents have to decide which health state they consider to be better. 
No indifference option was included. The assumption of a DCE is that the choices 
among sets of divergent health states are driven by differences in the levels of the 
dimensions from the QOLIBRI-OS which define the health states. Furthermore, by 
asking respondents to choose between health states with altering severity levels 
and different combinations, the opportunity arises to estimate the impact of the 
preferences based on the changes in levels.[30] We used colours in the online 
survey to indicate the severity level of the attribute, ranging from green indicating 
very satisfied to red indicating not at all satisfied. 
The second method used was the VAS, which is a valuation technique that requires 
participants to score the injury stage on a vertical scale graded from 0 (worst 
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imaginable health state) to 100 (best imaginable health state). As done previously 
by Stolk et al.,[23] a rescaled VAS, based on dead and the best and worst health 
states. was developed; health preference valuations of 0 to 100 on the VAS were 
rescaled from 0 to 1. This was done by the use of the following formula: 
It was necessary to rescale the VAS values in such a way that the value for death 
was explicitly set at 0 and the best health state (11111) to 1.[23]
Figure 2. Example of a QOLIBRI-OS DCE question
Step 3. Modelling the DCE health state valuations 
Statistical modelling was used to estimate the values for all potential health states 
according to the responses for the selected health states. The coefficients for each 
level and attribute were estimated by regression techniques. Whether a level has 
a positive or negative effect on utility depends on the sign of the coefficient. The 
relative importance of the level is revealed by the value of the coefficient. A level 
is considered to be important when the coefficient has been determined to be 
statistically significant (p<0.05).[31] Afterwards, the values for all the health states 
described by the QOLIBRI-OS were generated from these coefficients.[32] A utility 
score for the QOLIBRI-OS health states is generated from the DCE responses 
anchored on the VAS. DCE responses were defined as binary outcomes.
As described by Feng et al.,[32] a 20 parameter model (4 levels x 5 dimensions = 20 
parameters) was generated for the QOLIBRI-OS, which estimated four parameters 
for each dimension and one parameter per level, with the “very satisfied” level used as 
the reference. This model allowed for the coefficients to differ between dimensions, 
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and for the importance of each level of problems to differ between dimensions.[32] 
Regression models were estimated for the DCE in all three countries separately. 
DCE answers were analysed using a conditional logistic regression. Subsequently, 
we derived health state values from the DCE data on the QALY scale by anchoring 
the values on the estimated VAS value for the worst state (55555). The following 
formula was used for this process: 
Where β20 parameter DCE model  is the coefficient from the conditional logistic regression 
DCE model, estimated VASworst state is the pooled mean value given to the worst 
health state by all respondents, estimated DCEworst state is the intercept and all “not 
at all” level coefficients from the DCE model summed up, which generates a β 
anchored20 parameter DCE model for each attribute and level as output. The utilities are 
based on and have been calculated by the use of these anchored DCE coefficients. 
In addition, we implemented a generalized additive logistic regression using the 
bamlss package of R[33, 34] to relax the assumption of the standard logistic 
regression on the linear relationship between the predictors and the log-odds of 
the outcome. We compared the non-parametric model specifying an  additive (but 
otherwise unknown) utility function to the standard model assuming linear utility.
Statistical analysis
For the statistical analyses, responses on the QOLIBRI-OS were recoded with 
1 reflecting “very satisfied” and 5 reflecting “not at all satisfied” (similar to the 
convention used for the EQ-5D). Therefore 11111 was seen as the ‘best health 
state’ and 55555 as the ‘worst health state’. 
Rasch analysis was performed using Winsteps 3.92 (Winsteps.com, Chicago 
Illinois, USA). 
All other analyses were performed using SPSS version 24 for Windows (IBM SPSS 
Statistics, SPSS Inc, Chicago, IL) and R (R Core Team (2013). R: A language and 
environment for statistical computing. R Foundation for Statistical Computing, 
Vienna, Austria).
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Results
Study population
The characteristics of the survey respondents are shown in Table 2. A total of 13,623 
respondents divided over three countries completed the questionnaire. The median 
age of the respondents was 45 years old. Approximately half of the respondents 
(51.2%; N=6981) were employed and 15% (N=2068) were retired. One out of two 
respondents have experienced serious illness in their immediate family and/or 
reported to have chronic health complaints. 
DCE data 
An upward trend was shown in probability of respondents choosing health state 
A when the difference in sum score of health state A and B (e.g. probability of 
choosing health state 11111; sum score = 5 over health state 12345; sum score = 
15) becomes bigger and more positive, which is what was expected (Appendix B).
VAS data 
Table 3 shows the summary statistics for the three VAS health states considering 
the QOLIBRI-OS data. The lowest mean value was 38.01 (health state dead) 
and highest mean value was 81.49 (health state 11111 e.g. very satisfied with 
every attribute). As expected, when the summary score of the of the health state 
decreased (e.g. severity of health state becomes lower), which means the health 
state was comprised of lower attribute levels, the utility mean increased.  
Value sets
Table 4 shows the 20 parameters model per country for the QOLIBRI-OS which was 
based on the conditional logistic regression for the DCE data and the anchoring of 
the DCE coefficients. For all respondents and both the Netherlands and Italy, the 
lowest estimate for the DCE and anchored DCE data was found for ‘Quite satisfied 
with feelings and emotions’ and the highest estimate for ‘Not at all satisfied with 
how brain is working in terms of concentration, memory and thinking.’ When looking 
at the model specifically for the UK, the lowest estimate was found for ‘Moderately 
satisfied with personal and social life’ and the highest for ‘Not at all satisfied with 
how brain is working in terms of concentration, memory and thinking’. The biggest 
increase in weight for all attributes is seen from level four (slightly satisfied) to level 
five (not at all satisfied). Table 5 introduces an example for the QOLIBRI-OS value 
set based on the DCE and anchored DCE models. This enables the calculation of 
a utility weight per health state, which is how the utilities for the QOLIBIR-OS data 
can be obtained. The utility scores of the anchored DCE model of the QOLIBRI-
OS range from 0.383 for health state 55555 to 1.0 for health state 11111. Table 6 
shows an example of values for a mild, moderate and severe health state. Generally 
speaking, Italians value these health states lower compared to their counterparts 
in UK and the Netherlands. Appendix C shows the non-parametric models per 
country for the QOLIBRI-OS and Appendix D shows an example of values for a 
mild, moderate and severe health state based on the non-parametric models.  
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Table 2. Characteristics of the study population
All 
respondents UK
The 
Netherlands Italy
(N=13623) (N=5270) (N=4183) (N=4170)
N (%) N (%) N (%) N (%)
Age1 (years) 45 [33-57] 44 [32-57] 46 [33-58] 45 [34-57]
Gender (male) 6736 (49.4%) 2597 (49.3%) 2069 (49.5%) 2070 (49.6%)
Education2 
Low 3797 (27.9%) 1205 (22.9%) 1232 (29.5%) 1360 (32.6%)
Middle 6499 (47.7%) 2265 (43.0%) 1901 (45.4%) 2333 (55.9%)
High 3327 (24.4%) 1800 (34.2%) 1050 (25.1%) 477 (11.4%)
Work status3 
Employed 6981 (51.2%) 2759 (52.4%) 2214 (52.9%) 2008 (48.2%)
Unemployed 1915 (14.1%) 475 (9.0%) 447 (10.7%) 993 (23.8%)
Looking after others4 699 (5.1%) 358 (6.8%) 177 (4.2%) 164 (3.9%)
Student 849 (6.2%) 294 (5.6%) 270 (6.5%) 285 (6.8%)
Retired 2068 (15.2%) 855 (16.2%) 545 (13.0%) 668 (16.0%)
Unable to work 1111 (8.2%) 529 (10.0%) 530 (12.7%) 52 (1.2%)
Annual household income5
Low 3131 (23.0%) 1126 (21.4%) 759 (18.1%) 1247 (29.9%)
Middle 3315 (24.3%) 1604 (30.4%) 728 (17.4%) 983 (23.6%)
High 5076 (37.3%) 1994 (37.8%) 1787 (42.7%) 1295 (31.1%)
Do not know/do not want to tell 2100 (15.4%) 546 (10.4%) 909 (21.7%) 645 (15.5%)
Experience of serious illness 
In you yourself (yes) 3517 (25.8%) 1834 (34.8%) 1068 (25.5%) 615 (14.7%)
In your immediate family (yes) 7066 (51.9%) 3231 (61.3%) 2864 (68.5%) 971 (23.3%)
In caring for others (yes) 3224 (23.7%) 1689 (32.0%) 924 (22.1%) 611 (14.7%)
Chronic health complaints 
(yes)6 6896 (50.6%) 2778 (52.7%) 2223 (53.1%) 1895 (45.4%)
1 Data are displayed as median, with the first and third quartile given within brackets.
2 Education was divided up in low (junior school), middle (comprehensive school) and high (college and 
university).
3 Work status was categorized as employed (employee and self-employed), unemployed (consisting 
out of work for more than and less than 1 year), looking after others (e.g. a carer or parent), a student, 
retired and unable to work.
4 E.g. carer or parent.
5 Income was grouped as follows low (UK; less than £14,000, Italy and the Netherlands; less than 
€20,000), middle (UK; £14,000-£27,999, Italy and the Netherlands; €20,000-€39,999) and high (UK; 
more than £27,999, Italy and the Netherlands; more than €39,999).
6 Chronic health complaints were defined as: asthma, chronic bronchitis, severe heart disease, 
consequences of a stroke, diabetes, severe back complaints, arthrosis, rheumatism, cancer, memory 
problems due to neurological disease/dementia, memory problems due to ageing, depression or anxiety 
disorder, and other chronic health complaints.
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Table 3. QOLIBRI-OS summary statistics for the 3 selected VAS health states
Health state Observations (N) Mean VAS SD Rescaled mean Utility mean
dead 116 38.01 40.71 0 0
55555* 138 54.64 33.56 38.26 0.38
11111** 245 81.49 22.15 100 1
* worst possible health state; all attributes have ‘not at all satisfied’ level
** best possible health state; all attributes have ‘very satisfied’ level
Table 5. QOLIBRI-OS example: the value for health state 21232
DCE Anchored DCE
Full health (constant/intercept) 1 1
Minus constant 0 0
Quite satisfied with physical condition 0.143 0.015
Very satisfied with how brain is working, in terms 
of concentration, memory and thinking 0 0
Quite satisfied with feelings and emotions 0.05 0.005
Moderately satisfied with ability to carry out day to 
day activities 0.306 0.031
Quite satisfied with personal and social life 0.109 0.011
Utility weight health state 21232 0.392 0.938
1Calculation of utilities: utility = 1 - value 
Note: all respondents
Table 6. Example of values for a mild, moderate and severe health state
Anchored DCE 
All 
respondents UK
The 
Netherlands Italy
Best health state: 
11111 1 1 1 1
Mild health state: 
21232 0.902 0.94 0.955 0.918
Moderate health 
state: 34343 0.631 0.853 0.799 0.801
Severe health state: 
55455 0.449 0.465 0.472 0.396
Worst health state: 
55555 0.383 0.383 0.383 0.383
Abbreviations. DCE, Discrete Choice Experiment   
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Discussion
Our study demonstrates the first value sets for the QOLIBRI-OS. The main outcomes 
according to the preferences of our general sample suggested the biggest increase 
in weight was found when making the step from level slightly satisfied to level not at 
all satisfied within an attribute, which results in the largest impact on HRoQL. This 
is also in line with previous EQ-5D value set research.[32] Additionally, it was also 
found that ‘Not at all satisfied with how brain is working in terms of concentration, 
memory and thinking’ should receive the greatest weight in utility calculations in all 
three countries. 
When looking at the face validity of the value set it was shown that a lower level of 
satisfaction within a health state also corresponded to a lower utility.  
Strengths of our study include the representativeness of the study sample and the 
large number of survey respondents included in our survey. A general population 
sample was used instead of a brain injury group, because then the benefit gained 
has been determined from a public perspective, who ultimately are the taxpayers 
and potential patients. 
During this study, DCEs were used and as mentioned in previous research, this 
valuation technique has advantages in measuring health state valuations over 
methods such as standard gamble (SG) and time trade off (TTO) in terms of 
simplicity[35] and understandability. There are several methods of administration 
to conduct health state valuation studies, such as face-to-face using paper-and-
pencil methods and web-based questionnaires. The choice for a web-based 
survey during this study also implied using health state valuation methods that 
were amenable to online administration, in this case DCEs and VAS. Compared to 
personal interviews, web-based surveys are equipped to get answers from large 
samples in a relatively short time, have a flexible sampling frame, enable a range 
of background characteristics of non-respondents to be obtained, the order of 
the questions can be randomized, allow complex routing of questions, the time 
it takes a respondent can be recorded, and the errors associated with data entry 
are minimized.[36] Some limitations considering DCE research are the fact that 
a main effects only design, assuming that all attributes were value-independent 
of each other (i.e., all interactions between attributes were zero) was used. This 
may, however, be reasonable since main effects typically account for 70-90% 
of the explained variance in DCE.[37] Additionally, the complexity of a DCE can 
potentially cause some extra selection bias compared with general questionnaire 
surveys.[38] Furthermore, we have also encountered some limitations specific to 
our study. To ultimately get to five items for the QOLIBRI-OS, we based eliminating 
the last item on subjective researcher judgement, which could potentially lead to 
bias. Considering it was a web-based survey, we had no control on checking if 
respondents completely understood the task at hand. For future studies it would 
be advisable to build in a tool, to be able to check answers while respondents are 
taking the survey, for example to check if they are using the VAS correctly and 
are not turning it upside down. Additionally, face-to-face surveys will deliver higher 
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quality data, but also require larger monetary resources. However, web-based is 
the mostly used administration method in DCE research, especially because of the 
high costs associated with the face-to-face method. We based our health states and 
pairs on previous EQ-5D research; however, it could be that for the QOLIBRI-OS 
instrument different health states should have been asked and for future research 
it would be advised to develop an experimental design where the pairs of health 
states are selected specifically for the QOLIBIR-OS. Another problem is that the 
respondents saw a complete ‘clean’ VAS for every new question. In a situation 
where their given answers are shown on the scale during the following questions, 
the respondents can scale their own answers more easily, which ultimately leads to 
a better scale division. The VAS and DCE are different tasks; what people imagine 
when they use the VAS may vary relative to a DCE. Using the VAS to scale, such 
as was done in this study, makes mathematical sense, but does it also make sense 
when using it to scale coefficients giving utilities? In addition, the worst health state 
(health state 55555 e.g. not at all satisfied with every attribute) was given a mean 
VAS value of 54.64, which was expected to be lower, and could influence the 
rescaling. Furthermore, VAS scores used for rescaling in this study were not based 
on country-specific data due to small sample size. Future research could solve 
these limitations linked to the VAS values used in this study by doing a small TTO 
valuation task in each of the three countries, to provide anchors for the DCE scale. 
In addition, for the UK value set, an inconsistent coefficient in the final algorithm 
(“moderately satisfied with personal and social life”) was reported, which should be 
looked at in more detail in future research. Moreover, the DCE and VAS questions 
were completely randomized. The quality of the data would have most likely been 
higher, if we asked the DCE and VAS questions in blocks, which would be randomly 
assigned to the respondents and every block consisted of one of the better health 
states and the worst health state.[24] This makes for a more balanced way of asking 
the questions, because everyone gets a well-balanced set of questions, which 
accounts for the whole range of severity. In addition, red-green color blindness 
could have influenced our respondents while answering the DCE questions, 
however, color-coding does improve the results.[39] Building upon these findings, 
it would be recommended for future research to provide anchors for the DCE and to 
use different colors than red and green. Since we used a market research company 
to recruit our sample, some individuals might be ‘professional’ respondents: those 
who answer a large number of surveys, and whose responses are not typical for the 
general public and we do not know to what extent our samples are representative 
for the population in the three countries with regards to characteristics other than 
age, gender, and educational level. Nonetheless, this study is the first one to 
determine a value set for the QOLIBRI-OS in three different European countries and 
introduced the opportunity to compare HRQoL of TBI patients with other (patient) 
groups. Similar studies have been performed for the EQ-5D,[25, 32] and are used 
daily in HRQoL research. 
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Conclusions
By transforming the QOLIBRI-OS into utility scores we have enabled the potential 
application in economic evaluations, and in summary measures of population 
health, which may inform decision-makers on the best interventions and strategies 
for TBI patients.
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Appendix
Appendix A. Measures of Item Difficulty and Fit from Rasch Analysis of the 
QOLIBRI-OS
QOLIBRI-OS items
Item 
difficulty 
measure
Infit MNSQ Infit Z Outfit MNSQ Outfit Z
Physical condition 0.32 1.05 0.9 1.07 1.4
How brain is working, in 
terms of concentration, 
memory and thinking
0.23 1.11 2.2 1.12 2.3
Feelings and emotions -0.01 1.04 0.8 1.02 0.5
Ability to carry out day to 
day activities -0.35 0.99 -0.3 0.94 -1.2
Personal and social life -0.38 1 0.1 0.93 -1.4
Current situation and future 
prospects 0.19 0.81 -4.1 0.8 -4.4
Six items:
Person real separation: 1.57
Reliability: 0.71
Five items:
Person real separation: 1.63
Reliability: 0.73
* when the current situation and future prospects item has been excluded.
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Appendix B. The probability of choosing health state A when looking at the 
difference in sum scores between health state A and B.
Difference in sum scores between A and B
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Appendix D. Example of values for a mild, moderate and severe health state   
 
All 
respondents UK
The 
Netherlands Italy
Mild health state: 
21232 0.95 0.948 0.96 0.942
Moderate health 
state: 34343 0.833 0.879 0.789 0.827
Severe health state: 
55455 0.446 0.452 0.442 0.445
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Abstract
Background and purpose: The utility-weighted modified Rankin Scale (UW-mRS) 
has been proposed as a new patient-centered primary outcome in stroke trials. 
We aimed to describe utility weights for the mRS health states and to evaluate the 
statistical efficiency of the UW-mRS to detect treatment effects in stroke intervention 
trials.
Methods: We used data of the 500 patients enrolled in the MR CLEAN (Multicenter 
Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the 
Netherlands). Utility values were elicited from the EuroQol Group 5-Dimension Self-
Report Questionnaire assessed at 90 days after inclusion, simultaneously with the 
mRS. Utility weights were determined by averaging the utilities of all patients within 
each mRS category. We performed simulations to evaluate statistical efficiency. The 
simulated treatment effect was an odds ratio of 1.65 in favor of the treatment arm, 
similar for all mRS cutoffs. This treatment effect was analyzed using 3 approaches: 
linear regression with the UW-mRS as outcome, binary logistic regression with a 
dichotomized mRS (0-1/2-6, 0-2/3-6, and 0-4/5-6), and proportional odds logistic 
regression with the ordinal mRS. The statistical power of the 3 approaches was 
expressed as the proportion of 10 000 simulations that resulted in a statistically 
significant treatment effect (P≤0.05).
Results: The mean utility values (SD) for mRS categories 0 to 6 were: 0.95 (0.08), 
0.93 (0.13), 0.83 (0.21), 0.62 (0.27), 0.42 (0.28), 0.11 (0.28), and 0 (0), respectively, 
but varied substantially between individual patients within each category. The UW-
mRS approach was more efficient than the dichotomous approach (power 85% 
versus 71%) but less efficient than the ordinal approach (power 85% versus 87%).
Conclusions: The UW-mRS as primary outcome does not capture individual variation 
in utility values and may reduce the statistical power of a randomized trial. 
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Introduction
The modified Rankin Scale (mRS) is the most widely used primary outcome 
measure in trials for acute stroke interventions.[1, 2] The mRS is an ordinal scale 
ranging from 0 (no symptoms) to 6 (death) measuring the degree of disability or 
dependence in everyday life.[3] Previously, dichotomizing the mRS into dead or 
dependent (mRS, 3–6) versus independent (mRS, 0–2) was common, but this results 
in a reduction in statistical power to detect relevant treatment effects.[4] Therefore, 
statistical approaches preserving the ordinal nature of outcome measures, such as 
proportional odds logistic regression, have been recommended for stroke and other 
neurological disorders.[1, 5-8] Currently, the importance of incorporating quality of 
life (QoL) in outcome analysis in stroke trials is increasingly recognized.[9-11] For 
the mRS to reflect both treatment effect and patient perception, the utility-weighted 
mRS (UW-mRS) has been proposed and used as primary end point.[2, 12, 13] 
In the UW-mRS, utilities based on the EuroQol Group 5-Dimension Self-Report 
Questionnaire (EQ-5D-3L) values are assigned to the mRS health states. Two prior 
studies reported utility weights for the mRS health states: 1 representing the values 
of patients and 1 representing the values of clinicians. The utility weights that were 
proposed for the UW-mRS are based on these 2 studies.[12] Compared with the 
ordinal mRS, the UW-mRS showed similar statistical power to detect treatment 
effects in empirical data in a wide range of stroke trials.[12] However, because 
in empirical data, the true treatment effect is unknown, the only valid method to 
assess statistical power is simulation. We aimed to describe utility weights for the 
mRS health states and to evaluate the statistical efficiency of the UW-mRS to detect 
treatment effects in stroke trials. 
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Methods
Anonymized trial data and analytic methods that support our study findings are 
available from the principal investigator (e-mail: mrclean@erasmusmc.nl) on 
reasonable request.
Study Population
We used individual patient data of the 500 patients enrolled in the MR CLEAN 
(Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic 
Stroke in the Netherlands). MR CLEAN was a phase III, multicenter randomized 
clinical trial, designed to evaluate whether intra-arterial treatment (within 6 hours 
of symptom onset) plus usual care would be more effective than usual care alone 
in patients with acute ischemic stroke and a proximal arterial occlusion in the 
anterior cerebral circulation. The primary outcome was the mRS at 90 days, and the 
secondary outcome was the EQ-5D-3L at 90 days. In MR CLEAN, ethics approval 
was obtained from the local institutional review boards of the participating centers, 
and written informed consent was obtained from patients or legal representatives 
before randomization.[14]
Modified Rankin Scale
The mRS is a measure of functional outcome after stroke, evaluating the degree of 
disability or dependence in daily life. The scale is derived from clinical assessment 
by a trained nurse or a physician and consists of 7 grades ranging from 0 (no 
symptoms) to 6, with 5 indicating severe disability and 6 indicating death. A score 
of ≤2 indicates functional independence.[3] 
Utilities
Utilities represent preferences for mRS health states and range from 0 (death) to 1 
(perfect health). Utility values of poor outcome categories might even be negative, 
indicating that they are valued worse than death.[15] In MR CLEAN, utility values 
were elicited using the EQ-5D-3L responses of patient, proxy, or healthcare provider 
assessed at 90 days after inclusion, simultaneously with the mRS. The EQ-5D-3L 
consists of 5 dimensions (mobility, self-care, usual activities, pain/discomfort, and 
anxiety/depression) with 3 levels each (no problems, some problems, and extreme 
problems), thus defining 243 (35) distinct health states.[16] Converting the EQ-5D-
3L responses into utility values was done according to the Dutch tariff—a country-
specific value set established based on the time trade-off method.[17] Patients who 
died before the follow-up interviews at 90 days received a utility value of zero. The 
utility values ranged from −0.33 to 1.00. We determined utility weights for each 
mRS category by averaging the derived utilities (including the negative values) of 
all patients within each mRS health state (eg, the utility weight for mRS=1 is the 
average of the utilities of all patients with mRS=1). Additionally, we matched the 
utility values proposed by Chaisinanunkul et al,[12] who collapsed mRS 5 to 6 by 
assigning a utility weight of zero to both categories, to our mRS values.
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Simulations for Statistical Efficiency
Statistical efficiency was evaluated based on simulations that utilized the MR 
CLEAN database. For a single simulation, 500 patients were sampled at random 
with replacement. For each patient, the predicted probability of each possible 
outcome on the 7-point ordinal mRS was modeled as a function of the baseline 
covariates. These covariates were identical to those in MR CLEAN and included 
age, stroke severity (National Institutes of Health Stroke Scale) at baseline, time 
from stroke onset to randomization, status with respect to previous stroke, atrial 
fibrillation, diabetes mellitus, and occlusion of the internal carotid artery terminus 
(yes/no).[14]
Using these estimated probabilities, an actual outcome in terms of an mRS or UW-
mRS was simulated. Treatment (yes/no) was randomly assigned, and the simulated 
treatment effect was an odds ratio (OR) of 1.65 (β=0.5) in favor of the treatment arm, 
similar for all mRS cutoffs. We also evaluated a scenario with no treatment effect, by 
simulating a treatment effect of OR=1.0 (β=0). During this process, samples of 500 
subjects were generated representing 250 patients from the control group and 250 
from the intervention group, with a known treatment effect. This was then repeated 
10 000×.
The data were analyzed by 3 different statistical approaches. First, we dichotomized 
the 90-day mRS in 3 different ways of favorable versus unfavorable outcome: 0 to 1 
versus 2 to 6, 0 to 2 versus 3 to 6, and 0 to 4 versus 5 to 6. The treatment effect on 
the dichotomized mRS was determined using binary logistic regression. Second, 
we used proportional odds logistic regression for analysis of the treatment effect 
on the ordinal mRS. We fitted a proportional odds logistic regression model with 
the 7-point ordinal mRS scale as outcome. The proportional odds model estimates 
a common OR over all health state transitions within the mRS. According to the 
proportional odds assumption, the common OR is an accurate reflection of the 
overall treatment effect if the ORs are the same for each health state transition. If 
there is agreement regarding the ordinality of the mRS, the common OR can be 
interpreted as a summary measure of treatment effect even if the proportional odds 
assumption is violated.[18] Third, treatment effect on the UW-mRS was analyzed 
using linear regression, as proposed by Chaisinanunkul et al.[12]
Each of the 3 approaches yielded either a significant (P≤0.05) or a nonsignificant 
treatment effect (P>0.05, 2 sided). The power (or type 1 error in case of no treatment 
effect) of each statistical approach was estimated as the proportion of the 10 000 
analyses, which resulted in a statistically significant treatment effect.
Associations were expressed as ORs or β with 95% confidence intervals (CIs), 
averaged over all simulations. All analyses were performed unadjusted and adjusted 
for the prespecified covariates identical to those mentioned above. Statistical 
analyses were performed with R software, version 3.3.2 (R Foundation for Statistical 
Computing, Vienna, Austria). Missing data on time from stroke to randomization 
(0.4%) and level of vessel occlusion (0.2%) was statistically imputed using simple 
imputation (replacement by mean or mode, as applicable).
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Results
Study Population
All 500 participants from the MR CLEAN trial were included in our analysis. The 
mRS at 90 days was available for all patients. The EQ-5D-3L assessments, and 
consequently the utility values, were available in 457 patients (including 108 
patients who died before follow-up). In 43 patients (8.6%), mRS assessment could 
not be followed by an EQ-5D-3L assessment. In 192 patients (38%), the EQ-5D-3L 
was completed by a proxy.
The total study population had a mean age of 65 years (SD, 14 years), and most 
patients (58%) were men (Table 1). 
Table 1. Baseline characteristics of the 500 patients in the MR CLEAN trial.
Baseline variable
Intervention (n = 233) Control (n = 267)
Intra-arterial treatment plus usual care Usual care
Age, y; median (IQR) 65.8 (54.5-76.0) 65.7 (55.5-76.4)
Male sex 135 (58%) 157 (59%)
NIHSS score, median (IQR) 17 (14 - 21) 18 (14 - 22)
Previous ischemic stroke 29 (12%) 25 (9%)
Atrial fibrillation 66 (28%) 69 (26%)
Diabetes mellitus 34 (15%) 34 (13%)
Prestroke mRS
0 190 (82%) 214 (80%)
1 21 (9%) 29 (11%)
2 12 (5%) 13 (5%)
> 2 10 (4%) 11 (4%)
Treatment with IV alteplase 203 (87%) 242 (91%)
Time from stroke onset to 
start of IV alteplase, min; 
median (IQR)
85 (67-110) 87 (65-116)
Occlusion of the internal 
carotid artery terminus* 59 (25%) 75 (28%)
Time from stroke onset to 
randomization, min; median 
(IQR) †
204 (152 - 251) 196 (149 - 266)
Time from stroke onset to 
groin puncture, min; median 
(IQR)
260 (210-313) NA
* No vessel imaging in one patient in the control group.
** Data were missing for two patients in the intervention group. 
Abbreviations. IQR, interquartile range; IV, intravenous; mRS, modified Rankin Scale; NA, not applicable; 
and NIHSS, National Institutes of Health.
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The intervention and control groups were similar in terms of baseline and treatment 
characteristics. The number of patients with poor outcome (mRS, 3–6) at 90 days 
was lower in the intervention group than in the control group (Figure 1).
Figure 1. Distribution of the mRS at 90 days among intervention and control group.
Utility Weights
The mean utility values (SD) for mRS categories 0 to 6 were: 0.95 (0.08), 0.93 (0.13), 
0.83 (0.21), 0.62 (0.27), 0.42 (0.28), 0.11 (0.28), and 0 (0), respectively (Table 2). 
We observed substantial variation in utility values within each mRS category (Figure 
2). Within MR CLEAN, the mean UW-mRS for the intervention group was significantly 
higher when compared with the control group (Table 2).
Outcome Analysis in MR CLEAN
Ordinal analysis of the mRS showed improved functional outcomes in favor of 
the intervention, consistent throughout all categories of the mRS except for death 
(adjusted common OR, 1.67; 95% CI, 1.21–2.30; Figure 1). The dichotomous 
approach led to slightly stronger treatment effects for cutoffs mRS 0 to 1 and 0 to 2 
(adjusted OR, 2.07 [95% CI, 1.07–4.02] and 2.16 [95% CI, 1.39–3.38], respectively). 
The fact that the ORs were not equal for the different cutoffs might imply that the 
proportional odds assumption did not hold perfectly in the empirical data. Linear 
analysis of the UW-mRS resulted in an adjusted β of 0.086 (95% CI, 0.033–0.131).
Intervention (n = 233)
No symptoms Death
Control (n = 267)
Modified Rankin Scale
Patients
240
Chapter 11
Table 2. Mean utility values per mRS category and mean UW-mRS in MR CLEAN 
and the Study by Chaisinanunkul et al.
No. of Patients 
MR CLEAN Mean (SD)
Chaisinanunkul et al12, 
Mean Utility Values 
mRS
0 7 0.95 (0.081) 1
1 36 0.93 (0.133) 0.91
2 84 0.83 (0.210) 0.76
3 87 0.62 (0.265) 0.65
4 133 0.42 (0.286) 0.33
5 45 0.11 (0.284) 0
6 108 0 0
UW-mRS
Overall 500 0.45 (0.322) 0.4
Intervention group 233 0.50 (0.33)** 0.46
Control group 267 0.41 (0.31) 0.36
* Mean utility for the intervention group vs control group within MR CLEAN:
P=0.002 (Mann-Whitney U test). 
Abbreviations. MR CLEAN, Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute 
Ischemic Stroke in the Netherlands; mRS, modified Rankin Scale; and UW, utility weighted.
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Figure 2. Mean utility value per mRS category.
Simulations
For all 3 prespecified mRS dichotomizations, intra-arterial treatment was positively 
associated with better outcomes (adjusted OR, 1.66–1.68; Table 3). The estimated 
treatment effects were similar to the simulated (true) treatment effect of 1.65. When 
comparing the 3 different mRS cutoffs, the statistical efficiency for the cutoff of mRS 
0 to 2 versus 3 to 6 was highest (power 71% versus 62% for mRS 0–1 and 35% 
for mRS 0–4). This could be explained by an almost equal distribution of patients 
among both categories for this cutoff (Table 3).
Ordinal analysis of the mRS estimated an adjusted treatment effect of common 
OR=1.66 (95% CI, 1.41–1.95; Table 3), similar to the dichotomous approach. 
However, the ordinal approach was statistically more efficient (power 87% versus 
71%).
Linear regression analysis of the UW-mRS estimated an adjusted beneficial treatment 
effect of β=0.075 (95% CI, 0.027–0.125; Table 3). The UW-mRS approach was 
statistically less efficient in detecting treatment effects compared with the ordinal 
approach (power 85% versus 87%). Matching the utilities of Chaisinanunkul et al to 
Mean Utility per mRS category
M
ea
n 
ut
ili
ty
 v
al
ue
 a
t 9
0 
da
ys
mRS at 90 days
Error Bars: +/- 1 SD
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the mRS values in MR CLEAN led to similar results (Tables 2 and 3). However, the 
assumptions of the linear model were not met because there was non-normality of 
the residuals (Figure I in the online-only Data Supplement).
In the simulations without a treatment effect, a proportion of false-positives (type 1 
error) of around 5% was estimated for all 3 statistical approaches (data not shown). 
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Discussion
We evaluated the UW-mRS—a recently proposed patient-centered outcome 
measure in stroke. Our study, based on a Dutch stroke intervention trial, showed that 
the UW-mRS does not capture the individual variation in utility values within each 
mRS category. Moreover, our simulations revealed that the UW-mRS approach was 
more efficient in detecting treatment effects than dichotomous analysis of the mRS 
but less efficient than the ordinal approach.
Widely used functional outcome measures in stroke intervention trials, such as 
the mRS, have been extensively studied concerning their feasibility in measuring 
disability after stroke.[19, 20] Nevertheless, more attention has recently been aimed 
at incorporating patient-reported QoL in stroke outcome measures.[10, 11]
As part of this trend, the UW-mRS has been proposed as a new primary patient-
centered outcome measure in acute stroke intervention trials. In empirical data, the 
UW-mRS was equally statistically efficient in detecting treatment effects compared 
with ordinal analysis of the mRS.[12] Based on that study, the UW-mRS was recently 
used as the primary end point in the DAWN trial (Diffusion-Weighted Imaging or 
Computerized Tomography Perfusion Assessment With Clinical Mismatch in the 
Triage of Wake Up and Late Presenting Strokes Undergoing Neurointervention With 
Trevo),[13] and it is expected that more trials will follow. However, the study by 
Chaisinanunkul et al was only based on analyses of empirical sets of data. Because 
the true treatment effect in empirical data is unknown and different treatment effects 
on different outcome measures could be caused by random variation, the only valid 
method to assess the power of a statistical approach is a simulation study, as we 
performed.
Intuitively, patient-centered outcomes, such as the UW-mRS, are clinically useful 
because they concern patient-reported measures combined with the perception 
of the general public. These outcomes reflect patient perception and respect the 
nonequality of health state transitions on an ordinal scale. Nevertheless, averaging 
utility values for each mRS category does not reflect individual valuation of these 
health states: all patients within 1 mRS category receive the same utility weight, 
irrespective of their own valuation of this health state (Figure 2). So, the UW-mRS is 
in fact a revaluation of the mRS. Moreover, the utility distribution with mRS=5 being 
worse than death for some patients does not support collapsing mRS categories 
5 to 6 as proposed by Chaisinanunkul et al. To reflect true individual valuation of 
health states, QoL instruments should rather be used as outcome. However, utility 
values derived from the EuroQol Group 5-Dimension Self-Report Questionnaire 
may not cover the full range of limitations relevant to patients with stroke[21] 
and may, therefore, overestimate QoL in this group. An alternative would be to 
use utility values derived from QoL instruments designed specifically for patients 
with neurological disorders, such as Neuro-QoL.[22] Nevertheless, because QoL 
depends on many external factors, it might introduce noise, making it less suitable 
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as a primary outcome measure.[23, 24]
Our simulations revealed that the UW-mRS is not as statistically efficient as ordinal 
analysis of the mRS and may, therefore, cause a reduction in statistical power when 
used in randomized trials. Chaisinanunkul et al12 analyzed the UW-mRS with a t 
test, implying a continuous outcome variable. We used linear regression, which is a 
comparable approach but allows for multivariable analysis. In theory, linear analysis 
is expected to be more efficient than ordinal analysis when the assumptions of the 
linear model are met. A linear model assumes that the errors between observed and 
predicted values, that is, the residuals of the regression, are normally distributed. In 
our analyses, however, we found non-normality of the residuals of the linear model 
for the UW-mRS. Because the UW-mRS remains a scale with 7 outcome categories, 
the assumption of normally distributed residuals can never be met. Non-normality 
of the residuals might cause bias because of underestimation of the standard error. 
Therefore, the actual power of the UW-mRS approach will be even <85%. Ordinal 
analysis also makes an assumption (the proportional odds assumption), but it 
should be noted that the assumption of a normal distribution of the residuals in a 
linear model is more difficult to fulfill than the assumption of ordinality in proportional 
odds analyses. In line with theoretical expectations, the UW-mRS showed to be 
exactly as efficient as the mRS when it was analyzed with a proportional odds 
model (data not shown).
Defining a beneficial treatment effect in terms of the UW-mRS, and, therefore, 
clinical interpretability, might be difficult. Treatment effect on the UW-mRS scale 
is expressed as a difference in mean UW-mRS between treatment and control 
groups.[12] This difference can be converted into quality-adjusted life-years 
(QALYs) gained or lost by a certain treatment.[12, 25] The QALY measure assumes 
that a year of life lived in perfect health is worth 1 QALY, and a year of life lived in 
a state less than perfect health is worth <1 QALY, proportional to its utility value 
(QALY=years of life×utility). QALYs can be used to calculate cost-effectiveness 
to select a certain intervention for funding.[26] Also, the QALY measure has been 
argued to be more intuitive to patients (healthy life-years gained) and, therefore, to 
improve communication of treatment effects.[12, 25] However, when not converted 
into QALYs, treatment effects expressed as utility differences remain difficult to 
interpret. Moreover, clinicians and researchers are now used to working with the 
(common) OR.
Ordinal outcome scales are also used in other neurological disorders besides 
stroke. Examples are the Glasgow Outcome Scale in traumatic brain injury and 
the Guillain-Barre syndrome disability score in Guillain-Barre syndrome.[6, 7, 27] 
These ordinal outcomes could be transformed to patient-centered outcomes using 
utility values, similar to the UW-mRS. For randomized trials in patients with other 
neurological diseases, such as traumatic brain injury and Guillain-Barre syndrome, 
our study might, therefore, also implicate that ordinal analysis should remain the 
gold standard.
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Our study has several strengths. The simulation study was based on data from the 
MR CLEAN trial, with relatively broad inclusion criteria.[14] As such, our findings 
should be generalizable to future stroke trials. Furthermore, simulation is the most 
adequate method to evaluate statistical power. Also, we used utility values derived 
using the recommended time trade-off method, which should be less prone to bias 
compared with other elicitation methods.[24]
Some limitations should also be acknowledged. As with all simulation studies, we do 
not know how far our findings may be extrapolated beyond the modeled situations. 
For instance, we only simulated a model with a uniform treatment effect across all 
mRS health state transitions, which, therefore, adheres perfectly to the proportional 
odds assumption. However, if the proportional odds assumption would be violated, 
and treatment effect would not be uniform across the different outcome categories, 
ordinal analysis would still be the most efficient.[6] Nevertheless, further validation 
of our results is required. Finally, we used the EuroQol Group 5-Dimension Self-
Report Questionnaire assessed at 90 days after inclusion, which reflects neither 
short-term QoL nor the final health state. A better reflection of patient perception 
could be achieved by calculating QALYs based on multiple QoL measurements in 
1 patient. Nevertheless, the aim of this study is not to describe QoL but to evaluate 
efficiency in detecting treatment effects.
In conclusion, the UW-mRS has been received as a promising new patient-centered 
outcome in stroke research. However, the UW-mRS does not capture individual 
variation in utilities within each mRS health state. Also, interpretation of treatment 
effect on the UW-mRS scale might be more challenging than was first suggested. 
Finally, clinicians and researchers should be aware of the reduction in power 
compared with ordinal analysis of the mRS when they use the UW-mRS as outcome 
measure in acute stroke intervention trials. More thorough evaluation of the UW-
mRS in terms of its added value, analytic approach, and interpretation is required. 
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Appendix
Appendix A. Q-Q plot to test normality of the residuals of the UW-mRS in simulations.
Normal Q-Q
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Legend: Univariable linear model with UW-mRS as outcome and treatment effect as variable. 
(Standardized) residuals are the errors between observed and predicted values in a model. Theoretical 
quantiles are the residuals as theoretically expected when they are normally distributed. In a Q-Q plot, 
the residuals are normally distributed when they fall on the dashed line. 
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Abstract
The Quality of Life after Traumatic Brain Injury (QOLIBRI) instrument is an 
internationally validated patient-reported outcome measure for assessing disease-
specific health-related quality of life (HRQoL) in individuals after traumatic brain 
injury (TBI). However, no reference values for general populations are available yet 
for use in clinical practice and research in the field of TBI. The aim of the present 
study was, therefore, to establish these reference values for the United Kingdom 
(UK) and the Netherlands (NL). For this purpose, an online survey with a reworded 
version of the QOLIBRI for general populations was used to collect data on 4403 
individuals in the UK and 3399 in the NL. This QOLIBRI version was validated by 
inspecting descriptive statistics, psychometric criteria, and comparability of the 
translations to the original version. In particular, measurement invariance (MI) 
was tested to examine whether the items of the instrument were understood in the 
same way by different individuals in the general population samples and in the TBI 
sample across the two countries, which is necessary in order to establish reference 
values. In the general population samples, the reworded QOLIBRI displayed good 
psychometric properties, including MI across countries and in the non-TBI and 
TBI samples. Therefore, differences in the QOLIBRI scores can be attributed to 
real differences in HRQoL. Individuals with and without a chronic health condition 
did differ significantly, with the latter reporting lower HRQoL. In conclusion, we 
provided reference values for healthy individuals and individuals with at least one 
chronic condition from general population samples in the UK and the NL. These 
can be used in the interpretation of disease-specific HRQoL assessments after TBI 
applying the QOLIBRI on the individual level in clinical as well as research contexts. 
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Introduction
Traumatic brain injury (TBI) is often a source of long-lasting impairments and 
functional limitations.[1] It can affect participation in daily activities[2] and may lead 
to a stagnation in working life for several years[3] or permanently prevent a return 
to work.[4] TBI can have dramatic consequences for cognitive, behavioral, and 
emotional life domains, and increases the risk of experiencing other health-related 
problems such as increased alcohol consumption and depression.[5] However, 
a person’s perception of TBI sequelae, compared to an objectively assessed 
functional state, is a subjective dimension, and the relationship between these two 
types of measurement is not always straightforward.[6] Subjective assessments of 
health deficits and self-rated health-related quality of life (HRQoL) provide valuable 
additional information to clinical health examinations and ratings. Thus, patient-
reported outcomes (PROs) have now become widely used in assessing HRQoL 
in the field of TBI. HRQoL measures provide aggregated information on diverse 
health components, such as physical, psychological (mental and emotional), social 
and daily life aspects, and are, therefore, able to capture the multidimensionality of 
individually experienced consequences of TBI.[7]
A systematic review of assessments of HRQoL after TBI, covering the period from 
1991 to 2013, found that the most frequently used instruments were the generic 
Short Form (36) Health Survey (SF-36)[8] and the TBI-specific Quality of Life after 
Traumatic Brain Injury (QOLIBRI).[1] Both instruments display satisfactory to very 
good psychometric properties in TBI populations, with the QOLIBRI having higher 
discriminative powers when separate domains of the QOLIBRI and SF-36 are 
compared.[7, 9]
To gain a more in-depth understanding of TBI-specific consequences, one 
may apply a TBI-specific HRQoL instrument. However, from the perspective 
of rehabilitation after TBI, applying generic instruments may offer an advantage 
due to the availability of population-based reference values. Bearing in mind the 
unspecific nature of some post-TBI symptoms, such as headaches and nausea,[10] 
a comparison with general population samples is essential in order to evaluate the 
rehabilitation progress. Additionally, population-based reference values play a 
key role in differentiating between individuals after TBI with and without impaired 
HRQoL.
In previous research, the QOLIBRI was developed and validated exclusively in 
samples of individuals after TBI to establish its sensitivity for the TBI condition.[11] 
In the interest of enhancing the interpretability of its scores in clinical practice and 
research after TBI, we collected QOLIBRI scores from general population samples 
in the UK and the NL to provide respective reference values.
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Thus, the aims of the present study are:
To ensure the comparability of QOLIBRI translations between general and TBI 
samples by determining the measurement invariance (MI) in general population 
samples (healthy individuals and individuals with a chronic health condition) and 
TBI samples from the UK and the NL.
To provide reference values for healthy individuals and individuals with at least one 
chronic health condition from the UK and the NL.
Only when MI has been verified, reference values will be provided for healthy 
individuals (and individuals with a chronic health condition) from Dutch and UK 
general population samples. Separate reference values will be given for the presence 
and absence of chronic health conditions, age, sex, and level of education.
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Methods
Study Design
The present study is a web-based, self-reported, cross-sectional study based on 
quota sampling of general population samples from the UK and the NL (see below). 
Additional data of patients after TBI, needed for the MI analyses, were retrieved from 
the multicenter, prospective, longitudinal, observational Collaborative European 
Neuro Trauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) 
study.[12] These data were collected at three months post-TBI.
Setting
General Population Samples
Data Collection
The general population sample data were collected through a web-based survey. 
Respondents were recruited by a market research agency (https://www.dynata.
com/), which distributed the questionnaires and collected the data. The samples 
were based on existing large internet panels designed to be representative for 
individuals from the general population from the UK and the NL with regard to 
age, sex, and education. Data collection was carried out between 29 June and 
31 July 2017. The recruitment integrated several sources, e.g., proprietary loyalty 
partnerships (members of loyalty programs across travel, entertainment, retail, and 
other sectors), open recruitment to traditional online panels (e.g., via online banners, 
online all panels, cable TV advertising, mailings, social media influencers, and other 
methods), and integrated partnerships with online communities, publishers, and 
social networks. A broad variety of sources was chosen to reach participants from 
different social milieus to thereby increase the representativeness of the sample.
To avoid a self-selection bias, no specific project details were included in the 
invitation: participants were invited to “take a survey”. Details were disclosed later, 
after the system had selected the individuals for participation according to the given 
selection criteria. After completing the survey, participants received an incentive in 
the form of cash, points, prizes, or sweepstakes from the market research company. 
Respondents, who were identified by the agency as “speeders” (e.g., who took the 
survey in less than five minutes), were deleted. The electronic data capture system 
did not allow missing answers, thus respondents had to answer every question. The 
recruitment process continued until the required quotas were reached.
Informed Consent
Informed consent for the present survey was obtained by the agency from all those 
agreeing to complete the online survey. The process is described in the privacy 
agreement available at https://www.dynata.com/privacy-policy/. Participants were 
informed on the welcome page of the survey that its aim was a better understanding 
of the consequences of TBI on patients’ lives, that it would take approximately 20 
min to complete, and that all responses were confidential and anonymous. Data 
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were anonymized and each participant was assigned a number in the order of 
questionnaire completion.
Sample Composition
From a total of 11,759 survey participants, 4646 individuals from the UK and 3564 
from the NL were included for further analyses. Recruitment was carried out until the 
required quotas for age, gender, and education had been achieved, which ensured 
that samples were as comparable as possible to the general populations of the 
two countries. Nonresponse rates were below 20% (UK: 14.4%, NL: 19.5%). A 
more detailed analysis of these individuals was not possible due to the recruitment 
system used.
Prior to the analyses, responses to QOLIBRI items were examined for obvious 
contradictory response patterns in both general population samples, for example, 
the choice of the response option “not at all” for all items, meaning that responders 
were not at all satisfied and at the same time not at all bothered. This indicated 
that the person had chosen only left-hand side response options, ignoring the item 
polarity. Due to contradictory response patterns, the data of 243 individuals from the 
UK and of 165 individuals from the NL general population samples were excluded 
from further analyses. The individuals included and excluded were compared using 
chi-square (χ2-) tests with Yates correction for nominal variables and independent 
t-test for continuous variables. In both countries, excluded individuals were 
predominantly male and younger compared with the total sample (M = 35, SD = 12) 
and had a middle level of education. In the end, 7802 individuals from the general 
population (UK: 4403; NL: 3399) were included in the final analyses (see Figure 1).
TBI sample
Data Collection
Individuals after TBI were investigated in the (CENTER-TBI) study.[13] They were 
recruited between 9 December 2014 and 17 December 2017. The inclusion criteria 
were a clinical diagnosis of TBI, presentation to hospital within 24 h after the 
injury, a clinical indication for a computed tomography (CT) scan, and provision of 
informed consent adhering to local and national requirements. Data were collected 
applying an electronic case report form (e-CRF, QuesGen Systems Incorporated, 
Burlingame, CA, USA) either during the hospital visit, in a face-to-face visit, a 
telephone interview, or by mail combined with a telephone interview. The data were 
exported from the CENTER-TBI database, Neurobot version 2.0, on 8 November 
2018. Further study details can be found elsewhere.[12]
Informed Consent
Informed consent was obtained according to local and national requirements for 
all patients recruited in the Core Dataset of CENTER-TBI and documented in the 
e-CRF.[13]
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Figure 1. Sample attrition chart (general population).
*non-responder rates for the survey were below 20% (UK:14.4%, NL: 19.5%)
Figure 2. Sample attrition chart (traumatic brain injury (TBI) sample).
Participated in the 
survey*
n = 11,759
From Italy 
(not included 
in our study)
n = 3549
From the UK 
and the NL
n = 8210
Involved in the 
final sample
n = 7802
N = 408 with 
contradictory 
response patterns
n = 243 (UK)
n = 165 (NL)
UK
n = 4403
NL
n = 3399
Participated in the 
core study
n = 4509
From other countries 
(not included in our 
study)
n = 3019
From the UK 
and the NL
n = 1490
Involved in the 
final sample
n = 660
N = 830 not participated 
at 3-months QOLIBRI 
assessments
n = 326 (UK)
n = 504 (NL)
UK
n = 228
NL
n = 432
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Sample Composition
Out of the total of 4509 CENTER-TBI core study participants, 554 individuals after 
TBI from the UK and 936 from the NL participated in the assessments at three 
months post-TBI and were included in the present study. When there were less 
than 30% of missing answers per QOLIBRI subscale, scores were calculated by 
using the prorating method.[14] Of the 1490, 830 individuals did not complete the 
QOLIBRI at three months.
Chi-square tests with Yates correction for nominal variables and independent t-test 
for continuous variables showed that participants from the NL had a higher level 
of education, were mostly female, working or studying, and had predominantly 
sustained a mild TBI (84% in the NL and 72% in the UK) with a good recovery rated 
by the Glasgow Coma Scale Extended (GOSE),[15] compared to those who did 
not complete the QOLIBRI. Analyses of contradictory response patterns did not 
reveal any peculiarities. No exclusion based on QOLIBRI response patterns was 
necessary for the TBI sample. A total of 660 individuals (UK: 228, NL: 432) were, 
therefore, included in the further analyses. For more details on TBI sample attrition, 
see Figure 2.
Ethical Approvals
General Population Sample
The study on the general population sample was part of the CENTER-TBI study and 
ethical approval was obtained from the Leids Universitair Centrum—Commissie 
Medische Ethiek (approval P14.222/NV/nv).
TBI Sample
The CENTER-TBI study (EC grant 602150) was conducted in accordance with 
all relevant laws of the European Union, which were directly applicable or had a 
direct effect, and all relevant laws of the countries in which the recruiting sites were 
located, including but not limited to, the relevant privacy and data protection laws 
and regulations (the “Privacy Law”), the relevant laws and regulations on the use of 
human materials, and all relevant guidance relating to clinical studies including, but 
not limited to, the ICH Harmonised Tripartite Guideline for Good Clinical Practice 
(CPMP/ICH/135/95, “ICH GCP”) and the World Medical Association Declaration 
of Helsinki entitled “Ethical Principles for Medical Research Involving Human 
Subjects”. Ethical approval was obtained for each recruiting site. The list of sites, 
ethical committees, approval numbers, and approval dates can be found on the 
project’s website https://www.center-tbi.eu/project/ethical-approval.
Sociodemographic and Health Status Data
All study participants provided information regarding their age, sex, and level of 
education. Individuals from the general population samples were asked if they had 
one or more chronic health conditions (asthma, heart disease, stroke, diabetes, 
back complaints, arthrosis, rheumatism, cancer, memory problems due to a 
neurological condition like dementia, memory problems due to aging, depression, 
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or other problems). Multiple answers were allowed.
The severity of TBI was rated by attending clinical personnel using the Glasgow 
Coma Scale (GCS), with values of 3–8 indicating severe, 9–12 moderate, and 13–
15 mild TBI.[16] Recovery after TBI was rated using the Glasgow Outcome Scale 
Extended (GOSE) with scores of 3–4 indicating severe, 5–6 moderate disability, 
and 7–8 good recovery. Scores of 2 indicate a vegetative state and a score of 1 
death.[15]
Disease-Specific Health-Related Quality of Life after Brain Injury (QOLIBRI)
HRQoL was assessed administering the TBI-specific QOLIBRI questionnaire, which 
was developed and validated in accordance with the World Health Organization 
definition of health.[14, 17] It covers six life domains (Cognition, Self, Autonomy 
and Daily life, Social Relationships, Emotions and Physical Problems). Items 
contributing to the domains Emotions and Physical problems are negatively worded 
(“How bothered are you by…?”), the remaining items positively (“How satisfied are 
you with…?”). Thirty-seven items are rated on a 5-point Likert scale (“Not at all” = 
1, “Slightly” = 2, “Moderately” = 3, “Quite” = 4, “Very” = 5) and reverse coding was 
performed for negatively worded items. The QOLIBRI total score is scaled to vary 
between 0 (worst possible HRQoL) and 100 (best possible HRQoL).[14]
As not all items were directly applicable to the general population, three items were 
reworded to remove any reference to a TBI: “How satisfied are you with what you 
have achieved recently (instead of “since your brain injury”)?”, “How bothered are 
you by the effects of any injuries you sustained? (instead of “any other injuries you 
sustained at the same time as your brain injury”)”, and “Overall, how bothered are 
you by the effects of any health problems? (instead of “brain injury”)”.
Statistical Analyses
The statistical analyses comprised the following steps: (1) examination of the 
psychometric properties of the QOLIBRI on the item and scale level in the general 
population; (2) MI analyses between groups of individuals from the TBI and general 
population samples and between the countries, to ensure that the same concept 
of HRQoL was being measured; (3) multivariate linear regression analyses, which 
examined whether country of residence, age, sex, level of education, and the 
presence of chronic health conditions affected the HRQoL/QOLIBRI total score; (4) 
based on the regression results, computation of reference values for individuals with 
and without chronic health conditions for the QOLIBRI total score and subscales 
with respect to age, sex, and level of education.
Descriptive statistics (mean, standard deviation, response frequencies) were used 
to describe participants’ sociodemographic and health-related data.
Item Characteristics of the QOLIBRI in the General Populations
As the main focus of this study was to provide reference values for the QOLIBRI from 
general population samples, item properties such as mean, standard deviation, 
skewness, and ceiling effects are only reported for the general population samples. 
Items with absolute skewness values between 1.0 and 1.3 were interpreted as 
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moderately skewed and not affecting further analysis.[10, 18] Due to the high 
variation in cut-off values for ceiling effects (15–60%) in the current literature,[10, 
19] we set the cut-off value at 40% (twice as high as by chance, 1/5 = 20%) for the 
maximum response category “very”. Additionally, we checked if there were items 
with less than 10% of responses in the two lower response categories “not at all” 
and “slightly”.
Scale Characteristics of the QOLIBRI in the General Populations
The scales’ internal consistency was determined using Cronbach’s alpha, with 
values between 0.7 and 0.95 indicating good to excellent internal consistency.
[19] An item was defined as inconsistent when the corrected item-total correlation 
coefficient (CITC) exceeded 0.4.[20] Correlations between the QOLIBRI domains 
were investigated using Pearson correlation coefficients, with values ranging from 
0.36 to 0.67, indicating a moderate linear association.[21]
Construct Validity of the QOLIBRI in the General Populations
As a prerequisite for MI testing, construct validity was investigated in the general 
population samples to ensure the comparability of the reworded and the original 
QOLIBRI using confirmatory factor analysis (CFA) with the robust weighted least 
squares estimator (WLSMV, calculated with the lavaan-package in R [22]). Model 
fit was assessed by means of the scaled chi-square statistics, Comparative 
Fit Index (CFI), and root mean square error of approximation (RMSEA) with a 
90-percent confidence interval. As the standard cut-offs for CFI (>0.95) and RMSEA 
(<0.06),[23,24] indicating good model fit, have not been validated for the WLSMV 
estimator, and they should be interpreted with caution.[25] To address this issue, we 
compared fit indices across models with different factorial structures (one common 
factor, two correlated factors—one containing all positively worded “satisfaction” 
items, and the other one all negatively worded “bothered” items, and six correlated 
factors) with higher CFI values and lower RMSEA values indicating a better model.
2.5.4. Measurement Invariance in All Samples
By using modern statistical techniques, such as MI testing, it is possible to verify 
whether the questionnaire score differences between individuals, e.g., with and 
without TBI experience, can be attributed to true differences in HRQoL or rather 
to differences in interpretation of the items and response categories, as well as 
differences in items difficulty and their importance.[26]
Therefore, MI testing in the framework of CFA was applied to examine whether 
TBI experience and cultural/language differences influenced the comprehension 
of the QOLIBRI items. First, we examined the influence of the TBI experience on 
the invariance of model parameters by comparing groups of individuals from the 
TBI and general population samples separately for each country. To overcome 
estimation problems due to the large number of estimated parameters and relatively 
small sizes of the two TBI samples, the QOLIBRI items were dichotomized. The 
response categories “not at all”, “slightly” and “moderately” were coded as 0, and 
“quite” and “very” as 1. We then investigated the effect of the country by comparing 
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UK and NL general population samples.
The strategy for analyzing ordinary scaled response categories suggested by 
Wu and Estabrook (2016) was applied, resulting in three steps: testing of the (1) 
configural, (2) partial, and (3) full invariance model. For more details, see Wu and 
Easterbrook.[27]
For MI analyses, at least N = 200 observations per group are necessary to obtain 
reliable results.[28] All estimations for invariance testing (WLSMV-estimator, theta-
parameterization) were performed within the lavaan-package (version 0.6-3).[22] 
For model comparisons, we applied a scaled chi-square difference test with the 
significance level set to α = 0.05. As this test has been criticized for being very 
powerful in detecting small, possibly irrelevant effects in large samples,[29] in case 
of invariance violation, we estimated whether the effect had a practical significance 
for estimating the probability of choosing a particular response category. For 
example, if the full invariance model (invariant thresholds) had a significantly worse 
fit than the partial invariance model (noninvariant thresholds), the probabilities 
of individuals from general population samples choosing a particular response 
category were estimated in both models, and then compared. If the differences did 
not exceed 5%, we considered the thresholds to be invariant.[30]
Reference Values from General Population-Based Samples
As clinicians may be interested in the subjective health status and HRQoL of a 
single patient after TBI, population-based reference values were calculated 
as percentiles. Percentiles indicate the value below which a given percentage 
of observations falls. Based on this information, one can determine whether the 
QOLIBRI score of an individual after TBI is below, equal to, or above the value of 
the reference population. The following percentiles are provided for a patient-level 
interpretation: 2.5%, 5%, 16%, 30%, 40%, 50%, 60%, 70%, 85%, 95%, and 97.25%. 
HRQoL is considered to be impaired when scores are one standard deviation 
below the average of the general population sample,[31] which corresponds to the 
16%-quantile when the data are assumed to be normally distributed. Examples are 
given in the results section. 
Previous research has shown that 50 to 75 cases for each subgroup can already 
be sufficient to provide norm values.[32] However, as several factors can influence 
the required sample size (e.g., which type of norms are provided [33]), we have 
decided to report reference values when the number of cases was at least N = 100. 
All analyses were performed in R 3.6.0.[34]
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Results
Sociodemographic and Health-Related Data
General Population Sample
Study participants (N = 4403 from the UK and N = 3399 from the NL) from the 
general population samples were analyzed. Individuals without a chronic health 
condition (UK: 2016; NL: 1572) were differentiated from individuals with chronic 
health conditions (UK: 2387; NL: 1827; for details, see Table 1). In both countries, 
up to 55% of individuals from the general population samples indicated that they 
had at least one chronic health condition, and, in comparison with the TBI samples, 
significantly more individuals described themselves as being unable to work (UK: 
10%, NL: 12.8%).
TBI Sample
The TBI sample contained 660 individuals (N = 228 from the UK and N = 432 from 
the NL), who had filled in the QOLIBRI at three months post-TBI. The majority of 
individuals from both TBI samples had experienced a mild TBI (71.9% and 84.1 % 
in the UK and NL, respectively). In the UK, almost half of all individuals after TBI 
made a good recovery 48.7% (NL: 66.2%) and 20% were still severely disabled 
(NL: 8.8%) at three months post-TBI. Sociodemographic and health-related data for 
all samples are presented in Table 1.
Table 1. Sociodemographic and health-related data.
UK NL
Gen. pop. 
Sample TBI Sample
Gen. pop. 
Sample TBI Sample
N = 4403 N = 228 p N = 3399 N = 432 p
Age in years
mean ± SD 44.52 ± 15.66 49.73 ± 17.79 <0.001 45.2 ± 15.3 55.4 ± 18.8 <0.001
Age category
18–40 1885 (42.8%) 67 (29.4%) <0.001 1338 (39.4%) 98 (22.7%) <0.001
41–64 1954 (44.4%) 113 (49.6%) 1651 (49.6%) 175 (40.5%)
65+ 564 (12.8%) 48 (21.1%) 410 (11.0%) 159 (36.8%)
Gender
Male 2134 (48.5%) 152 (66.7%) <0.001 1665 (49.0%) 253 (58.6%) <0.001
Female 2269 (51.5%) 76 (33.6%) 1734 (51.0%) 179 (41.4%)
Educational level
Low 1002 (22.8%) 7 (3.1%) <0.001 1024 (30.1%) 14 (3.3%) <0.001
Middle 1884 (42.8%) 99 (43.4%) 1526 (44.9%) 239 (55.3%)
High 1517 (34.5%) 98 (43%) 849 (25.0%) 137 (31.7%)
NA 24 (10.5%) 42 (9.7%)
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Work status (before TBI)
In work 2267 (51.5%) 145 (63.6%) <0.001 1776 (52.3%) 202 (46.8%) <0.001
Out of work 399 (9.0%) 7 (3.1%) 374 (11.0%) 12 (2.8%)
Looking after 
others 305 (6.9%) 1 (0.4%) 145 (4.3%) 7 (1.6%)
Student 265 (6.0%) 10 (4.4%) 223 (6.6%) 34 (7.9%)
Retired 725 (16.5%) 50 (21.9%) 446 (13.1%) 143 (33.1%)
Unable to work 442 (10.0%) 3 (1.3%) 435 (12.8%) 7 (1.6%)
NA 12 (5.3%) 27 (6.2%)
Type of chronic health condition *
Asthma 602 (13.0%) - - 336 (9.4%) - -
Heart disease 109 (2.3%) - 102 (2.9%) -
Stroke 74 (1.6%) - 81 (2.3%) -
Diabetes 390 (8.4%) - 274 (7.7%) -
Back conditions 567 (12.2%) - 355 (10.0%) -
Arthrosis 141 (3.0%) - 346 (9.7%) -
Rheumatisms 192 (4.1%) - 218 (6.1%) -
Cancer 128 (2.8%) - 140 (3.9%) -
Memory 
problems 
(dementia)
82 (1.8%) - 94 (2.6%) -
Memory 
problems 
(aging)
205 (4.4%) - 82 (2.3%) -
Depression 1254 (27%) - 423 (11.9%) -
Other 493 (10.6%) - 628 (19.3%) -
Number of chronic health conditions
None 2016 (45.8%) - - 1572 (46.2%) - -
One 1379 (31.3%) - 1088 (32.0%) -
Two and more 1008 (22.9%) - 739 (21.8%) -
TBI-severity (GCS)
Mild - 164 (71.9%) - - 366 (84.7%) -
Moderate - 7 (3.1%) - 27 (6.3%)
Severe - 51 (22.4%) - 29 (6.7%)
NA - 6 (2.6%) - 10 (2.3%)
Recovery status (GOSE) at 3 months postinjury
Good recovery - 111 (48.7%) - - 286 (66.2%) -
Moderate 
disability - 68 (29.8%) - 107 (24.8%)
Severe disability - 47 (20.6%) - 38 (8.8%)
NA - 2 (0.9%) - 1 (0.2%)
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Note. Type of chronic health condition: multiple answers were allowed, therefore percentages were 
calculated separately for each complaint based on the total sample size; 65+: general population 
sample: 65–75, TBI-sample: 65–95; - : when data was not assessed; In work: general population sample: 
employee and self-employed, TBI-sample: 35+ h/week and 20–34 h/week and <20 h/week and currently 
on sick leave and special employment; Out of work: general population sample: for more than 1 year 
and less than 1 year, TBI-Sample: unemployed; Housekeeper: general population sample: looking after 
others, e.g., kids or parents; Education level: TBI-sample: “low”: currently in school and primary school, 
“middle”: currently in diploma and secondary school/high school and post-high school, “high”: college/
university.
Abbreviations. UK = the United Kingdom; NL = the Netherlands; Gen. pop. = general population sample; 
TBI = TBI sample; p = p-value obtained with independent samples t-test for age or with chi-square test 
with Yates correction for gender, educational level, and work status; GCS = Glasgow Coma Scale; 
GOSE = Glasgow Outcome Scale Extended.
Comparison of the General Population Samples with TBI Samples
In both countries, significant differences were identified between the general 
population samples and the TBI samples concerning age, sex, educational level, 
and work status. In both general population samples, individuals were younger than 
in the TBI samples (with an average age difference of five years in the UK and of 
10 years in the NL) and had a lower male incidence (UK: 48.5% vs. 66.7%, NL: 
49.0% vs. 58.6%). The rate of individuals with a high level of education (diploma, 
secondary/high school, or post-high school) was lower in the general population 
samples compared with the TBI samples (UK: 34.5% vs. 43%; NL: 25% vs. 31.7). 
In the UK, the number of working individuals was lower in the general population 
sample compared with the TBI sample (51.5% vs. 63.6%, respectively), whereas 
in the NL the general population sample contained more employed individuals 
compared with the TBI sample (52.3% vs. 46.8%, respectively).
Item Characteristics of the QOLIBRI in the General Population Samples
On a descriptive level, there were some differences between countries concerning 
the item characteristics: individuals from the UK general population sample scored 
lower on average but with higher dispersion and mean values varying from 3.0 
(satisfaction with sex life) to 4.1 (satisfaction with the ability to find a way around; 
NL: from 3.5 to 4.2); items were less skewed ((−1; −0.2), NL: (−1.3; −0.3)), and a 
ceiling effect was observed for only six items, compared with 10 in the NL sample. 
All items in the UK sample and 22 items in the NL sample had over 10% responses 
in two adjusted response categories “not at all” and “slightly”. For more detailed 
information, see Appendix A Table A1.
Scale Characteristics of the General Population Samples
The total scale Cronbach’s alpha was high in both general population samples (UK: 
0.94, NL: 0.96), and per-scale alpha coefficients ranged between 0.86 (Emotions) 
and 0.95 (Cognition) in the UK general population sample, and between 0.86 and 
0.92 in the NL, indicating a very good internal consistency of the scales. Also based 
on CITC, all items were found to be consistent in both samples. QOLIBRI domains 
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were moderately to highly correlated (UK: 0.39–0.77, NL: 0.46–0.76). For more 
detailed information, see Appendix A Table A2.
Construct Validity of the General Population QOLIBRI
Based on CFA results, a six-factorial structure was most appropriate for the QOLIBRI 
in the UK (χ2(614) = 15,441, p < 0.001, CFI = 0.957, RMSEA = 0.074, 90%CI (0.073; 
0.075)) and also in the NL (χ2(614) = 10,276, p < 0.001, CFI = 0.952, RMSEA 
= 0.068, 90%CI (0.067; 0.069)) general population samples. For more detailed 
information, see Appendix A Table A3.
Measurement Invariance
When the general population and TBI samples were compared for each country, 
the fit of the model with six correlated factors was not negatively affected by 
constraining equal intercepts, loadings, and residuals across all groups (UK: 
Δχ2(Δdf) = 23.00 (25), p = 0.577, NL: Δ χ2(Δdf) = 8.27 (25), p = 0.999). However, 
assuming equality of thresholds resulted in significantly higher chi-square values, 
indicating that some thresholds may not be invariant across groups. When UK and 
NL general population samples were compared, significant, yet very small, and 
thus, negligible chi-square differences (Δχ2(Δdf) = 87.27 (25), p < 0.001) were 
observed.[32] The model fit deteriorated meaningfully when the thresholds were 
restricted to be equivalent across groups (Δχ2(Δdf) = 2395.26 (148), p < 0.001). 
For details, see Appendix A Table A4.
More detailed analyses on the estimated thresholds using the partial invariance 
model showed that the thresholds obtained in the general population sample were 
significantly higher than those in the TBI sample. Comparing the UK and NL general 
population samples, the thresholds obtained from the UK sample were lower in 
all cases (see Appendix A, Figure A1). However, for individuals from the general 
population samples, differences in the probabilities of choosing a particular response 
category did not exceed 5% (Appendix A, Table A5). Therefore, the violation of the 
threshold invariance may be interpreted as not significant. This implies that the 
QOLBRI scores can be compared between countries, and between the general 
population and TBI samples. More important, differences in the QOLIBRI scores 
should be attributed to “real” differences in HRQoL.
Reference Values for the General Population Samples
A significant difference in HRQoL as indicated by the QOLIBRI total score, was 
found between the countries. The NL sample experienced a significantly higher 
HRQoL compared with the UK general population sample (β = 8.76, p < 0.001). 
Regression analyses identified a significant effect of age, level of education, 
presence of at least one chronic health condition, and interactions between age 
and sex and health status in both general population samples. No significant effects 
for sex were found in both general population samples (Table 2).
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Table 2. Results of the multiple regression analyses (total sample, UK, and the NL).
Total Sample UK NL
Predictors and 
Interactions
Reference 
Group Β p β p β p
NL UK 8.76 <0.001 - - - -
Age (41–64)
Age (18–40)
7.57 <0.001 9.36 <0.001 5.41 <0.001
Age (65–75) 13.11 <0.001 15.26 <0.001 9.91 <0.001
Sex (female) Sex (male) 0.63 0.257 0.67 0.393 0.13 0.863
Education (middle)
Education (low)
3.07 <0.001 2.55 <0.001 3.57 <0.001
Education (high) 5.3 <0.001 5.35 <0.001 5.35 <0.001
Chronic health 
conditions (yes)
Chronic health 
conditions (no) −16.38 <0.001 −16.70 <0.001 −15.88 <0.001
Age (41–64) × 
Chronic health 
conditions (yes) Age (18–40) × 
Chronic health 
conditions (no)
−0.43 0.598 −2.80 0.015 2.02 0.066
Age (65–75) × 
Chronic health 
conditions (yes)
4.89 <0.001 4.91 0.004 4.98 0.004
Sex (female) × 
Chronic health 
conditions (yes)
Sex (male) × 
Chronic health 
conditions (no)
−0.19 0.805 −2.05 0.057 2.58 0.012
Note. β: regression coefficient; p: p-value; bold: p-values are significant on α = 0.05.
Reference values of the general population-based samples for the QOLIBRI total 
score are presented in Table 3 for the UK and Table 4 for the NL. The tables with the 
reference values for the QOLIBRI subscales can be found in the Online Supplement 
Materials (Table S1: UK; Table S2: NL).
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The following example illustrates how to apply these norms. After a TBI, a 70-year-
old woman from the UK without any chronic health condition reports a QOLIBRI 
total score of 75. The table depicts that around 20% of healthy individuals in her 
age group reported the same level of HRQoL or a lower HRQoL. In other words, 
80% of the reference population experience better HRQoL. Should a chronic health 
condition be known, 60% of the reference population from her age and health 
status group report better HRQoL and 40% of the general population with similar 
conditions experience a better HRQoL than she does.
Based on the 16%-percentile cut-off value, HRQoL is interpreted as impaired for 
female healthy individuals in the age range of 64–75 years when the QOLIBRI total 
score is under 69, or under 50 if any chronic health condition is reported. The score 
of 75 exceeds both cut-off values and can, therefore, be interpreted as indicating 
that she is not impaired (compared with individuals from the UK general population 
aged between 65–75 years with and without any chronic health condition). 
Discussion
The aim of our study was to enhance the interpretability of disease-specific 
HRQoL after TBI using the QOLIBRI by establishing reference values from general 
population samples in the UK and the NL, based on representative quotas with 
regard to sex, age, and educational level. The representation of these characteristics 
corresponds to their distribution in the UK and the NL general populations (e.g., 
see the Organisation for Economic Co-operation and Development (OECD) [35] for 
sociodemographic characteristics in European countries). In this respect, the data 
from our general population samples are comparable to the general population of 
each country. This study is unique, as such general population-based reference 
values are currently not available for the QOLIBRI.
The results indicated that the reworded QOLIBRI is applicable to general 
population samples and displays good psychometric properties. Measurement 
invariance testing demonstrated that for the six HRQoL subdomains, all QOLIBRI 
items have the same meaning for individuals with and without a TBI experience 
and in the different countries. Therefore, we conclude that the QOLIBRI scores can 
be compared across general population samples and TBI samples in the UK and 
the NL. The differences in the scores have to be explained by “real” differences 
in HRQoL and not by other factors, such as differences in the understanding of 
items or response categories. Thus, we were able to establish population-based 
reference values.
In previous research, individuals from the NL general population reported higher 
mental summary component scores in the SF-36 in comparison to seven other 
countries, including five European countries.[36] Lower HRQoL was associated with 
the presence of chronic health conditions.[37] Our results replicate these findings, 
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with individuals from the NL general population sample reporting significantly higher 
HRQoL compared to those from the UK. Previous findings concerning the association 
of HRQoL with age are ambiguous: in the general populations of Norway and 
Canada, higher age was positively associated with the mental summary component 
score of the SF-36 and negatively with the physical summary component.[38,39] 
Our data showed that older individuals from the general population samples from 
both countries and subsamples with and without chronic health conditions report 
better HRQoL. Our study did not identify any sex differences in the two countries, 
with the exception of the subgroups with and without any chronic health conditions 
in the NL sample. This finding is also comparable to a study assessing the generic 
HRQoL by means of the SF-36: here only the general health perception scale was 
sensitive to sex differences, with females reporting lower generic HRQoL.[8,40]
Previously, the interpretation of the QOLIBRI total score was facilitated through a 
cross-walk analysis with the mental component summary score of the SF-36, for 
which US population-based norms were used.[41] HRQoL was considered to be 
impaired when scores were one standard deviation below the average of the general 
population sample.[35] Therefore, QOLIBRI values under 60 indicated impaired 
disease-specific HRQoL.[41] Our reference values provide a country-adapted 
basis because they were obtained from general population samples. Here, cut-off 
values of 56 for the UK and 65 for the NL should be taken to identify impaired TBI-
specific HRQoL when comparing individuals after TBI with healthy individuals. As 
we found significant differences between the countries, we strongly recommend 
using the respective population-based reference values presented in the current 
study when the QOLIBRI is applied.
Strengths and Limitations
A strength of the present study is the large size of the general population samples, 
which allowed for high-powered statistical analyses. The stratification into healthy 
individuals and those having reported at least one chronic health complaint offers 
an additional possibility for the interpretation of HRQoL of individuals after TBI.
The representativeness of the recruited samples may be questioned. First, the 
selection of participants was based on different web-based panels. This might 
have led to different selection biases, even when several platforms were used for 
recruiting in order to increase the representativeness of different groups. Second, 
no information was available from the survey agency concerning participants who 
were contacted but did not take part in the survey. In other words, it was not possible 
to determine how many and which individuals could have potentially participated 
in the study, as a means of demonstrating a selection bias. Third, answers given 
in the online survey could be associated with (self-)selection and nonresponse 
bias,[42,43] as some individuals may systematically participate in online surveys.
Yet, the sampling procedure was strictly based on demographic characteristics 
such as age, sex, and education, and on a very large panel involving individuals 
from different sources. The quota sampling with respect to age, sex, and level of 
education corresponded to the distribution in the general populations of the two 
countries (see OECD statistics [35]). Therefore, the samples seem valid for providing 
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reference values to evaluate the degree of impairment of HRQoL in individuals after 
TBI.
Another limitation was the lack of precise information concerning previously 
experienced TBIs in the general population samples. However, the estimated TBI 
prevalence based on reported age-adjusted hospital discharge rates due to TBI 
is quite low and reaches 312.7 per 100,000 in the UK and 173.7 per 100,000 in 
the NL.[44] Thus, the presence of individuals, who experienced TBI in the general 
population samples, was very unlikely to cause a bias concerning the reference 
values and evaluation of HRQoL.
The baseline characteristics of the general and the TBI sample displayed differences 
with regard to sex, age, and education status. However, such differences are 
unavoidable bearing in mind the two times higher prevalence of TBI among males 
[45] and increasing TBI incidence in elderly people,[46] resulting in differences in 
work status distribution, and in higher rates of retired individuals in the TBI samples.
Furthermore, the relatively small sizes of the TBI samples required dichotomization 
of the QOLIBRI response categories for MI testing, which is associated with a 
loss of information concerning response patterns. However, the TBI sample was 
only used to ensure the methodological comparability of the QOLIBRI in general 
population samples by MI analyses. It turned out that the factorial structure and the 
understanding of the HRQoL construct measured by the QOLIBRI were comparable 
between the general population samples and the TBI samples in both countries. 
Thus, the reference values established here are reliable.
Conclusions
This paper aimed to provide a basis for a better understanding of HRQoL after TBI in 
research and clinical practice. For this purpose, population-based reference values 
were developed to add value to the interpretation and clinical meaningfulness of 
QOLIBRI scores of individuals after TBI. Significant differences in the reported levels 
of HRQoL were found between the UK and the NL general population samples as 
well as between the TBI and the general population samples. Therefore, we have 
presented population-based reference values separately for the two countries. 
We recommend establishing population-based reference values also for other 
countries in future research, especially for lower-income countries, as these are 
a key component for understanding therapeutic progress in individual cases and 
enabling research on HRQoL.
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Appendix
Table A1. Characteristics of the QOLIBRI items.
General Population Sample
UK NL UK NL UK NL UK NL
QOLIBRI Items mean ± SD Skewness Ceiling (%) % “not at all” and “slightly”
Cognition 71.1 ± 24.4 78.4 ± 18.1 −0.8 −0.9 15.1 16.8 - -
Concentrate 3.7 ± 1.2 4.0 ± 0.9 −0.6 −1 30.4 34.5 17 7
Express yourself 3.8 ± 1.1 4.1 ± 0.9 −0.8 −1.1 35.2 38 13 6
Memory 3.7 ± 1.1 4.1 ± 0.9 −0.6 −1 26.8 33.8 15 6
Plan and problem 
solve 3.9 ± 1.1 4.2 ± 0.9 −0.8 −1.2 35 41 12 5
Decisions 3.9 ± 1.1 4.1 ± 0.9 −0.9 −1.1 38.6 39 11 5
Navigate 4.1 ± 1.1 4.2 ± 0.9 −1 −1.2 46.2 44.7 10 4
Speed of thinking 3.9 ± 1.1 4.2 ± 0.9 −0.8 −1.2 32.7 39.6 12 5
Self 54.8 ± 27.4 68.6 ± 20.3 −0.2 −0.7 6.2 6.4 - -
Energy 3.2 ± 1.2 3.5 ± 1.0 −0.3 −0.6 13 15.1 27 15
Motivation 3.2 ± 1.2 3.7 ± 1.0 −0.3 −0.7 15.4 21.2 26 11
Self-esteem 3.2 ± 1.3 3.8 ± 1.0 −0.2 −0.8 17.2 28.2 30 11
Appearance 3.1 ± 1.2 3.8 ± 1.0 −0.2 −0.8 13.4 20.2 31 10
Achievements 3.2 ± 1.2 3.8 ± 1.0 −0.2 −0.8 16.2 25.8 29 11
Self-perception 3.2 ± 1.2 3.8 ± 1.0 −0.3 −0.9 14.8 21.7 28 11
Future 3.2 ± 1.2 3.7 ± 1.0 −0.2 −0.8 15.4 21.5 29 12
Daily life and 
autonomy 66.5 ± 26.2 75.5 ± 19.4 −0.6 −0.8 11.9 13.2 - -
Independence 3.7 ± 1.2 4.1 ± 1.0 −0.7 −1 33.3 38.4 16 7
Get out and about 3.8 ± 1.2 4.2 ± 0.9 −0.8 −1.3 40.2 45.3 16 5
Domestic activities 3.9 ± 1.2 4.1 ± 1.0 −0.8 −1.1 40.7 42.5 15 7
Run personal 
finances 3.8 ± 1.2 4.2 ± 0.9 −0.8 −1.2 36.7 43.5 16 6
Participation work 3.5 ± 1.3 3.8 ± 1.2 −0.5 −0.9 27.4 30.6 22 15
Social and leisure 
activities 3.3 ± 1.3 3.8 ± 1.1 −0.3 −0.8 21.5 26.9 28 13
In charge of life 3.6 ± 1.2 4.0 ± 0.9 −0.6 −1 28.8 35 18 7
Social relationships 63.9 ± 26.0 74.0 ± 19.6 −0.5 −0.8 11 11.5 - -
Affection towards 
others 3.8 ± 1.2 4.2 ± 0.9 −0.7 −1.2 34 43.9 15 6
Family 3.8 ± 1.2 4.0 ± 1.0 −0.7 −1 33.8 35.9 15 8
Friends 3.6 ± 1.2 4.0 ± 0.9 −0.6 −1.1 28.8 34.9 18 7
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Partner 3.7 ± 1.3 4.0 ± 1.1 −0.7 −1.1 37.1 43 19 10
Sex life 3.0 ± 1.4 3.5 ± 1.2 −0.1 −0.7 20.6 23.9 35 19
Attitudes of others 3.4 ± 1.1 3.9 ± 0.9 −0.4 −0.9 19.7 26.4 19 7
Emotions 59.4 ± 28.0 68.4 ± 24.4 −0.2 −0.4 11.6 15.4 - -
Feel lonely 3.5 ± 1.3 3.5 ± 1.3 −0.4 −0.3 32.1 29.2 24 25
Feel bored 3.4 ± 1.3 3.6 ± 1.2 −0.3 −0.5 26.2 28.2 26 20
Feel anxious 3.3 ± 1.4 3.7 ± 1.2 −0.2 −0.6 25.1 35.2 32 15
Feel sad 3.3 ± 1.4 3.7 ± 1.3 −0.2 −0.6 27 35.5 31 18
Feel angry 3.6 ± 1.3 3.9 ± 1.2 −0.5 −0.8 34.7 41.6 22 13
Physical problems 66.8 ± 27.0 70.0 ± 23.5 −0.5 −0.5 15.6 15.3 - -
Slow/clumsiness 3.8 ± 1.2 3.9 ± 1.1 −0.7 −0.7 40.8 38.8 17 14
Effects injuries 3.9 ± 1.2 3.9 ± 1.2 −0.8 −0.9 46.4 47.2 15 16
Pain 3.5 ± 1.3 3.6 ± 1.2 −0.4 −0.4 28.6 28.8 23 22
See/hear 4.0 ± 1.2 4.0 ± 1.1 −0.9 −0.8 46 40.1 14 11
Effects health 
problems 3.5 ± 1.3 3.7 ± 1.2 −0.4 −0.5 28.8 31.1 23 19
QOLIBRI total score 63.8 ± 20.6 72.8 ± 16.6 −0.3 −0.5 1.6 1.9 - -
Note. Ceiling effects are expressed as a percentage and represent the proportion of individuals who 
chose the response category “very” on the QOLIBRI items or reached the maximum of 100 on the 
respective QOLIBRI scales.
Abbreviations. Mean = mean value; SD = standard deviation.
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Table A2. Psychometric properties of the QOLIBRI scales.
Cronbach’s 
Alpha
Item-Total Correlation 
Range Correlations between Subscales Scores
UK general population sample
QOLIBRI 
domain (1) (2) (3) (4) (5)
Cognition (1) 0.94 0.77–0.83 1
Self (2) 0.95 0.76–0.87 0.67 1
Daily life and 
autonomy (3) 0.93 0.71–0.81 0.75 0.77 1
Social 
relationships (4) 0.9 0.60–0.76 0.65 0.73 0.71 1
Emotions (5) 0.87 0.62–0.79 0.46 0.51 0.49 0.47 1
Physical 
problems (6) 0.88 0.61–0.74 0.5 0.44 0.55 0.39 0.48
NL general population sample
QOLIBRI 
domain (1) (2) (3) (4) (5)
Cognition (1) 0.92 0.69–0.77 1
Self (2) 0.92 0.70–0.81 0.68 1
Daily life and 
autonomy (3) 0.89 0.61–0.73 0.7 0.76 1
Social 
relationships (4) 0.86 0.60–0.72 0.58 0.66 0.66 1
Emotions (5) 0.88 0.72–0.82 0.54 0.57 0.56 0.55 1
Physical 
problems (6) 0.86 0.54–0.78 0.52 0.57 0.62 0.45 0.49
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Table A3. Results of confirmatory factor analyses.
UK General Population Sample
Model Comparison
Model with 
Factors CFI RMSEA (90%CI) χ
2 (df) p Model with Factors Δχ
2 (Δdf) p
one 0.802 0.156 (0.155; 0.157)
68,302 
(629) <0.001
two 0.889 0.117 (0.116; 0.118)
38,601 
(628) <0.001 one vs. two 3111.5 (1) <0.001
six 0.957 0.074 (0.073; 0.075)
15,441 
(614) <0.001 two vs. six 5696.1 (14) <0.001
NL General Population Sample
Model Comparison
Model with 
Factors CFI RMSEA (90%CI) χ
2(df) p Model with Factors Δχ
2(Δdf) p
one 0.8 0.137 (0.136; 0.138)
40,659 
(629) <0.001
two 0.868 0.111 (0.110; 0.113)
27,135 
(628) <0.001 one vs. two 1725.3 (1) <0.001
six 0.952 0.068 (0.067; 0.069)
10,276 
(614) <0.001 two vs. six 4313.8 (14) <0.001
Abbreviations. CFI = scaled Comparative Fit Index; RMSEA (90%CI) = scaled root mean square error of 
approximation with 90% confidence interval; χ2 = scaled chi-square statistics; df = scaled degrees of 
freedom; p = p-value of chi-square (difference) statistics; Δχ2 = difference in chi-square statistics under 
Sattora.Bentler.2001 correction; Δdf = difference in degrees of freedom.
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Table A4. Results of measurement invariance testing.
 
UK: General Population Sample vs. TBI Sample
Model Comparison
CFI RMSEA (90%CI) χ2 (df) p Invariance Models Δχ
2 (Δdf) P
0.989 0.033 (0.032; 0.034) 4264 (1228) <0.001
0.991 0.029 (0.028; 0.031) 4740 (1253) <0.001
Configural vs. 
partial 23.00 (25) 0.577
0.991 0.029 (0.028; 0.030) 4854 (1290) <0.001 Partial vs. full 66.95 (37) 0.002
NL: General Population Sample vs. TBI Sample
Model Comparison
CFI RMSEA (90%CI) χ2 (df) p Invariance Models Δχ
2 (Δdf) P
0.983 0.032 (0.031; 0.034) 3409 (1228) <0.001
0.986 0.029 (0.027; 0.030) 3544 (1253) <0.001
Configural vs. 
partial 8.27 (25) 0.999
0.986 0.029 (0.028; 0.030) 3702 (1290) <0.001 Partial vs. full 108.10 (37) <0.001
UK vs. NL: General Population Samples
Model Comparison
CFI RMSEA (90%CI) χ2 (df) p Invariance Models Δχ
2 (Δdf) P
0.956 0.071 (0.071; 0.072)
16696 
(1228) <0.001
0.966 0.062 (0.061; 0.063)
17884 
(2153) <0.001
Configural vs. 
partial 87.27 (25) <0.001
0.962 0.062 (0.061; 0.063)
20051 
(1410) <0.001 Partial vs. full
2395.26 
(148) <0.001
Note. Identification constraints for the invariance models: Configural: item intercepts = 0, residual 
variances = 1, latent factor means = 0, latent factor variances = 1 Partial: item intercepts = 0, residual 
variances = 1. Only in the reference group latent factor means = 0 and variances = 1; Full: item intercepts 
= 0, residual variances = 1. Only in the reference group factor means = 0, factor variances = 1.
Abbreviations. CFI = scaled Comparative Fit Index; RMSEA (90%CI) = scaled root mean square error of 
approximation with 90% confidence interval; χ2 = scaled chi-square statistics; df = scaled degrees of 
freedom; p = p-value of chi-square (difference) statistics; Δχ2 = difference in chi-square statistics under 
Sattora-Bentler (2001) correction; Δdf = difference in degrees of freedom. 
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General Discussion 
“Recovering from mild traumatic brain injury has been my biggest challenge. And 
after a very difficult 17 months I have come to realize that my priorities have changed 
and I can no longer be the athlete I have been, so proudly and for so long. The 
challenge of returning to play following my head injury is too much, and the risks 
too high. With my head injury and a different outlook on life, my family old and new 
are now my priority.” -- Alex Danson, Olympic hockey Gold and Bronze medalist
The above quote perfectly portrays why research into mild traumatic brain injury is 
essential. Life can be turned upside down completely because of something that 
is classified as a ‘mild’ injury. Currently, there is no clear view on which patients 
will experience symptoms and longer lasting problems related to the injury, which 
is one of the main focus points of this thesis. The aim of this thesis was to study 
outcome assessment following traumatic brain injury (TBI) and measure outcome 
preferences in the fields of TBI and stroke. An overview of the main findings for the 
specific research questions presented in Chapter 1 can be found in Box 1. This 
chapter describes the main findings of this thesis. These findings will be discussed 
separately for assessing outcome and measuring outcome preferences, followed 
by recommendations for future research, research policy and clinical practice. 
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Box 1. Overview of main findings per research question.
1. What is the association between post-concussion symptoms and 
HRQoL in mTBI?
We observed an association between post-concussion syndrome (PCS) and 
lower health-related quality of life (HRQoL) for adult and paediatric patients. 
Approximately 20% of adult patients with mTBI suffering from PCS had a 
considerably lower HRQoL compared to patients without PCS at 6 months post-
injury. 
a. What is the outcome in divergent mTBI patient groups?
Approximately 30% of adult patients after mTBI were functionally impaired. 
Furthermore, patients after complicated mTBI reported worse functional 
outcome and lower generic and disease-specific HRQoL at three and six months 
post-injury compared to patients after uncomplicated mTBI. We observed no 
considerable improvement in outcomes from three to six months.
b. What are the prevalences and risk factors of post-concussion symptoms in 
mTBI patients and the general population?    
Prevalence - Fatigue (42%), forgetfulness/poor memory (38%), and poor 
concentration (33%) were the most prevalent post-concussion symptoms 
reported by adult mTBI patients at six months post-injury. More than 60% of 
paediatric patients reported having at least one post-concussion symptom of 
at least mild severity. Remarkably high frequencies of post-concussion-like 
symptoms, such as fatigue (50%) and sleep disturbance (42%), were also found 
in the general population.
Risk factors - We identified female gender, education, injury severity, assault, 
hospitalization, complicated mTBI and post-concussion symptoms as risk 
factors for PCS in adult mTBI patients. For paediatric patients specifically, 
female gender was identified. For the general population age, female gender, 
education, work status, income level, chronic health complaints were identified 
as risk factors. 
c. How can we classify post-concussion symptoms and post-concussion 
syndrome after mTBI and to what extent are pre-injury ratings reliable?
The choice of classification method and rating score both influenced PCS 
diagnosis at a population and at an individual level. Currently, there is no 
unambiguous and universal classification of PCS, however, we believe that 
patients should be evaluated for post-concussion symptoms and syndrome 
by the use of a combination between self-report and clinical evaluation (e.g. 
a multidimensional comprehensive assessment). In addition, we believe rating 
score 2 should be applied as cut-off for severity in self-report instruments. 
Pre-injury ratings are not reliable since we found that more than half of patients 
were inconsistent in their post-injury ratings over time when reporting their pre-
injury functioning. 
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2. What are preferences and utility weights for TBI and stroke health states 
and how could they be applied?
The responses on generic and disease specific measurements represent 
preferences for health states measured by these instruments, which ultimately 
means that preferences represent the value or desirability for individual health 
states. Preference elicitation methods can be used to assign utility weights to 
each item level of a preference-based instrument. Responses from the general 
population sample reflect preferences between different health states. Utility 
weights represent the relative preference for a year of life in a given health state 
and a greater weight is given to a more desirable/preferred health state. Value 
sets are needed to apply these utility weights in economic evaluations. 
a. What are preferences of the general population for disease specific outcome 
measures for TBI and which utility weights can be assigned to TBI value sets?
The preferences of the general population determined that the biggest weight 
increase for all attributes of a disease specific outcome measure for TBI (e.g. 
QOLIBRI-OS) should be from the level ‘slightly’ to ‘not at all satisfied’, which 
consequently results in the largest impact on HRQoL. Health states values have 
to be anchored on a scale from 0 (dead) to 1 (full health) to be able to assign 
utility weights to value sets.
b. How can value sets and patient data be used to determine utility and/or 
disability weights for TBI and stroke health states?
A value set represents the collection of utility values for all possible health states 
described in a preference-based measure, which means that each health state 
can be converted into a single summary index. Patient data can be used to 
determine utility weights by averaging the derived utilities of all patients within 
each health state, after which this patient data can be used in a simulation study 
to evaluate statistical efficiency. Disability weights can be derived by mapping 
HRQoL data to preference-based instruments. 
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Main findings and interpretation
Part I - Outcome assessment following traumatic brain injury
In this part of the thesis, we focused on outcome assessment following mild TBI 
(mTBI) and described the association between post-concussion symptoms and 
health-related quality of life (HRQoL) in mTBI with an emphasis on prevalence 
and risk factors of post-concussion symptoms in mTBI patients and the general 
population. In addition, we focused on the classification of post-concussion 
symptoms and post-concussion syndrome (PCS) after mTBI and assessed to 
what extent pre-injury ratings of post-concussion symptoms are reliable. Lastly, we 
assessed the outcome in divergent mTBI patient groups. 
Post-concussion symptoms and post-concussion syndrome
The majority (70-90%) of all TBI cases can be classified as mTBI. Many patients 
following mTBI experience post-concussion symptoms such as physical symptoms 
(e.g., headaches, dizziness, blurred vision, fatigue, and sleep disturbances), 
cognitive deficits (e.g., poor memory, and attention and executive difficulties), 
and behavioral/emotional symptoms (e.g., depression, irritability, anxiety-related 
disorders, and emotional lability)(1, 2). These symptoms will resolve and/or diminish 
for most patients within weeks to months after the injury, however, a subgroup of 
patients (estimated between 5%–43%(3-6)), will continue to report these symptoms 
for weeks, months or sometimes even longer. When a set of these symptoms persist 
for over 3 months, it is generally referred to as post-concussion syndrome (PCS)
(5, 6). 
Prevalence
In this thesis, considerable differences were found in prevalence rates for post-
concussion symptoms and post-concussion syndrome (PCS). Prevalence rates are 
dependent on population, case-mix of the sample, setting, measurement instrument, 
and diagnostic criteria and classification methods applied (Chapter 2, 3, 4, 6, 7, 8). 
Fatigue, forgetfulness/poor memory, and poor concentration were the most prevalent 
post-concussion symptoms reported by adult patients (age ≥ 16) after mTBI at six 
months post-injury (Chapter 2). Almost 40% of adult patients were experiencing 
PCS six months post-injury (Chapter 3). 
The most commonly reported symptoms by paediatric patients were headaches, 
fatigue, poor concentration, and forgetfulness and more than one third of paediatric 
patients reported at least one symptom of moderate or severe intensity. Roughly 
55% of paediatric patients were experiencing PCS six months post-injury (Chapter 
7). 
Representative respondents from the United Kingdom, the Netherlands and Italy 
were used as norm population. Concentrating on the general population, we found 
high frequencies of post-concussion-like symptoms. Symptoms such as fatigue 
and sleep disturbance were the most frequently reported. Forty-five percent of 
respondents were classified as having PCS (Chapter 6). 
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When looking specifically at complicated (Glasgow Coma Scale (GCS) 13-15 and 
presence of computed tomography (CT) abnormalities) and uncomplicated (GCS 
13-15 and absence of CT abnormalities) mTBI patients, patients after complicated 
mTBI reported slightly more post-concussion symptoms compared to those after 
uncomplicated mTBI. Approximately 43% of patients after complicated mTBI 
were classified as having PCS at six months compared to 34% of patients after 
uncomplicated mTBI (Chapter 4). 
In this thesis, we found high prevalence rates of post-concussion symptoms and 
PCS in adult and paediatric patients after mTBI six months post-injury. Additionally, 
we found high prevalence rates of post-concussion-like symptoms and PCS in the 
general population, indicating that these symptoms are not specific for patients 
following mTBI and PCS is not a unique syndrome after mTBI. Consequently, 
implying that other factors play a role. For this reason, these concepts should be 
interpreted with caution and should never solely be used as outcome following 
mTBI. 
Health-related quality of life 
With regard to health-related quality of life (HRQoL), six months following mTBI, one 
in five adult patients suffering from PCS had a considerably lower HRQoL compared 
to patients without PCS and almost half of these patients were dissatisfied with their 
functioning (Chapter 3). Furthermore, paediatric patients with PCS had significant 
lower Quality of Life after Traumatic Brain Injury (QOLIBRI) total scores, indicating 
lower HRQoL, compared to patients without PCS. Lastly, in the general population, 
patients classified with PCS had lower EQ-5D utility and total scores, and EQ-5D 
visual analogue scale (VAS) scores (Chapter 6), which again indicates that PCS has 
strong impact on an individuals’ HRQoL. 
We evaluated the correlation between post-concussion symptoms and different 
HRQoL instruments, to assess the relation between these symptoms and the 
various HRQoL instruments. We found negative correlations between all items 
of the Rivermead Post-Concussion Symptoms Questionnaire (RPQ) and the 36-
Item Short Form (SF-36) domains, Perceived Quality of Life (PQoL) subscales 
and QOLIBRI total scores, and positive correlations between all RPQ items and 
EQ-5D dimensions, illustrating that reporting problems on any items of the RPQ is 
associated with decreasing HRQoL (Chapter 3), which is also in line with previous 
research(7). 
Better assessment tools and intervention strategies for PCS are needed, because 
intervention and support strategies can be targeted more appropriately when mTBI 
patients with PCS are detected shortly after sustaining the injury. Additionally, a 
better understanding of the relationship between PCS and HRQoL and possible 
mediating factors in this relationship could improve intervention strategies and the 
recovery process (Chapter 3).
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Classification
Post-concussion symptoms and PCS can be assessed by different instruments and 
classification methods, which mostly rely on subjective endorsement of symptoms 
by patients. A frequently used instrument to assess the presence and severity of 
post-concussion symptoms is the RPQ (8), and despite the majority of studies 
using this instrument, there is currently no gold standard regarding the use and 
analysis of the RPQ. In addition, specifically looking at the severity ratings, there is 
currently no set standard available for which rating score should be used as a cut-
off when using the RPQ, resulting in two possible cut-offs: rating score 2, indicating 
items with score ≥ 2 (symptoms mild or higher) or rating score 3, indicating items 
with score ≥  3 (symptoms moderate or higher). Not only that, an unambiguous 
and universal classification of PCS is also missing(9) (Chapter 2). Furthermore, in 
previous research, it has already been described that the inconsistency in definition, 
classification criteria and rating score interferes with the righteous classification 
and identification of patients with PCS(10). This ultimately leads to inconsistencies, 
over- and/or underestimation of symptoms, incommensurable prevalence rates and 
outcome, and hampers research and therapy(4) (Chapter 2).
The majority of studies use the International Classification of Diseases, 10th revision 
(ICD-10)(11) and or the Diagnostic and Statistical Manual of Mental Disorders, 
4th edition (DSM-IV)(12) as criteria to diagnose PCS. Throughout this thesis, we 
have mainly utilized the mapped ICD-10/DSM-IV definition to classify PCS, which 
requires the endorsement of three or more post-concussion symptoms (Chapter 2). 
More classification methods can be found in Chapter 2. 
Previous research reported prevalence rates of PCS ranging from 5% to 43%(5, 6, 
13-16). Notwithstanding, we found prevalence rates for six month PCS ranging from 
11% to 40%, depending on the classification method used and rating score applied. 
Furthermore, research in this thesis determined that the choice of classification 
method and rating score influenced PCS diagnosis both at a population and at an 
individual level (Chapter 2). In addition, the association between PCS and functional 
outcome was significantly influenced by the divergent classification methods. This 
was shown by the fluctuating percentages (46% to 73%) of patients with PCS being 
classified as functionally impaired dependent on the classification method applied 
(Chapter 2). 
We believe that patients should be evaluated for post-concussion symptoms and 
syndrome by the use of a combination between self-report and clinical evaluation 
(e.g. a multidimensional comprehensive assessment).
In this thesis, it was shown that the rating score has a significant impact on the 
reported prevalence rates for post-concussion symptoms and PCS. When using 
the more stringent cut-off (e.g. rating score 3) we found that in most cases the 
prevalence rates dropped substantially and were sometimes even reduced by half 
(Chapter 2, 3, 4, 6, 7). Some argue that symptoms reported as moderate or worse 
are more likely to represent clinically relevant symptomatology than symptoms 
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reported as mild because patients with head injury were distinguished more easily 
from healthy controls when using rating score 3 as cut-off (17). In addition, when 
rating score 2 is used a substantial proportion of healthy individuals from the general 
population are diagnosed with PCS (Chapter 6). 
At present, we cannot give a well-supported verdict on which classification method 
is the best and should become the gold standard. This is mainly related to the fact 
that there is currently no way to objectively evaluate patients on post-concussion 
symptoms and assess which method classifies the ‘correct’ patients (e.g. false-
negatives vs. false-positives) for PCS. PCS was taken out of the Diagnostic and 
Statistical Manual of Mental Disorders, 5th edition (DSM-V) and instead they have 
introduced the terms “major or mild neurocognitive disorder due to TBI”(18), and 
clinicians are instructed to base their diagnosis depending on the severity of 
cognitive deficits and functional disability present(19). We do not agree with this 
and highly recommend to reinstate PCS. In this thesis, we have shown that high 
prevalence rates of post-concussion symptoms and PCS were found for diverse 
patient groups, which were not solely based on cognitive deficits and functional 
disability, and it remains a very relevant problem after mTBI. The first step would be 
to develop a universal guideline to classify PCS and reach consensus regarding the 
usage of the RPQ, which is highly needed to enhance and facilitate comparability 
across studies. In addition, more research into the usage of biomarkers and more 
refined imaging studies in patients with mTBI is required, since this might shine 
light into the black box of objective assessment of post-concussion symptoms. 
Furthermore, we believe that rating score 2 should be applied as cut-off, even 
though we determined that these symptoms might not be specific for mTBI. We 
believe this for the following two reasons: first, when patients are asked to self-
report their symptoms after mTBI, they are always asked to compare this with their 
situation before the injury. Second, even mild symptoms can have a significant 
impact on individuals’ HRQoL, as was shown in this thesis, and this cannot be 
disregarded. Ultimately, we believe that patients should be evaluated for post-
concussion symptoms and syndrome by the use of a combination between self-
report and clinical evaluation (e.g. a multidimensional comprehensive assessment). 
All of the above will result in improved insights in post-concussions symptoms and 
PCS. 
Pre-injury ratings 
Symptoms are often assessed by using a self-report instrument and patients after 
mTBI are asked to rate their current symptoms compared to their pre-injury situation. 
Nonetheless, patients have the tendency to remember their pre-injury functioning as 
better, underestimate their past problems and might have a hard time to remember 
pre-injury symptoms accurately(20), which is commonly specified as the ‘good-old-
days’ bias(21). 
Patients may misattribute post-concussion symptoms to their sustained injury 
(e.g mTBI) since these symptoms might be non-specific and do not have to be 
exclusively associated with injury(22), and this increases the likelihood of inaccurate 
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post-concussion symptoms and PCS prevalence rates(23). We found that more 
than half of patients were inconsistent in their post-injury ratings over time when 
reporting their pre-injury functioning, which was evaluated by assessing pre-injury 
and current symptoms at four times post injury. In addition, we determined that 
pre-existing psychiatric morbidity is strongly associated with a PCS diagnosis post-
injury, which reflects that PCS might not be a consequence of the sustained mTBI 
but a result from pre-existing psychiatric problems (Chapter 8). For future research, 
a good alternative for recruiting healthy controls in this type of research is the ‘friend 
controls’ approach (24), which could limit potential bias. 
Risk factors
Identifying individuals at high risk for post-concussion symptoms and syndrome is 
desirable and clinically very relevant. Knowing beforehand which patients might 
experience symptoms, will allow patients and clinicians to act accordingly.
We found that PCS was more often experienced by females, those with lower 
education, those with higher injury severity scores (ISS) and abbreviated injury scale 
(AISH) scores, those who were injured by assault compared with other causes of 
injury, those who were hospitalized, those with complicated mTBI, and those who 
reported a higher RPQ total score (Chapter 3, 4 and 7). For paediatric patients 
specifically, female gender was identified as a significant predictive factor (Chapter 
7). Furthermore, the following risk factors were found to be associated with PCS 
in the general population: lower age, female gender, low education, work status, 
low-income level, chronic health complaints, and when individuals experience 
serious illness in themselves and or in their immediate family, and when they care 
for others. These risk factors should also be taken into consideration when studying 
post-concussion symptoms and PCS (Chapter 6). When adjusting for possible 
confounding effects of baseline differences between patients with and without PCS, 
it was shown that PCS decreases HRQoL. In addition, when specifically looking 
at patients after complicated and uncomplicated mTBI, the effect of complicated 
versus uncomplicated mTBI appeared to be minimal (Chapter 3 and 4). 
Multivariable prediction models explained 6-14% (Nagelkerke R2) of the variance 
in six-month PCS according to different classification methods (Chapter 2). In the 
general population, 26% (rating score 2) and 24% (rating score 3) of the variance in 
PCS was explained. A prediction model for post-concussive symptoms and PCS in 
paediatric patients using only baseline clinical and demographical factors, directly 
available in the emergency department performed reasonably (area under the 
receiver operating characteristics curve (AUC) rating score 2: 0.75; rating score 
3: 0.79; Chapter 7). To enhance the internal and external validation of prediction 
models, advanced statistical methods such as shrinkage and bootstrap validation 
should be explored. 
Post-injury care could considerably be improved by e.g. scheduling closer follow-
up meetings, prolonging rest periods or establishing additional psychological or 
educational support. Besides the clinical relevance, patients, care givers (e.g. 
families) and employers would all benefit from this. 
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Overall conclusion post-concussion symptoms and post-concussion 
syndrome
To conclude, we determined that the RPQ is based on self-report rather than clinical 
examination, and does not include information on the duration of the symptoms and 
clinically significant impairment, and for this reason cannot accurately diagnose PCS 
(25) (Chapter 2). Nevertheless, it is essential that definitions, classification methods 
and terminology regarding post-concussion symptoms and PCS are standardized, 
since it was shown that all these factors lead to differences in prevalence rates 
and risk factors. It should be required for all researchers to clearly describe how 
self-report measurements were used and which cut-off points were employed. 
To enhance our knowledge regarding the different RPQ classification methods 
which could be used to classify PCS, sensitivity and specificity analyses should 
be performed. Post-concussion symptoms and PCS entail a difficult interaction 
between biological, psychological and social factors, which also include pre-
injury health, such as pre-injury psychological, personality, psycho-social factors, 
severity of the injury, troubles in life, and issues concerning compensation and 
litigation (26-28). In addition, clinicians should be aware of the high endorsement of 
post-concussion-like symptoms and prevalence of PCS in the general population, 
anticipate on the concept of the ‘good-old-days’ bias and try to keep the patients’ 
specific circumstances and risk factors in mind with a key focus on a patients’ pre-
injury situation(10). Ultimately, all these factors should be considered and taken 
into account when dealing with post-concussion symptoms and PCS (Figure 1) 
(Chapter 2, 3, 4, 6). 
Figure 1. A model for the study of post-concussion symptoms after mTBI
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Outcome following mild traumatic brain injury 
Aside from post-concussion symptoms and syndrome, outcome can also be 
assessed by other outcome measurements such as clinical outcome and HRQoL. 
A better understanding of the relation between mTBI and outcome may improve 
intervention strategies and the recovery process in divergent mTBI patient groups. 
Six months post-injury, approximately 30% of adult patients after mTBI were 
functionally impaired (GOSE ≤6) (Chapter 2). However, functional measurement 
scales as the GOSE have been criticized since they just describe the clinical 
outcome and do not represent a patient’s subjective experience of their health(29). 
Especially for patients with mTBI, the majority of patients will be categorized in the 
upper level categories (GOSE > 6), because they will not be assessed by a clinician 
as functionally impaired in their daily life(30). However, these patients could be 
affected in various other aspects of life and could be limited physically, mentally, 
cognitively and socially(26, 31, 32). For this reason, we used a variety of outcome 
measures and to achieve a comprehensive multidimensional approach outcome 
was assessed by generic and disease-specific HRQoL, functional outcome and 
symptomatology, such as post-traumatic stress, depression and anxiety. Moreover, 
we compared individuals after complicated mTBI and uncomplicated mTBI and 
analysed the effects on outcome by the use of a comprehensive multidimensional 
approach. We concluded that patients after complicated mTBI reported worse 
functional outcome and lower generic and disease-specific HRQoL at three and six 
months post-injury. Nevertheless, when specifically concentrating on the longitudinal 
effects, considerable improvement in outcomes from three to six months were not 
found (Chapter 5). 
A recommendation for future research would be to develop mobile phone 
applications, which could track patient’s post-concussion symptoms and certain 
outcomes in the months following their injury. This would be an easy way to track 
patients who reach a certain cut-off point and to ask these patients to come and 
see a clinician, who could, together with the patient, come up with an individualized 
rehabilitation plan. Subsequently, the growing usage of social media (e.g. Twitter, 
Instagram and Facebook) could be utilized to inform patients about everything 
surrounding a brain injury and create a community online of patients, care givers and 
clinicians. However, privacy-sensitive data and confidential information regarding 
individuals are principles that we must hold dear in this context. In addition, return 
to work or school should be used as a measure of outcome assessment, since this 
might objectively portray how an individual copes with the sustained injury in their 
everyday life. 
Ultimately, the short and long-term impact on outcome for patients diagnosed 
with mTBI should be taken into consideration by patients, clinicians, researchers 
and decision-makers in health care and should not be taken lightly by anyone. 
Clinical follow-up should be provided to all patients after mTBI and complicated 
and uncomplicated mTBI groups should not be treated differently. New treatments 
options should be explored such as aerobic exercises: “pushing through 
symptoms”. Rehabilitation services and concussion treatment centres for mTBI in 
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specific should be realized and organized, since these patients often fall through 
the cracks of care under the misplaced ideology that it is just a ‘mild’ injury. Lastly, 
we should always keep in mind that: “there are no two identical TBIs”, and the 
implications and repercussions for a top sport athlete compared to an elderly are 
very diverse and for this reason precision rehabilitation should be provided.
 
Part II - Preferences for outcome in traumatic brain injury
In the second part of this thesis, we focused on preferences and utility weights for 
TBI and stroke health states and determined what was needed to apply them. We 
specifically focused on preferences of the general population for disease specific 
outcome measures for TBI and which utility weights can be assigned to TBI value 
sets. Additionally, we assessed how value sets and patient data can be used to 
determine utility and/or disability weights for TBI and stroke health states. 
Preferences
Cost-effectiveness analyses have become an integral part of decision making 
processes in TBI(33, 34) and stroke(35) research since both diseases have high 
economic costs. With a growing health care demand and the rate of increase 
in healthcare costs currently exceeding economic growth, using limited health 
care resources sufficiently are at the center of attention (36, 37). The responses 
on generic and disease specific measurements represent preferences for health 
states measured by these instruments, which ultimately means that preferences 
represent the value or desirability for  individual health states(38). Nevertheless, to 
be able to use the responses on HRQoL measurements in economic evaluations, 
they first have to be converted into utility weights. 
Health utility indices 
Utility weights represent the relative preference for a year of life in a given health 
state and a greater weight is given to a more desirable/preferred health state(39, 
40). Utilities are always anchored on a scale ranging from 0 (death) to 1 (perfect 
health) and a less than 0 value is given to health states which are reported to be 
worse than dead(41).
In this thesis, we have determined utility weights for the most widely used outcome 
measure in trials for acute stroke interventions, which is the modified Ranking 
Scale (mRS)(42, 43). In previous research, the utility-weighted mRS (UW-mRS) was 
developed, to reflect both treatment and patient perception, and this has since then 
been used as primary outcome in a clinical trial. We established utility weights for 
the mRS health states and evaluated the statistical efficiency of the UW-mRS by the 
usage of a simulation study. Utility weights were derived for each mRS category 
and it was shown that these do not capture the individual variation within each 
category. Our simulation study disclosed that the original ordinal analysis of the 
mRS was more efficient in detecting treatment effects than the newly proposed UW-
mRS approach. This shows the importance of evaluating the statistical efficiency 
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of a new patient-centred outcome measure first, before it is widely implemented 
into research or clinical practice. Future research should focus on a more thorough 
evaluation of the UW-mRS in terms of its added value, analytical approach and 
interpretation, and subsequently validating our results. 
Value sets 
A value set is a collection of utility values for all possible health states described in 
an instrument, which are needed to be able to use the health states described by 
this instrument in economic evaluations. Chapter 9 presents the first value sets for 
the QOLIBRI-OS, since before this study, utilities were not available for the QOLIBRI-
OS. With the development of value sets for three different European countries, we 
have enabled the application of the QOLIBRI-OS in economic evaluations and in 
summary measures of population health. We determined that the biggest weight 
increase for all attributes of the QOLIBRI-OS was from the level ‘slightly’ to ‘not at 
all satisfied’, which consequently results in the largest impact on HRQoL. Table 1 
shows an example of utility weights per QOLIBRI-OS health state, which have been 
generated from a value set. 
Table 1. Example of values for a mild, moderate and severe health states from the 
QOLIBRI-OS
Anchored DCE 
All respondents UK the Netherlands Italy
Best health state: 11111 1 1 1 1
Mild health state: 21232 0.902 0.94 0.955 0.918
Moderate health state: 34343 0.631 0.853 0.799 0.801
Severe health state: 55455 0.449 0.465 0.472 0.396
Worst health state: 55555 0.383 0.383 0.383 0.383
Note: See Chapter 9 for the full description.
Abbreviations. DCE, Discrete Choice Experiment; UK, United Kingdom.
The generated value sets were based on health states and pairs of previous EQ-5D 
research, however, it could be that for the QOLIBRI-OS instrument different health 
states should have been included. For future research in generating value sets, it 
would be recommended to perform health state and pair selection per instrument 
separately, to ensure that the right set of health states specifically important to 
these preference-based health state measures are being valued. There are several 
methods of administration to conduct health state valuation studies, such as face-
to-face, paper-and-pencil methods and web-based questionnaires. When choosing 
a web-based survey it also implies using health state valuation methods that are 
amenable to online administration, such as discrete choice experiments (DCEs) 
and VAS. Compared to personal interviews, web-based surveys are equipped to 
get answers from large samples in a relatively short time, have a flexible sampling 
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frame, enable a range of background characteristics of non-respondents to be 
obtained, the order of the questions can be randomized, allow complex routing 
of questions, the time it takes a respondent can be recorded, and the errors 
associated with data entry are minimized.(44) However, during a web-based survey 
one cannot check if respondents completely understood the task at hand. For this 
reason it would be advisable to starting with some rounds of face-to-face to test the 
web-based survey to  identify the teething troubles. Additionally, building in a tool to 
be able to check answers while respondents are taking the survey, for example to 
check if they are using the VAS correctly and are not turning it upside down, would 
also be suggested. Nevertheless, face-to-face surveys will deliver higher quality 
data, but will also require larger monetary resources.
Norm scores 
Currently, with the focus in research increasingly being on HRQoL, and on top of that 
explicitly focusing on disease-specific HRQoL, the QOLIBRI has been an instrument 
the majority of researchers have started using to assess disease-specific HRQoL 
after TBI. Nevertheless, to achieve a better understanding of HRQoL after TBI and 
to be able to interpreted the QOLIBRI scores in research and clinical practice, 
population-based norms need to be generated. In Chapter 12, we established 
these population-based norms from representative general population samples 
in the United Kingdom and the Netherlands, and samples of individuals after TBI 
from these same countries were used as a reference. Foremost, we found that 
the QOLIBRI has good psychometric properties in the general population samples 
and showed measurement invariance across countries and in TBI and general 
population samples. Surprisingly, individuals after mTBI at three months post-injury 
did not have significantly different HRQoL compared to individuals from the general 
population. Nevertheless, it was determined that functional disability and symptoms 
of emotional disorder, which are common after mTBI, negatively affect HRQoL 
(Chapter 12). Future research should focus on developing population-based norms 
for all HRQoL instruments used in TBI and stroke research specifically per country 
and to limit costs, options for ‘crosswalking’ should be explored. 
Disability 
In current research, disability-adjusted life year (DALY) are increasingly being 
used and researchers have concluded that, in case of injury, disability weights 
should be derived from empirical HRQoL follow up data from individual patients 
(45-48). An advantage of using HRQoL data to derive disability weights is that they 
can be linked to epidemiological date more precisely and are able to capture the 
heterogeneity within an injury group (49). A logical and homogeneous grouping is 
the preferred option, such as the Glasgow Outcome Scale Extended (GOSE) which 
was specifically designed and has been a widely used instrument to describe 
outcome for TBI patients (29, 50-53) . Utilities for the GOSE are widely available 
(39), however, we were the first ones to develop disability weights per GOSE level. 
We found that HRQoL disability weights increased with increasing severity level 
of GOSE. In addition, since there is currently no gold standard available on which 
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preference-based measure of health to use, we derived HRQoL utility and disability 
weights from three different preference based measures of health. This resulted 
in different weights and hampers generalizability, which shows the importance for 
future research establishing assessment criteria for which instrument would be best 
to derive disability weights from. Generating disability weights per GOSE severity 
level have enabled the evaluation and comparison of disease burden across 
countries and effectiveness of health care and economic evaluations. The results 
from Chapter 10 will provide a promising framework to enhance our knowledge 
on DALYs and for future research seeking to apply DALYs in cost-effectiveness 
analyses and policy making (Chapter 10).
Overall conclusion Part II
Several aspects should be considered when assessing utility and disability weights. 
First, one should recognize that patients after TBI may suffer from pre-existing chronic 
disease  (11% in the CENTER-TBI cohort), which could contaminate the HRQoL 
utility and disability weights. Second, researchers should always acknowledge the 
strengths and limitations of different elicitation methods and preferably use face-to-
face interviews performed by experienced researchers in this field, which will deliver 
high quality data. Lastly, every respondent in a health state valuation task should 
see a well-balanced set of health states representing the whole range of severity 
and given answers on the VAS should be shown during the following questions so 
respondents can scale their answers based on previous responses, which provides 
them with a better overview.  
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Limitations
The cohort data in this thesis is mainly collected in academic hospitals/research 
settings and these patients are not representative for the overall mTBI population 
(Chapter 3), especially in the CENTER-TBI study where included patients were 
required to have an indication for CT imaging as eligibility criterion (Chapter 7). In 
addition, patients who have confirmed structural damage to the brain as shown on 
a CT or MRI scan (e.g. complicated mTBI) might act differently and report more and 
give higher ratings to self-report symptoms since they are aware of the objective 
evidence of the brain injury. Correspondingly, health care providers might treat 
these patients differently and this might be completely subconsciously (Chapter 4). 
Further, a considerable fraction of patients after TBI was lost to follow-up, e.g. attrition, 
and this might imply selection bias, which could have important implications for the 
interpretation of our results. While this number within CENTER-TBI is comparable 
to other large, prospective studies, a non-response bias limiting external validity is 
possible (Chapter 7 and 8).
Self-report is the most frequently used mechanism of symptom reporting within 
this thesis, nevertheless, this may lead to under- or over reporting of symptoms 
(Chapter 3). Patients who are not experiencing symptoms might be less likely to 
get involved in a study because they might have moved on and might not see the 
importance of participating (Chapter 4 and 5). Additionally, recall bias might play a 
role as patients might underestimate their pre-injury symptoms (Chapter 7). It has 
been debated whether TBI patients, especially patients with cognitive impairment, 
are able to provide useful and complete answers to questionnaires (Chapter 3, 5 
and 10). Moreover, method of administration of questionnaires (e.g. web-based, 
face-to-face or postal) could influence the type and amount of symptoms reported 
(Chapter 4 and 6). 
Our findings, when using the web-based survey data, should be interpreted with 
caution since it is not known how much respondents involved in a market research 
panel influence the results, since they might be ‘professional’ in taking and filling out 
surveys and it could also be questioned how representative these respondents are 
for the general population (Chapter 6, 9 and 12). Additionally, the usage of complex 
DCE questions might potentially cause extra selection bias compared with general 
questionnaire surveys (Chapter 9).
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Recommendations
Based on our main findings and interpretation regarding outcome assessment and 
measuring outcome preferences in TBI and stroke, we have summarized specific 
recommendations for the next steps in future research, policy and clinical practice 
below. 
Recommendations for research
Research on outcome assessment following traumatic brain injury
- Develop one universal guideline regarding definitions, classification 
 methods and terminology for post-concussion symptoms and syndrome. 
- For reporting, clearly describe how self-report measurements were used 
 and especially for the RPQ which cut-off points were utilized
- Examine the pathophysiology of post-concussion symptoms and syndrome 
 in patients after mTBI and especially take pre-injury factors into account
- Study use of biomarkers and more refined imaging studies when assessing 
 outcome in patients with mTBI
- Assess outcome after TBI through a multidimensional approach including 
 clinical outcome, HRQoL and symptomatology such as GOSE, SF-36/12, 
 QOLIBRI/-OS, RPQ and psychological tests
- Study outcome after mTBI longitudinally and at follow-up times later than 1 
 year post-injury
- Perform multidimensional analyses to investigate outcome differences 
 between TBI groups 
- Perform advanced statistical methods such as shrinkage and bootstrap 
 validation to enhance the internal and external validity of prediction models
- Study differences in treatment and treatment policies and investigate the 
 possibilities for personalized intervention strategies 
Research on preferences for outcome in traumatic brain injury
- Consider using ‘shorter’ versions of a questionnaire
- Recognize comorbidity when assessing utility and disability weights
- Perform health state and pair selection for the QOLIBRI/-OS
- Consider the strengths and limitations of the preference elicitation method 
 used
- Summarize state-of-the-knowledge for development of value sets 
- Develop a universal guideline considering assessment criteria to compare 
 different utility instruments
- Explore options of ‘crosswalking’ and develop population-based norms for 
 all HRQoL instruments per country
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Recommendations for policy 
- Do not focus all attention on severe TBI, since mTBI often gets forgotten: 
 provide funding for research projects focusing on outcome after mTBI
- Provide funding to generate country-specific utility and disability weights 
 for disease-specific HRQoL instruments for TBI and stroke. 
- Make the population more aware of the consequences of TBI and mTBI in 
 specific 
- Obligate researchers to report how they used an outcome instrument (e.g. 
 cut-off points) and add this to the STROBE criteria.
- Allow for different rehabilitation programs to be covered by health insurance 
 (e.g. a life coach)
Recommendations for clinical practice
- Inform patients after mTBI about the potential consequences of the injury 
- Evaluate patients for post-concussion syndrome by the use of a combination 
 between self-report and clinical evaluation, e.g. a multidimensional 
 comprehensive assessment
- Use a biopsychosocial model to assess symptoms after mTBI
- Acknowledge potential outcome differences between divergent mTBI 
 groups and act accordingly 
- Provide precision rehabilitation (e.g. individualized precision medicine)
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Overall conclusion
The aim of this thesis was to expand our knowledge on assessing outcome following 
TBI, and measuring outcome preferences for TBI and stroke among patients and 
the general population. 
In the first part of this thesis, we initially described the association between post-
concussion symptoms and HRQoL in mTBI patients with an emphasis on the 
prevalence, risk factors and pre-injury reporting of post-concussion symptoms and 
the classification of post-concussion symptoms and PCS. After this, we assessed 
the outcome in divergent mTBI patient groups.
Prevalence rates for post-concussion symptoms and PCS fluctuated extensively and 
dependent on population, case-mix of the sample, setting, measurement instrument, 
and diagnostic criteria and classification methods applied. Nevertheless, high 
prevalence rates of post-concussion symptoms and PCS six months post-injury in 
adult and paediatric patients were found, which shows that even though the injury 
might be classified as ‘mild’, patients still experience debilitating problems months 
after sustaining the injury. Outcome after mTBI is multidimensional and defined by 
a difficult interaction between biological, psychological and social factors and has 
a different effect on each individual. Ultimately, a patients specific situation should 
be taken into account and precision rehabilitation should be provided. 
In the second part of this thesis, we examined the preferences and utility weights for 
TBI and stroke health states and assessed to what extent these could be applied. 
Generating utility and disability weights for disease-specific HRQoL instruments 
will enable the evaluation and comparison of disease burden across countries and 
effectiveness of health care and the application in economic evaluations and in 
summary measures of population health. 
MTBI is very complex and a good example of a patient group that could really 
benefit from a coordinated collaboration between health care providers. The 
physical, psychological, social and economic impact on the patients after mTBI, 
but also the caregivers, families, friends and society, is tremendous. Given this, 
it is imperative that new research into the evaluation of costs and the relation with 
outcome, will help to ameliorate the impact of mTBIs. – Daphne Cloë Voormolen 
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Summary
Introduction 
Traumatic brain injury (TBI) is a leading cause of death and disability worldwide 
with 2.5 million new cases in the European Union (EU; 28 Member States) each 
year. In addition, it is costing the global economy approximately $US400 billion per 
year. The large majority of patients (70-90%) are diagnosed with mild TBI (mTBI). 
However, despite the term ‘mild’, patients after mTBI can also experience long-
lasting symptoms. Other than all the research efforts in the last couple decades, 
substantial improvement in outcome for patients has been lagging behind and many 
questions remain unanswered regarding the impact of mTBI. Health-related quality 
of life (HRQoL) has been the focus of outcome assessment in current research 
endeavors, since this reflects an individual’s perception of how an illness and its 
treatment affect the physical, mental, and social aspects of his or her life. 
Stroke is the second leading cause of death worldwide, with an increasing incidence 
due to an ageing population. Even though the causes of TBI and stroke are different, 
the consequences and effects are often very similar, since both result in physical, 
cognitive, psychological, and social dysfunction.
TBI and stroke both have high economic costs and because of this cost-effectiveness 
analyses have become an integral part of decision making processes in both 
diseases. Nevertheless, essential components to be able to perform economic 
evaluations, namely quality-adjusted life years, health-utility indices, value sets and 
population based norms, are missing in current TBI and stroke research.  
This thesis consists of two parts. Part I focused on assessing outcome following 
mTBI, with an emphasis on prevalence, risk factors, classification and pre-injury 
reporting of post-concussion symptoms and post-concussion syndrome (PCS). In 
part II, we examined the preferences and utility weights for TBI and stroke health 
states and their application. Prospective observational longitudinal patient data, 
survey data of the general population, and a simulation study were used. The aim 
of this thesis is operationalised in the following research questions:
1. What is the association between post-concussion symptoms and HRQoL in 
 mTBI?
 a. What is the outcome in divergent mTBI patient groups?  
 b. What are the prevalence and risk factors of post-concussion   
  symptoms in mTBI patients and the general population? 
 
 c. How can we classify post-concussion symptoms and post-
  concussion syndrome after mTBI and to what extent are pre-injury  
  ratings reliable?
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2. What are preferences and utility weights for TBI and stroke health states  
 and how could they be applied? 
 
 a. What are preferences of the general population for disease specific 
  outcome measures for TBI and which utility weights can be 
  assigned to TBI value sets? 
 b. How can value sets and patient data be used to determine utility 
  and/or disability weights for TBI and stroke health states?
Part I - Outcome assessment following traumatic brain 
injury
In Chapter 2 and 3 a total of 731 mTBI patients from a prospective observational 
cohort study performed in the Netherlands were included. In Chapter 2 we examined 
how four divergent classification methods and two different rating scores as cutoff 
defining post-concussion syndrome (PCS) differ among patients six months after 
mTBI. The Rivermead Post-Concussion Symptoms Questionnaire (RPQ) was used 
to assess post-concussion symptoms and the following classification methods 
were used to classify patients as having PCS: the RPQ mapped to the ICD-10/
DSM-IV, the RPQ total score, the RPQ-3 and the RPQ three-factor model. We found 
prevalence rates of PCS ranging from 11% to 39%, a different set of risk factors 
to be statistically significantly associated with PCS, and a different percentage of 
overlap with functional impairment. These differences in results were all dependent 
on the classification method and rating score used. In Chapter 3 we assessed 
the association between PCS and health-related quality of life (HRQoL) six months 
after mTBI and we additionally looked at the correlation between post-concussion 
symptoms, assessed by the RPQ, and different HRQoL domains. HRQoL was 
measured with the 36-item Short-Form Health Survey (SF-36) and the Perceived 
Quality of Life Scale (PQoL). We found that 39% of patients were classified as 
suffering from PCS, and these patients had significantly lower HRQoL, e.g. lower 
scores on all SF-36 domains and lower mean PQoL scores. Furthermore, all RPQ 
items were negatively correlated to all SF-36 domains and PQoL subscale scores, 
which indicates a decreasing effect on different aspects of an individuals’ HRQoL 
when reporting problems on any of the RPQ symptoms. 
In Chapter 4, 5 and 7 we presented results based on the Collaborative European 
NeuroTrauma Effectiveness Research in TBI (CENTER-TBI) study, which is a large 
multicenter, prospective observational longitudinal cohort study conducted in Europe 
and Israel. In Chapter 4 and 5 we differentiated patients in complicated (intracranial 
abnormalities present on computed tomography (CT)) and uncomplicated (no 
intracranial abnormalities present on CT) mTBI. In Chapter 4 we assessed the 
occurrence of post-concussion symptoms and PCS in a large sample of patients 
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with complicated and uncomplicated mTBIs at three and six months post-injury. A 
complete case analysis was performed and a total of 1302 patients with mTBI who 
completed the RPQ were included. Approximately 46% of patients were identified 
as complicated mTBI and they reported significantly more symptoms and have 
higher PCS prevalence rates compared to patients after uncomplicated mTBI at 
three and six months. However, when adjusting for baseline covariates, e.g. age, 
gender, education, injury mechanism, Glasgow Coma Score, complicated vs. 
uncomplicated, psychiatric medical history and stratum, the differences between 
both patient groups became less clear and this indicated that the association 
could be explained by differentiations in baseline characteristics. In Chapter 5 we 
compared outcome of patients after complicated and uncomplicated mTBI at three 
and six months post-injury. Outcome was assessed as a multidimensional construct 
to compare patients on different outcome levels: generic and disease specific 
HRQoL, functional outcome and symptomatology such as post-traumatic stress, 
depression and anxiety measured by the following instruments: SF-36 and Quality 
of Life after Brain Injury (QOLIBRI), Glasgow Outcome Scale Extended (GOSE), 
Posttraumatic Stress Disorder Checklist-5 (PCL-5), Patient Health Questionnaire 
(PHQ-9) and Generalized Anxiety Disorder questionnaire (GAD-7), respectively. A 
complete case analyses was performed and a total of 1104 patients with mTBI who 
completed the seven assessed outcome instruments were included. The results 
of this study showed that patients after complicated mTBI reported lower generic 
and disease-specific HRQoL and worse functional outcome compared to patients 
after uncomplicated mTBI at three and six months post-injury. Nevertheless, no 
significant differences were found between time points.
In Chapter 6 we evaluated the frequency of post-concussion-like symptoms and 
prevalence and risk factors of PCS, determined the relationship between the items of 
the RPQ with self-perceived health (EQ-5D) and ultimately investigated differences 
in the general population of three European countries, e.g. Italy, the Netherlands, 
and the United Kingdom. We conducted a web-based survey among representative 
samples in three European countries, and a total of 11,759 respondents who 
completed the RPQ and EQ-5D were included. The most frequently reported 
symptom was fatigue (50%),  approximately half of the respondents were classified 
as having PCS and chronic health complaints was found to be a significant risk 
factor for PCS. These results indicate that post-concussion-like symptoms are 
not specific for patients with TBI, and PCS is not a unique syndrome after TBI. 
Furthermore, positive correlations were determined between all RPQ items and 
EQ-5D dimensions and summary score. This suggest that post-concussion-like 
symptoms are debilitating and they also have a major effect on HRQoL in the 
general population.  
In Chapter 7 we analyzed the prevalence and associated risk factors for the 
development of post-concussion symptoms, and the relationship with Quality of life 
(QoL) in pediatric and adolescent patients with mTBI  at six months post-injury. We 
used data from the CENTER-TBI study and included 196 patients who completed 
the RPQ at six months post-injury. At least one moderate or severe symptom of 
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the RPQ was experienced by 36% of patients and PCS was present in 13% when 
considering symptoms of at least moderate severity (score > 2). A prediction model 
for PCS using only baseline clinical and demographical factors, directly available 
in the emergency department, was developed and regression analyses identified 
females as a significant risk factor. Pediatric patients with PCS had lower QoL 
compared to patients without PCS since they had significant lower QOLIBRI total 
scores.
In Chapter 8 we assessed the reliability of patient’s post-injury ratings of symptoms 
compared with their pre-injury ratings in a large and representative sample of 
patients with mTBI at several time points during the first year following injury. We 
included 836 patients with mTBI, 191 trauma patients without brain injury history and 
100 healthy controls and the latter two groups served as control groups. To assess 
pre-injury and current symptoms the Head Injury Symptom Checklist (HISC) was 
used. Almost half of all patients with mTBI inconsistently reported their pre-injury 
functioning over time. Patients who were classified with post-injury PCS reported 
higher percentages of pre-injury symptoms and were often more inconsistent. 
Patients who were classified with pre-injury PCS more often had psychiatric 
morbidity and this premorbidity also showed a strong association with post-injury 
PCS.
Part II - Preferences for outcome in traumatic brain injury
Chapter 9 describes the development of value sets for the Quality of Life after Brain 
Injury overall scale (QOLIBRI-OS), which is a TBI specific instrument to measure 
HRQoL. A web-based valuation study was performed in the Netherlands, United 
Kingdom and Italy. We found that the biggest weight increase for all attributes 
of the QOLIBRI-OS is seen from “slightly” to “not at all satisfied”, resulting in the 
largest impact on HRQoL. In addition, the item “Not at all satisfied with how brain 
is working” should receive the greatest weight in utility calculations in all three 
countries. By transforming the QOLIBRI-OS into utility scores we have enabled 
the potential application in economic evaluations, and in summary measures of 
population health, which may ultimately be used to inform decision makes on the 
best interventions and strategies for TBI patients. 
In Chapter 10 we described the impact following TBI by developing disability 
weights for the GOSE, which is a functional outcome instrument after TBI, and we 
used HRQoL data of patients with TBI to achieve this. Data were obtained through 
CENTER-TBI research project and a total of 2200 patients after TBI were included. 
Generic HRQoL was assessed with the Short Form 36-Questionnaire Health Survey 
version 2 (SF-36v2) and a crosswalk was performed to convert this to the Short 
Form 12-Questionnaire Health Survey version 2 (SF-12v2). After this we mapped the 
SF-12 onto three different preference-based measures of health: the Short Form Six-
Dimension (SF-6D), EQ-5D-3L and Health Utility Index Mark 3 (HUI3). Thereafter, 
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we assessed the SF-6D, EQ-5D and HUI3 utility scores per patient. Ultimately, we 
derived the following mean disability weights ranging from 0.045, 0.010, 0.008 
(GOSE 8; upper good recovery) to 0.185, 0.142, 0.200 (GOSE 3; lower severe 
disability), respectively for SF-6D, EQ-5D and HUI3. We determined that HRQoL 
disability weights increased with increasing severity levels of GOSE. The results of 
this study enable the evaluation and comparison of disease burden across countries 
and the effectiveness of health care and economic evaluations. Moreover, future 
researchers can use these results when applying disability-adjusted life years in 
cost-effectiveness analyses and policy making.
In Chapter 11 we evaluated the statistical efficiency of a new patient-centred 
outcome measure in stroke research (utility-weighted modified Rankin Scale (UW-
mRS)) and describe this by the use of a simulation study. The simulation study 
was based on individual data from 500 patients from the MR CLEAN trial, which is 
a multicentre clinical trial evaluating the effectiveness of intra-arterial treatment in 
ischemic stroke. The linear analysis of the UW-mRS (power 85%) was more efficient 
in detecting treatment effects than dichotomous analysis of the mRS (power 71%) 
but less efficient than the ordinal analysis of the mRS (power 87%). Additionally, 
the individual variation in utility within each mRS category is not captured by the 
UW-mRS.
In Chapter 12 we provided a basis for better understanding of HRQoL after 
TBI in research and clinical practice. We established population-based norms 
from representative general population samples in the United Kingdom and the 
Netherlands and samples of individuals after TBI from the United Kingdom and 
the Netherlands were used as a reference. Data was obtained through a web-
based survey and CENTER-TBI data for the general population and TBI samples, 
respectively. The QOLIBRI showed good psychometric properties in the general 
population samples and measurement invariance was demonstrated across 
countries and in TBI and general population samples. We found that HRQoL of 
individuals after mTBI at three months post-injury did not differ significantly from 
HRQoL assessed in the general population. However, we did determine that 
post-TBI factors such as functional disability and symptoms of emotional disorder 
affected HRQoL negatively.
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Discussion 
The aim of this thesis is to expand our knowledge on assessing outcome following 
TBI, and measuring outcome preferences for traumatic brain injury and stroke 
among patients and the general population. 
Despite an abundance of studies, there is currently no gold standard regarding the 
use and analysis of instruments assessing post-concussion symptoms. Not only that, 
an unambiguous and universal classification of PCS is missing as well. This leads 
to large variation in reported prevalence rates, inconsistencies, incommensurable 
outcome, and hampers research and therapy. Utility and disability weights, 
population-based norms and value sets are currently not available for all generic 
and disease-specific outcome measurements after TBI, which limits the utilization 
of these instruments in economic evaluations. 
We found that prevalence rates for post-concussion symptoms and PCS fluctuated 
extensively dependent on population, case-mix of the sample, setting, measurement 
instrument, and diagnostic criteria and classification methods applied. Furthermore, 
since we found high prevalence rates of post-concussion symptoms in adult and 
paediatric patients six months post-injury, we can conclude that mTBI could be 
debilitating months after the injury. Outcome after mTBI is multidimensional and 
defined by a difficult interaction between biological, psychological and social 
factors and impacts every individual differently.
Generating utility and disability weights for disease-specific HRQoL instruments 
enables the evaluation and comparison of disease burden across countries and 
effectiveness of health care and the application in economic evaluations and in 
summary measures of population health.
Specific recommendations for future research, policy and clinical practice were 
formulated, based on the interpretation of the main results of the studies included 
in this thesis. These recommendations include one universal guideline regarding 
definitions, classification methods and terminology for post-concussion symptoms 
and syndrome and researchers should clearly describe how self-report measurements 
were used and especially for the RPQ which cut-off points were utilized. In addition, 
outcome after TBI should be assessed through a multidimensional approach 
including clinical outcome, HRQoL and symptomatology and we recommend to 
investigate the possibilities for personalized intervention strategies. For research 
on preferences for outcome in traumatic brain injury, we recommend to summarize 
the state-of-the-knowledge for development of value sets in a systematic review 
and to develop a universal guideline considering assessment criteria to compare 
different utility instruments. For clinical practice, we recommend a multidimensional 
comprehensive assessment in which patients are evaluated for post-concussion 
syndrome by the use of a combination between self-report and clinical evaluation, to 
take patient specific situations into account and to provide precision rehabilitation. 
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Samenvatting
Introductie
Traumatisch hersenletsel is wereldwijd een van de meest voorkomende oorzaken 
van de dood en/of gezondheidsverlies met 2,5 miljoen nieuwe gevallen in de 
Europese Unie (EU; 28 lidstaten) per jaar. Bovendien kost het de wereldwijde 
economie gemiddeld 400 miljard dollar per jaar. Het grootste gedeelte (70-80%) 
van deze patiënten wordt gediagnosticeerd met mild/licht traumatisch hersenletsel 
(LTH). Echter, ondanks de benaming ‘mild’, kunnen patiënten met LTH langdurig 
symptomen ervaren. De afgelopen tientallen jaren is er veel onderzoek gedaan 
naar LTH, maar echte substantiële verbeteringen in de uitkomst van patiënten blijft 
achter en veel vragen rondom de impact van LTH blijven onbeantwoord. Onderzoek 
omtrent uitkomsten na LTH focust vandaag de dag veel meer op gezondheids-
gerelateerde kwaliteit van leven (GKvL), omdat dit een betere weerspiegeling geeft 
van de perceptie van een individu over hoe een ziekte en de behandeling hiervan 
invloed heeft op fysieke, mentale en sociale aspecten in zijn/haar leven. 
Beroerte is wereldwijd de tweede belangrijke doodsoorzaak, waarvan de incidentie 
nog steeds stijgt vanwege een vergrijzende populatie. Ondanks dat de oorzaken 
van traumatisch hersenletsel en een beroerte verschillen, lijken de consequenties 
vaak erg op elkaar, omdat beide resulteren in fysieke, cognitieve en psychologische, 
en sociale disfunctie. 
Traumatisch hersenletsel en beroerte hebben beiden hoge economische en 
maatschappelijke kosten en om deze reden spelen kosteneffectiviteitsanalyses een 
grote rol wanneer keuzes gemaakt moeten worden rondom beide ziektebeelden. 
Niettemin, in het huidige traumatisch hersenletsel- en beroerteonderzoek ontbreken 
essentiële componenten om economische evaluaties te kunnen uitvoeren, namelijk 
voor kwaliteit gecorrigeerde levensjaren (quality-adjusted life year, QALY), utiliteiten, 
waardensets en populatie-gebaseerde normen.
Onderzoeksvragen
Het hoofddoel van dit proefschrift is om onze kennis uit te breiden over het vaststellen 
van uitkomsten na traumatisch hersenletsel, en het meten van preferenties bij 
patiënten en de algemene bevolking voor traumatisch hersenletsel en beroerte. 
We hebben een breed scala aan methoden gebruikt, waaronder het analyseren 
van prospectieve observationele longitudinale patiëntgegevens, analyseren van 
survey-data van de algemene bevolking, en een simulatieonderzoek. 
Deze doelen zijn geoperationaliseerd in de volgende onderzoeksvragen: 
1. Wat is het verband tussen postcommotionele symptomen en 
 gezondheids-gerelateerde kwaliteit van leven (GKvL) in licht traumatisch  
 hersenletsel (LTH)?
 a. Wat is de uitkomst in diverse groepen van patiënten met LTH?
 b. Wat is de prevalentie en wat zijn de risicofactoren van  
  postcommotionele symptomen bij patiënten met LTH en in de 
  algemene bevolking?
 c. Hoe kunnen we postcommotionele symptomen en het Post  
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  Commotioneel Syndroom na LTH classificeren en in hoeverre zijn 
  beoordelingen – over de situatie vóór het ongeluk - achteraf 
  betrouwbaar?
2. Wat zijn preferenties en utiliteiten voor gezondheidstoestanden binnen 
 traumatisch hersenletsel en beroerte en hoe kunnen deze toegepast 
 worden? 
 a. Wat zijn de preferenties van de algemene bevolking voor ziekte 
  specifieke uitkomstmaten binnen traumatisch hersenletsel en welke 
  utiliteiten kunnen worden toegewezen aan waardensets voor   
  traumatisch hersenletsel? 
 b. Hoe kunnen waardensets en patiëntgegevens gebruikt worden om 
  utiliteiten en/of wegingsfactoren voor gezondheidstoestanden 
  binnen traumatisch hersenletsel en beroerte te bepalen?
Deel I - Vaststellen van uitkomst na traumatisch 
hersenletsel
In Hoofdstuk 2 en 3 zijn in totaal 731 patiënten met LTH geïncludeerd uit een 
prospectief observationeel cohortonderzoek uitgevoerd in Nederland. In 
Hoofdstuk 2 hebben we onderzocht hoe vier uiteenlopende classificatiemethoden 
en twee verschillende beoordelingsscores als grenswaarde voor het definiëren 
van postcommotioneel syndroom (PCS) verschillen aantonen tussen patiënten zes 
maanden na LTH. De Rivermead Post-Concussion Symptoms Questionnaire (RPQ) 
werd gebruikt om postcommotionele symptomen vast te stellen. De volgende 
classificatiemethoden zijn gebruikt om patiënten met PCS te classificeren: de RPQ 
items gelinkt aan de ICD-10 / DSM-IV criteria, de RPQ totaal score, de RPQ-3 en 
het RPQ drie-factorenmodel. We hebben PCS prevalenties gevonden variërend van 
11% tot 39%. Bovendien hebben wij geconstateerd dat een andere set risicofactoren 
statistisch significant geassocieerd is met PCS, en een verschil in overlap met 
functionele beperkingen en deze verschillen in resultaten waren allemaal afhankelijk 
van de classificatiemethoden en de gebruikte beoordelingsscore. In Hoofdstuk 
3 hebben we de associatie tussen PCS en gezondheids-gerelateerde kwaliteit 
van leven (GKvL) zes maanden na LTH beoordeeld en hebben we ook gekeken 
naar de correlatie tussen postcommotionele symptomen, gemeten door de RPQ, 
en verschillende GKvL -domeinen. GKvL is gemeten met de 36-item Short-Form 
Health Survey (SF-36) en de Perceived Quality of Life Scale (PQoL). De prevalentie 
voor patiënten met PCS was 39%, en deze patiënten hadden een significant 
lagere GKvL, b.v. lagere scores op alle SF-36-domeinen en lagere gemiddelde 
PQoL-scores. Bovendien waren alle RPQ-items negatief gecorreleerd aan alle SF-
36-domeinen en de sub schaal scores van de PQoL, wat wijst op het feit dat het 
rapporteren van problemen op de RPQ een negatief effect heeft op verschillende 
aspecten van een individu’s GKvL.
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In Hoofdstuk 4, 5 en 7 hebben wij resultaten gepresenteerd op basis van het 
Collaborative European NeuroTrauma Effectiveness Research in TBI (CENTER-
TBI) -onderzoek, een groot multicenter, prospectief observationeel longitudinaal 
cohortonderzoek uitgevoerd in Europa en Israël. In Hoofdstuk 4 en 5 hebben 
we onderscheid gemaakt tussen patiënten met gecompliceerd (intracraniële 
afwijkingen aanwezig op de computertomografie (CT)-scan) en ongecompliceerd 
(geen intracraniële afwijkingen aanwezig op de CT-scan) LTH. In Hoofdstuk 4 
hebben we het optreden van postcommotionele symptomen en PCS bij een grote 
steekproef van patiënten met gecompliceerd en ongecompliceerd LTH op drie 
en zes maanden na het letsel beoordeeld. In totaal hebben we 1302 patiënten 
met LTH die de RPQ volledig hadden ingevuld geïncludeerd. Ongeveer 46% van 
de patiënten werd geïdentificeerd met gecompliceerd LTH en deze patiënten 
rapporteerden significant meer symptomen en hadden een hogere PCS prevalentie 
vergeleken met patiënten met ongecompliceerd LTH drie en zes maanden na het 
letsel. Niettemin, nadat wij gecorrigeerd hebben voor basisvariabelen zoals leeftijd, 
geslacht, opleiding, trauma mechanisme, Glasgow Coma Score, gecompliceerd 
vs. ongecompliceerd LTH, psychiatrische voorgeschiedenis en stratum, werden 
de verschillen tussen beide patiëntengroepen minder duidelijk en gaf dit aan 
dat de associatie verklaard kon worden door differentiaties in basiskenmerken 
tussen beide groepen. In Hoofdstuk 5 hebben we de resultaten vergeleken van 
patiënten met gecompliceerd en ongecompliceerd LTH op drie en zes maanden 
na het letsel. Uitkomst is vastgesteld door middel van een multidimensionaal 
concept om patiënten te kunnen vergelijken op verschillende uitkomstniveaus: 
generieke en ziekte specifieke GKvL, functionele uitkomst en symptomatologie 
zoals posttraumatische stress, depressie en angst. In totaal zijn 1104 patiënten 
met LTH, die alle zeven beoordeelde uitkomstinstrumenten in zijn volledigheid 
hadden ingevuld, geïncludeerd in onze studie. Patiënten met gecompliceerd 
LTH rapporteerden een lagere generieke en ziekte specifieke GKvL en slechtere 
functionele uitkomst dan patiënten met ongecompliceerd LTH drie en zes maanden 
na het letsel. Desondanks werden er geen significante verschillen gevonden tussen 
de twee genoemde tijdpunten.
In Hoofdstuk 6 hebben we de frequentie van postcommotionele symptomen en 
de prevalentie en risicofactoren van PCS in de algemene populatie geëvalueerd. 
Daarnaast hebben we de relatie tussen de items van de RPQ met de zelf ervaren 
gezondheid (EQ-5D) bepaald en onderzochten we de verschillen in de algemene 
bevolking van drie Europese landen ( Italië, Nederland en het Verenigd Koninkrijk). 
We hebben een online enquête uitgevoerd om representatieve steekproeven uit 
deze drie Europese landen te verkrijgen, en in totaal hebben 11.759 respondenten 
de RPQ en EQ-5D voltooid. Het meest frequent gerapporteerde symptoom was 
vermoeidheid (50%), ongeveer de helft van de respondenten werd geclassificeerd 
met PCS en chronische gezondheidsklachten bleken een significante risicofactor 
voor PCS. Deze resultaten geven aan dat postcommotionele symptomen niet 
specifiek zijn voor patiënten met traumatisch hersenletsel en dat PCS niet 
een uniek syndroom is na traumatisch hersenletsel. Bovendien zijn positieve 
correlaties bepaald tussen alle RPQ-items en EQ-5D-dimensies- en totaal score. 
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Dit suggereerde dat postcommotionele symptomen slopend zijn en ook een groot 
effect hebben op de GKvL van mensen in de algemene bevolking.
In Hoofdstuk 7 hebben we de prevalentie en bijbehorende risicofactoren voor 
de ontwikkeling van postcommotionele symptomen en de relatie met kwaliteit van 
leven (KvL) bij pediatrische en adolescente patiënten met LTH zes maanden na 
het letsel geanalyseerd. We gebruikten gegevens van de CENTER-TBI-studie en 
includeerden 196 patiënten die de RPQ zes maanden na het letsel voltooiden. Ten 
minste één matig of ernstig symptoom van de RPQ werd door 36% van de patiënten 
ervaren en PCS was aanwezig bij 13% wanneer symptomen van ten minste matige 
ernst werden overwogen (score> 2). Het ontwikkelde voorspellingsmodel voor PCS 
wat uitsluitend klinische en demografische basisgegevens gebruikte die direct 
beschikbaar zijn op de spoedeisende hulp afdeling, identificeerde door middel van 
een regressieanalyse vrouwen/meisjes als een significante risicofactor voor PCS. 
Pediatrische patiënten met PCS hadden een lagere Kvl in vergelijking met patiënten 
zonder PCS, omdat ze significant lagere traumatisch hersenletsel gerelateerde KvL 
totaal scores hadden.
In Hoofdstuk 8 hebben we de betrouwbaarheid beoordeeld van symptomen 
die patiënten na het letsel rapporteren in vergelijking met de symptomen die 
zij na het letsel rapporteren van hoe zij er voor het letsel aan toe waren, in een 
grote en representatieve steekproef van patiënten met LTH op verschillende 
tijdstippen in het eerste jaar na het letsel. De studie bestond uit 836 patiënten 
met LTH, 191 traumapatiënten zonder voorgeschiedenis van hersenletsel en 100 
gezonde controles, waar de laatste twee groepen als controlegroepen dienden. 
Om symptomen van zowel voor als na het letsel te beoordelen, werd de Head 
Injury Symptom Checklist (HISC) gebruikt. Bijna de helft van alle patiënten met 
LTH rapporteerden hun functie voor het letsel inconsequent door de tijd heen. 
Patiënten die werden geclassificeerd met PCS na het letsel, rapporteerden hogere 
percentages symptomen vóór het letsel en waren vaker inconsequent. Patiënten 
die geclassificeerd werden met het hebben van PCS vóór het letsel hadden 
vaker psychiatrische morbiditeit en deze premorbiditeit vertoonde ook een sterke 
associatie met PCS na het letsel. 
Deel II - Preferenties voor traumatisch hersenletsel
Hoofdstuk 9 beschrijft de ontwikkeling van waardensets voor de QOLIBRI-OS en 
dit is een instrument specifiek ontwikkeld om GKvL na traumatisch hersenletsel 
te kunnen meten. In Nederland, het Verenigd Koninkrijk en Italië is een online 
waarderingsonderzoek uitgevoerd. We ontdekten dat de grootste gewichtstoename 
voor alle kenmerken van de QOLIBRI-OS wordt gezien op de levels van “licht” tot 
“helemaal niet tevreden”, wat resulteert in de grootste impact op de GKvL. Bovendien 
zou het item “Helemaal niet tevreden over hoe de hersenen werken” in alle drie de 
327
1
9
5
13
3
11
7
4
12
8
2
10
6
14
landen het grootste gewicht moeten krijgen bij de berekeningen van utiliteiten. Door 
de QOLIBRI-OS om te zetten in utiliteiten, hebben we de mogelijkheid gecreëerd 
om dit instrument te in economische evaluaties en in samenvattende metingen van 
de volksgezondheid toe te passen, die uiteindelijk weer kunnen worden gebruikt 
om beslissingen te nemen over de beste interventies en strategieën voor patiënten 
met traumatisch hersenletsel.
In Hoofdstuk 10 hebben we de impact na traumatisch hersenletsel omschreven 
door het ontwikkelen van wegingsfactoren voor de GOSE, een functioneel 
uitkomstinstrument na traumatisch hersenletsel. Hiervoor hebben we GKvL-
gegevens van patiënten met traumatisch hersenletsel gebruikt. Voor deze studie 
zijn de gegevens verkregen via het CENTER-TBI-onderzoeksproject en een totaal 
van 2.200 patiënten met traumatisch hersenletsel zijn geïncludeerd. Generieke 
GKvL werd beoordeeld met de Short Form 36-Questionnaire Health Survey versie 
2 (SF-36v2) en dit is omgezet naar de Short Form 12-Questionnaire Health Survey 
versie 2 (SF-12v2). Hierna hebben we de SF-12 drie verschillende, op voorkeur 
gebaseerde gezondheidsmetingen toegepast: de Short Form Six-Dimension (SF-
6D), EQ-5D-3L en Health Utility Index Mark 3 (HUI3). Daarna hebben we de SF-
6D-, EQ-5D- en HUI3-scores per patiënt uitgerekend. Uiteindelijk hebben we de 
volgende gemiddelde wegingsfactoren afgeleid: 0,045, 0,010, 0,008 (GOSE 8; goed 
herstel) tot 0,185, 0,142, 0,200 (GOSE 3; lagere ernstige invaliditeit), voor de SF-6D, 
EQ-5D en HUI3 respectievelijk. We hebben vastgesteld dat GKvL-wegingsfactoren 
toenemen met toenemende ernst van de GOSE. De resultaten van deze studie 
maken de evaluatie en vergelijking van ziektelast tussen landen en het meten 
van de effectiviteit van gezondheidszorg en economische evaluaties mogelijk. 
Bovendien kunnen toekomstige onderzoekers deze resultaten gebruiken bij het 
vergelijken van de ziektelast en bij het toepassen van kosteneffectiviteitsanalyses 
en beleidsvorming.
In Hoofdstuk 11 hebben we de statistische efficiëntie van een nieuwe 
patiëntgerichte uitkomstmaat in beroerteonderzoek (utility-weighted modified 
Rankin Scale (UW-mRS)) geëvalueerd en hebben we dit gedaan door middel van 
een simulatieonderzoek. Het simulatieonderzoek was gebaseerd op individuele 
gegevens van 500 patiënten uit het MR CLEAN-onderzoek, een multicenter klinisch 
onderzoek dat de effectiviteit van intra-arteriële behandeling bij ischemische 
beroerte evalueert. De lineaire analyse van de UW-mRS (power 85%) was efficiënter 
in het detecteren van behandelingseffecten dan de dichotome analyse van de mRS 
(power 71%), maar minder efficiënt dan de ordinale analyse van de mRS (power 
87%). Bovendien wordt de individuele variatie in bruikbaarheid binnen elke mRS-
categorie niet vastgelegd door de UW-mRS.
In Hoofdstuk 12 hebben we de basis gelegd het begrip GKvL na traumatisch 
hersenletsel beter te gaan begrijpen in onderzoek en in de klinische praktijk. We 
hebben populatie-gebaseerde normen opgesteld op basis van representatieve 
steekproeven uit de algemene bevolking in het Verenigd Koninkrijk en Nederland, 
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en steekproeven van patiënten met traumatisch hersenletsel uit het Verenigd 
Koninkrijk en Nederland zijn gebruikt als referentie. Gegevens voor de algemene 
populatie zijn verkregen via een online enquête en CENTER-TBI-gegevens zijn 
gebruikt voor de traumatisch hersenletsel patiënten. De QOLIBRI vertoonde goede 
psychometrische eigenschappen in de steekproeven van de algemene populatie 
en de gemeten invariantie werd aangetoond in alle landen en in steekproeven 
van de traumatisch hersenletsel patiënten en de algemene bevolking. De GkvL 
van individuen met traumatisch hersenletsel verschilt drie maanden na het letsel 
niet significant van de beoordeelde GKvL in de algemene bevolking. Factoren die 
na het hersenletsel opspelen, zoals functionele ongemakken en symptomen van 
emotionele stoornis beïnvloeden GKvL negatief. 
Discussie
Het doel van dit proefschrift is het uitbreiden van onze kennis over het vaststellen 
van de uitkomsten na traumatisch hersenletsel, en het meten van de preferenties 
voor traumatisch hersenletsel en beroerte bij patiënten en de algemene bevolking.
Ondanks dat er een overvloed aan onderzoek gedaan wordt, is er momenteel 
geen gouden standaard voor het gebruik en de analyse van instrumenten die 
postcommotionele symptomen beoordelen. Niet alleen dat, ook een eenduidige 
en universele classificatie van PCS ontbreekt. Dit leidt tot grote variatie in 
gerapporteerde prevalentiecijfers, inconsistenties, onvergelijkbare uitkomsten 
en belemmert onderzoek en therapie. Utiliteiten en wegingsfactoren, populatie-
gebaseerde normen en waardensets zijn momenteel niet beschikbaar voor alle 
generieke en ziekte specifieke uitkomstmaten na traumatisch hersenletsel, wat het 
gebruik van deze instrumenten in economische evaluaties beperkt.
In dit proefschrift hebben wij geconcludeerd dat de prevalentiecijfers voor 
postcommotionele symptomen en PCS sterk fluctueerden, afhankelijk van de 
populatie, case-mix van de geïncludeerde patiënten, setting, meetinstrument en 
diagnostische criteria en toegepaste classificatiemethoden. Bovendien, aangezien 
we hoge prevalenties van postcommotionele symptomen bij volwassen en 
pediatrische patiënten zes maanden na het letsel hebben gevonden, kunnen we 
concluderen dat LTH maanden na het ongeluk nog steeds een rol kan spelen in 
alle aspecten van het leven. De uitkomst na LTH is multidimensionaal en wordt 
gekenmerkt door een moeilijke interactie tussen biologische, psychologische en 
sociale factoren en beïnvloedt elk individu anders.
Het genereren van utiliteiten en wegingsfactoren voor ziekte specifieke GKvL-
instrumenten maakt de evaluatie en vergelijking van ziektelast tussen landen en het 
meten van de effectiviteit van de gezondheidszorg mogelijk. Bovendien kan dit ook 
toegepast worden in economische evaluaties en gebruikt worden in samenvattende 
metingen van de volksgezondheid.
Gebaseerd op de interpretatie van de belangrijkste resultaten van de studies 
die in dit proefschrift zijn opgenomen, hebben we specifieke aanbevelingen 
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voor toekomstig onderzoek, beleid en de klinische praktijk geformuleerd. Deze 
aanbevelingen bevatten het volgende: één universele richtlijn met betrekking 
tot definities, classificatiemethoden en terminologie voor postcommotionele 
symptomen en PCS, en onderzoekers moeten duidelijk beschrijven hoe een 
meetinstrument gebruikt moet worden/is en vooral voor de RPQ welke afkappunten 
gebruikt zijn. Bovendien moet de uitkomst na traumatisch hersenletsel beoordeeld 
worden door middel van een multidimensionale benadering, waar klinische 
uitkomst, GKvL en symptomatologie allemaal aan bod komen, en we raden aan om 
de mogelijkheden voor gepersonaliseerde interventiestrategieën te onderzoeken. 
Voor onderzoek naar preferenties voor traumatisch hersenletsel raden we aan om 
een overzicht te creëren omtrent de ontwikkeling van waardensets en dit samen te 
vatten in een systematische review. Daarnaast moet er een universele richtlijn met 
beoordelingscriteria ontwikkeld worden om verschillende meetinstrumenten, die 
utiliteiten genereren, te kunnen vergelijken. Voor de klinische praktijk raden we een 
uitgebreid multidimensionaal onderzoek aan waarbij patiënten worden geëvalueerd 
op postcommotionele symptomen door een combinatie van een klinische evaluatie 
en de patiënt die zelf een vragenlijst invult. Dit alles om rekening te houden met 
patiënt specifieke situaties en om het revalidatietraject aan te kunnen passen aan 
het individu.
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Dankwoord
Door middel van dit dankwoord wil ik graag de mensen bedanken die bijgedragen 
hebben bij de totstandkoming van dit proefschrift. Ik heb buitengewoon veel 
geleerd en hele leuke dingen mogen meemaken. Hartelijk dank aan allen met wie 
ik het genoegen heb gehad om samen te werken, maar ik niet bij naam heb kunnen 
noemen. 
Om te beginnen natuurlijk, Ewout. Dat je mij, nadat ik in het 2de ronde gesprek 
op de vraag: “Wat vind je van deze R2?” antwoordde: “Ja, wel prima”, nog steeds 
hebt aangenomen is een waar wonder. Jouw rol tijdens mijn gehele promotietraject 
was misschien iets meer op de achtergrond, maar toch lukte het je altijd weer om 
een “Steyerberg-sausje” over mijn artikelen te gieten, zelfs als het onderwerp niet 
helemaal jouw expertise was. Ik kan ontzettend met je lachen en bewonder jouw 
intelligentie. 
Suzanne, ontzettend bedankt dat jij vanaf het begin in mij geloofd hebt en mij de 
kans geboden hebt om promoveren te combineren met tophockey. Gebonden door 
onze topsport-mind en onze hunkering naar organisatorisch overzicht, zaten we 
al snel op een lijn. Bedankt dat je de lat altijd hoog hebt gelegd en mij tot nieuwe 
hoogtes hebt willen pushen. Af en toe heb jij mij tot een halt moeten roepen, omdat 
ik alles leuk vind, maar jij hebt mij laten inzien dat prioriteren een erg handige 
eigenschap is om te hebben ;).  
Juanita, wat heb jij veel van mij moeten aanhoren de afgelopen jaren. Al die verhalen 
over al dat sporten, terwijl jij hier zelf helemaal niks mee hebt. Ik heb mij vanaf 
moment één op mijn gemak gevoeld bij jou door jouw oprechte interesse in mij als 
persoon. Je moest er even aan wennen, deadlines stellen etc., maar uiteindelijk wist 
je precies hoe je mij kon triggeren, en dit gebeurde dan ook altijd met de nodige 
dosis humor. Jij hebt mij een fantastisch mooi voorbeeld laten zien over hoe ik 
mijzelf ook hoop te profileren binnen de academische wereld.
Hester, bedankt voor het lachen en een luisterend oor, ook al was je niet een van 
mijn copromotoren, dit voelde soms wel zo! 
Vervolgens gaat mijn dank uit naar de leden van de promotiecommissie voor het 
lezen en beoordelen van mijn proefschrift en het zitting nemen in de commissie. 
Mijn MGZ-besties, Branko, Robbin (oftewel Lobbin) en Laura. Wat hebben wij 
een leuke tijd gehad samen op MGZ. Als laatste sloot ik mij aan bij dit zooitje 
ongeregeld, maar vanaf dag één hebben jullie mij welkom doen voelen. Van 
heerlijke klaagsessies, samen naar de Parade, tot uren intranet reacties lezen, het 
was altijd een dolle boel. 
Inge, Lotte, Sandra en Marjolein, ook al is het jullie niet gelukt om mij officieel lid te 
krijgen van de traploop groep, ik heb altijd erg genoten van onze lunch momentjes 
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en sectie/afdelingsuitjes.
Lieve CENTER-TBI collega’s: Jilske, Ernest, Eveline, Ana, Dana, Isabel, Victor en 
Kelly, het was een waar genoegen om met jullie samen op zo’n mooi project te 
mogen werken. Bedankt voor het sparren over analyses en onderwerpen, maar 
bovenal de gezellige momenten buiten het werk om.
Wat was ik een bofkont, want ik was onderdeel van twee secties: D&I en CMB, allen 
bedankt voor de samenwerking en de gezelligheid.
Furthermore, I would like to thank all my coauthors. Special thanks to Simone, 
Lennart, Anastasia, Marina and Mark. Beste Mark, zonder jou was hoofdstuk 9 er 
nooit, maar dan ook nooit gekomen. Bedankt voor al je tijd en je tomeloze geduld!  
Subsequently, I would like to thank all CENTER-TBI investigators and participants. It 
has been an absolute delight and huge honor to have been involved in a project of 
this magnitude and to collaborate with researchers and clinicians from all over the 
world. In addition, I would like to express my gratitude towards Andrew. Bedankt 
dat je altijd de tijd hebt genomen om met jouw kritische blik echt naar mijn stukken 
te kijken en ze naar een hoger plan te tillen. Special thanks to Nicole and Lindsay, 
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